aromatic carboxylate - Ontology Report - Rat Genome Database

Submit Data | Help | Video Tutorials | News | Publications | Download | REST API | Citing RGD | Contact

CHEBI ONTOLOGY - ANNOTATIONS

{{ watchLinkText }}

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.

Term:	aromatic carboxylate	go back to main search page
Accession:	CHEBI:91007	browse the term
Definition:	A carboxylic acic anion obtained by deprotonation of the carboxy group of any aromatic carboxylic acid. Major species at pH 7.3.
Synonyms:	related_synonym:	Formula=CO2R; SMILES=*C([O-])=O; an aromatic carboxylate
	cyclic_relationship:	is_conjugate_base_of CHEBI:33859

show annotations for term's descendants Sort by:
Rat (1275) Mouse (1287) Human (1341) Chinchilla (0) Bonobo (0) Dog (0) Squirrel (0) Pig (1) Green Monkey (0) Naked Mole-rat (0) All
Genes (1341)

3,4-dihydroxybenzoate

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

endothelial PAS domain protein 1

increases expression
multiple interactions

3,4-dihydroxybenzoate results in increased expression of EPAS1 mRNA
[3,4-dihydroxybenzoate co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of EPAS1 mRNA

NCBI chr 2:46,297,407...46,386,697
Ensembl chr 2:46,293,667...46,386,697

G

hypoxia inducible factor 1 subunit alpha

increases expression
affects localization
multiple interactions

3,4-dihydroxybenzoate results in increased expression of HIF1A mRNA
3,4-dihydroxybenzoate affects the localization of HIF1A protein
[3,4-dihydroxybenzoate co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine metabolite] affects the localization of HIF1A protein
[3,4-dihydroxybenzoate co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of HIF1A mRNA

NCBI chr14:61,695,513...61,748,258
Ensembl chr14:61,695,513...61,748,259

G

heme oxygenase 1

multiple interactions
increases expression

[3,4-dihydroxybenzoate co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of HMOX1 mRNA; [3,4-dihydroxybenzoate co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of HMOX1 protein
3,4-dihydroxybenzoate results in increased expression of HMOX1 mRNA; 3,4-dihydroxybenzoate results in increased expression of HMOX1 protein

NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214

G

solute carrier family 40 member 1

multiple interactions

3,4-dihydroxybenzoate inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of SLC40A1 protein]

NCBI chr 2:189,560,590...189,580,786
Ensembl chr 2:189,560,590...189,583,758

G

superoxide dismutase 2

multiple interactions
increases expression

[3,4-dihydroxybenzoate co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of SOD2 protein
3,4-dihydroxybenzoate results in increased expression of SOD2 protein

NCBI chr 6:159,669,069...159,762,281
Ensembl chr 6:159,669,069...159,762,529

benzoates

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

adenosylhomocysteinase

decreases expression

Benzoates analog results in decreased expression of AHCY mRNA

NCBI chr20:34,231,981...34,311,836
Ensembl chr20:34,280,268...34,311,802

G

aryl hydrocarbon receptor

decreases expression

Benzoates analog results in decreased expression of AHR mRNA

NCBI chr 7:17,298,652...17,346,147
Ensembl chr 7:16,916,359...17,346,152

G

activated leukocyte cell adhesion molecule

decreases expression

Benzoates analog results in decreased expression of ALCAM mRNA

NCBI chr 3:105,366,909...105,576,900
Ensembl chr 3:105,366,909...105,576,900

G

annexin A4

decreases expression

Benzoates analog results in decreased expression of ANXA4 mRNA

NCBI chr 2:69,643,808...69,827,112
Ensembl chr 2:69,644,425...69,827,112

G

basic leucine zipper ATF-like transcription factor 3

increases expression

Benzoates analog results in increased expression of BATF3 mRNA

NCBI chr 1:212,686,417...212,699,840
Ensembl chr 1:212,686,417...212,699,840

G

BCL2 apoptosis regulator

decreases expression

Benzoates analog results in decreased expression of BCL2 mRNA

NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128

G

bone morphogenetic protein 2

decreases expression

Benzoates analog results in decreased expression of BMP2 mRNA

NCBI chr20:6,767,686...6,780,246
Ensembl chr20:6,767,686...6,780,246

G

capping actin protein, gelsolin like

decreases expression

Benzoates analog results in decreased expression of CAPG mRNA

NCBI chr 2:85,391,602...85,419,540
Ensembl chr 2:85,394,753...85,418,432

G

caspase 3

decreases expression
increases expression

Benzoates analog results in decreased expression of CASP3 mRNA
Benzoates analog results in increased expression of CASP3 protein modified form

NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062

G

cyclin D2

decreases expression

Benzoates analog results in decreased expression of CCND2 mRNA

NCBI chr12:4,273,762...4,305,353
Ensembl chr12:4,269,771...4,305,353

G

cyclin D3

decreases expression

Benzoates analog results in decreased expression of CCND3 mRNA

NCBI chr 6:41,934,933...42,050,035
Ensembl chr 6:41,934,934...42,050,357

G

cyclin E1

decreases expression

Benzoates analog results in decreased expression of CCNE1 mRNA

NCBI chr19:29,811,991...29,824,312
Ensembl chr19:29,811,991...29,824,312

G

CD44 molecule (IN blood group)

affects expression

Benzoates analog affects the expression of CD44 mRNA

NCBI chr11:35,139,171...35,232,402
Ensembl chr11:35,138,882...35,232,402

G

CD48 molecule

increases expression

Benzoates analog results in increased expression of CD48 mRNA

NCBI chr 1:160,678,746...160,711,822
Ensembl chr 1:160,678,746...160,711,831

G

CD81 molecule

decreases expression

Benzoates analog results in decreased expression of CD81 mRNA

NCBI chr11:2,376,180...2,397,397
Ensembl chr11:2,376,177...2,397,802

G

CDC42 small effector 2

decreases expression

Benzoates analog results in decreased expression of CDC42SE2 mRNA

NCBI chr 5:131,210,052...131,394,672
Ensembl chr 5:131,245,493...131,398,447

G

cell division cycle 6

decreases expression

Benzoates analog results in decreased expression of CDC6 mRNA

NCBI chr17:40,287,879...40,304,657
Ensembl chr17:40,287,879...40,304,657

G

cytokine inducible SH2 containing protein

increases expression

Benzoates analog results in increased expression of CISH mRNA

NCBI chr 3:50,606,489...50,611,774
Ensembl chr 3:50,606,489...50,611,774

G

cytoskeleton associated protein 4

increases expression

Benzoates analog results in increased expression of CKAP4 mRNA

NCBI chr12:106,237,881...106,248,020
Ensembl chr12:106,237,881...106,304,279

G

colony stimulating factor 1

increases expression

Benzoates analog results in increased expression of CSF1 mRNA

NCBI chr 1:109,910,506...109,930,992
Ensembl chr 1:109,910,242...109,930,992

G

cystatin F

increases expression

Benzoates analog results in increased expression of CST7 mRNA

NCBI chr20:24,949,269...24,959,928
Ensembl chr20:24,949,269...24,959,928

G

cathepsin Z

increases expression

Benzoates analog results in increased expression of CTSZ mRNA

NCBI chr20:58,995,185...59,007,254
Ensembl chr20:58,985,686...59,008,238

G

C-X-C motif chemokine ligand 10

increases expression

Benzoates analog results in increased expression of CXCL10 mRNA

NCBI chr 4:76,021,118...76,023,497
Ensembl chr 4:76,021,118...76,023,497

G

C-X-C motif chemokine ligand 2

increases expression
decreases expression

Benzoates results in increased expression of CXCL2 protein
Benzoates results in decreased expression of CXCL2 protein

NCBI chr 4:74,097,040...74,099,195
Ensembl chr 4:74,097,040...74,099,196

G

cytoplasmic FMR1 interacting protein 1

decreases expression

Benzoates analog results in decreased expression of CYFIP1 mRNA

NCBI chr15:22,867,052...22,980,898
Ensembl chr15:22,867,052...22,981,063

G

decapping enzyme, scavenger

decreases expression

Benzoates analog results in decreased expression of DCPS mRNA

NCBI chr11:126,304,060...126,350,005
Ensembl chr11:126,304,060...126,350,005

G

DENN domain containing 5A

increases expression

Benzoates analog results in increased expression of DENND5A mRNA

NCBI chr11:9,138,825...9,265,350
Ensembl chr11:9,138,825...9,265,959

G

dehydrogenase/reductase 3

decreases expression

Benzoates analog results in decreased expression of DHRS3 mRNA

NCBI chr 1:12,567,910...12,618,210
Ensembl chr 1:12,567,910...12,618,210

G

extracellular matrix protein 1

decreases expression

Benzoates analog results in decreased expression of ECM1 mRNA

NCBI chr 1:150,508,109...150,513,789
Ensembl chr 1:150,508,062...150,513,789

G

EEF1A lysine methyltransferase 1

decreases expression

Benzoates analog results in decreased expression of EEF1AKMT1 mRNA

NCBI chr13:20,728,731...20,773,961
Ensembl chr13:20,728,731...20,773,961

G

epithelial membrane protein 1

increases expression

Benzoates analog results in increased expression of EMP1 mRNA

NCBI chr12:13,196,726...13,219,941
Ensembl chr12:13,196,723...13,219,941

G

estrogen receptor 1

increases activity

Benzoates results in increased activity of ESR1 protein

NCBI chr 6:151,656,672...152,129,619
Ensembl chr 6:151,656,691...152,129,619

G

ETS variant transcription factor 4

decreases expression

Benzoates analog results in decreased expression of ETV4 mRNA

NCBI chr17:43,527,846...43,546,340
Ensembl chr17:43,527,844...43,579,620

G

fumarylacetoacetate hydrolase

increases expression

Benzoates analog results in increased expression of FAH mRNA

NCBI chr15:80,152,789...80,186,949
Ensembl chr15:80,152,490...80,186,946

G

fibrinogen like 2

decreases expression

Benzoates analog results in decreased expression of FGL2 mRNA

NCBI chr 7:77,193,369...77,199,819
Ensembl chr 7:77,193,369...77,199,848

G

fms related receptor tyrosine kinase 3

increases response to substance

FLT3 protein mutant form results in increased susceptibility to Benzoates analog

NCBI chr13:28,003,274...28,100,576
Ensembl chr13:28,003,274...28,100,592

G

GABA type A receptor associated protein like 1

increases expression

Benzoates analog results in increased expression of GABARAPL1 mRNA

NCBI chr12:10,212,877...10,223,128
Ensembl chr12:10,212,458...10,223,128

G

growth arrest and DNA damage inducible beta

increases expression

Benzoates analog results in increased expression of GADD45B mRNA

NCBI chr19:2,476,127...2,478,257
Ensembl chr19:2,476,122...2,478,259

G

galactose mutarotase

decreases expression

Benzoates analog results in decreased expression of GALM mRNA

NCBI chr 2:38,666,114...38,734,765
Ensembl chr 2:38,666,081...38,741,237

G

guanylate binding protein 4

decreases expression

Benzoates analog results in decreased expression of GBP4 mRNA

NCBI chr 1:89,181,144...89,198,942
Ensembl chr 1:89,181,144...89,198,942

G

growth hormone 1

multiple interactions

Benzoates analog inhibits the reaction [GH protein promotes the reaction [STAT5A protein binds to STAT5A protein]]; Benzoates analog inhibits the reaction [GH protein results in increased phosphorylation of STAT5A protein]

NCBI chr17:63,917,203...63,918,839
Ensembl chr17:63,917,200...63,918,839

G

glycerol-3-phosphate dehydrogenase 1

multiple interactions

[INS1 protein co-treated with Benzoates] results in increased activity of GPD1 protein

NCBI chr12:50,104,008...50,111,313
Ensembl chr12:50,103,982...50,111,313

G

glutathione peroxidase 4

decreases expression

Benzoates analog results in decreased expression of GPX4 mRNA

NCBI chr19:1,103,994...1,106,779
Ensembl chr19:1,103,982...1,106,791

G

glutamate ionotropic receptor AMPA type subunit 1

multiple interactions

Benzoates analog binds to and results in decreased activity of GRIA1 protein

NCBI chr 5:153,489,615...153,813,869
Ensembl chr 5:153,489,615...153,813,869

G

glutamate ionotropic receptor AMPA type subunit 2

multiple interactions

Benzoates analog binds to and results in decreased activity of GRIA2 protein

NCBI chr 4:157,220,120...157,366,075
Ensembl chr 4:157,204,182...157,387,146

G

glutamate ionotropic receptor AMPA type subunit 3

multiple interactions

Benzoates analog binds to and results in decreased activity of GRIA3 protein

NCBI chr X:123,184,278...123,490,915
Ensembl chr X:123,184,153...123,490,915

G

glutamate ionotropic receptor AMPA type subunit 4

multiple interactions

Benzoates analog binds to and results in decreased activity of GRIA4 protein

NCBI chr11:105,609,616...105,982,090
Ensembl chr11:105,609,535...105,982,090

G

glutamate ionotropic receptor kainate type subunit 1

multiple interactions

Benzoates analog binds to and results in decreased activity of GRIK1 protein

NCBI chr21:29,536,933...29,939,996
Ensembl chr21:29,536,933...29,940,033

G

glutamate ionotropic receptor kainate type subunit 2

multiple interactions

Benzoates analog binds to and results in decreased activity of GRIK2 protein

NCBI chr 6:101,393,708...102,070,083
Ensembl chr 6:100,962,701...102,081,622

G

glutathione S-transferase omega 1

decreases expression

Benzoates analog results in decreased expression of GSTO1 mRNA

NCBI chr10:104,254,173...104,267,455
Ensembl chr10:104,235,356...104,267,459

G

hexokinase 2

decreases expression

Benzoates analog results in decreased expression of HK2 mRNA

NCBI chr 2:74,834,127...74,893,359
Ensembl chr 2:74,834,127...74,893,359

G

interferon induced transmembrane protein 3

decreases expression

Benzoates analog results in decreased expression of IFITM3 mRNA

NCBI chr11:319,676...320,860
Ensembl chr11:319,676...329,475

G

interferon gamma receptor 1

increases expression

Benzoates analog results in increased expression of IFNGR1 mRNA

NCBI chr 6:137,197,484...137,219,385
Ensembl chr 6:137,197,483...137,219,449

G

interleukin 10 receptor subunit alpha

decreases expression

Benzoates analog results in decreased expression of IL10RA mRNA

NCBI chr11:117,986,394...118,003,037
Ensembl chr11:117,986,370...118,003,037

G

interleukin 1 alpha

increases expression

Benzoates results in increased expression of IL1A protein

NCBI chr 2:112,773,925...112,784,493
Ensembl chr 2:112,773,925...112,784,493

G

interleukin 2 receptor subunit beta

increases expression

Benzoates analog results in increased expression of IL2RB mRNA

NCBI chr22:37,125,838...37,175,118
Ensembl chr22:37,118,666...37,175,118

G

interleukin 3

multiple interactions

Benzoates analog inhibits the reaction [IL3 protein results in increased activity of STAT5A protein]

NCBI chr 5:132,060,655...132,063,204
Ensembl chr 5:132,060,655...132,063,204

G

interleukin 4 receptor

decreases expression

Benzoates analog results in decreased expression of IL4R mRNA

NCBI chr16:27,313,756...27,364,778
Ensembl chr16:27,313,668...27,364,778

G

interleukin 6

multiple interactions

Benzoates analog inhibits the reaction [IL6 protein results in increased activity of STAT3 protein]

NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002

G

INS-IGF2 readthrough

multiple interactions

[INS1 protein co-treated with Benzoates] results in increased activity of GPD1 protein

NCBI chr11:2,129,117...2,161,209
Ensembl chr11:2,132,538...2,161,209

G

interferon regulatory factor 4

decreases expression

Benzoates analog results in decreased expression of IRF4 mRNA

NCBI chr 6:391,752...411,443
Ensembl chr 6:391,739...411,443

G

interferon regulatory factor 8

decreases expression

Benzoates analog results in decreased expression of IRF8 mRNA

NCBI chr16:85,899,162...85,922,609
Ensembl chr16:85,899,116...85,922,606

G

integrin subunit alpha 6

decreases expression

Benzoates analog results in decreased expression of ITGA6 mRNA

NCBI chr 2:172,427,336...172,506,459
Ensembl chr 2:172,427,354...172,506,459

G

KLF transcription factor 6

increases expression

Benzoates analog results in increased expression of KLF6 mRNA

NCBI chr10:3,775,996...3,785,209
Ensembl chr10:3,775,996...3,785,281

G

LIF interleukin 6 family cytokine

decreases expression

Benzoates analog results in decreased expression of LIF mRNA

NCBI chr22:30,240,453...30,246,759
Ensembl chr22:30,240,453...30,246,759

G

mitogen-activated protein kinase kinase kinase 8

increases expression

Benzoates analog results in increased expression of MAP3K8 mRNA

NCBI chr10:30,434,021...30,461,833
Ensembl chr10:30,434,021...30,461,833

G

MAPK activated protein kinase 2

decreases expression

Benzoates analog results in decreased expression of MAPKAPK2 mRNA

NCBI chr 1:206,684,905...206,734,281
Ensembl chr 1:206,684,905...206,734,281

G

marker of proliferation Ki-67

decreases expression

Benzoates analog results in decreased expression of MKI67 protein

NCBI chr10:128,096,659...128,126,423
Ensembl chr10:128,096,659...128,126,423

G

MAX dimerization protein 1

increases expression

Benzoates analog results in increased expression of MXD1 mRNA

NCBI chr 2:69,915,109...69,942,945
Ensembl chr 2:69,897,688...69,942,945

G

MYC proto-oncogene, bHLH transcription factor

decreases expression

Benzoates analog results in decreased expression of MYC mRNA

NCBI chr 8:127,735,434...127,742,951
Ensembl chr 8:127,735,434...127,742,951

G

myosin IC

affects expression

Benzoates analog affects the expression of MYO1C mRNA

NCBI chr17:1,464,186...1,492,686
Ensembl chr17:1,464,186...1,492,686

G

nuclear receptor coactivator 3

increases expression

Benzoates analog results in increased expression of NCOA3 mRNA

NCBI chr20:47,501,887...47,656,872
Ensembl chr20:47,501,887...47,656,877

G

neuronal calcium sensor 1

decreases expression

Benzoates analog results in decreased expression of NCS1 mRNA

NCBI chr 9:130,172,404...130,237,303
Ensembl chr 9:130,172,404...130,237,303

G

N-myc downstream regulated 1

increases expression

Benzoates analog results in increased expression of NDRG1 mRNA

NCBI chr 8:133,237,175...133,297,252
Ensembl chr 8:133,237,175...133,302,022

G

nuclear factor, interleukin 3 regulated

increases expression

Benzoates analog results in increased expression of NFIL3 mRNA

NCBI chr 9:91,409,045...91,483,497
Ensembl chr 9:91,409,045...91,423,832

G

NFKB inhibitor zeta

increases expression

Benzoates analog results in increased expression of NFKBIZ mRNA

NCBI chr 3:101,827,990...101,861,022
Ensembl chr 3:101,827,991...101,861,022

G

NOP2 nucleolar protein

decreases expression

Benzoates analog results in decreased expression of NOP2 mRNA

NCBI chr12:6,556,871...6,568,291
Ensembl chr12:6,556,863...6,568,691

G

ornithine decarboxylase 1

decreases expression

Benzoates analog results in decreased expression of ODC1 mRNA

NCBI chr 2:10,439,968...10,448,327
Ensembl chr 2:10,439,968...10,448,327

G

purinergic receptor P2X 4

increases expression

Benzoates analog results in increased expression of P2RX4 mRNA

NCBI chr12:121,210,129...121,234,106
Ensembl chr12:121,210,065...121,234,106

G

prolyl 4-hydroxylase subunit alpha 1

increases expression

Benzoates analog results in increased expression of P4HA1 mRNA

NCBI chr10:73,007,217...73,096,866
Ensembl chr10:73,007,217...73,096,974

G

poly(ADP-ribose) polymerase 1

increases cleavage

Benzoates analog results in increased cleavage of PARP1 protein

NCBI chr 1:226,360,691...226,408,093
Ensembl chr 1:226,360,210...226,408,154

G

platelet derived growth factor receptor beta

decreases expression

Benzoates analog results in decreased expression of PDGFRB protein

NCBI chr 5:150,113,839...150,155,845
Ensembl chr 5:150,113,839...150,155,872

G

pleckstrin homology like domain family A member 1

decreases expression

Benzoates analog results in decreased expression of PHLDA1 mRNA

NCBI chr12:76,025,447...76,031,776
Ensembl chr12:76,025,447...76,031,776

G

putative homeodomain transcription factor 2

decreases expression

Benzoates analog results in decreased expression of PHTF2 mRNA

NCBI chr 7:77,798,773...77,957,504
Ensembl chr 7:77,798,773...77,957,503

G

Pim-1 proto-oncogene, serine/threonine kinase

decreases expression

Benzoates analog results in decreased expression of PIM1 mRNA

NCBI chr 6:37,170,152...37,175,428
Ensembl chr 6:37,170,152...37,175,428

G

perilipin 2

increases expression

Benzoates analog results in increased expression of PLIN2 mRNA

NCBI chr 9:19,108,388...19,127,492
Ensembl chr 9:19,108,375...19,149,290

G

phospholipid scramblase 1

increases expression

Benzoates analog results in increased expression of PLSCR1 mRNA

NCBI chr 3:146,515,180...146,544,607
Ensembl chr 3:146,515,180...146,544,856

G

purine nucleoside phosphorylase

decreases expression

Benzoates analog results in decreased expression of PNP mRNA

NCBI chr14:20,469,406...20,477,089
Ensembl chr14:20,461,992...20,477,094

G

prion protein (Kanno blood group)

increases expression

Benzoates analog results in increased expression of PRNP mRNA

NCBI chr20:4,686,456...4,701,588
Ensembl chr20:4,686,350...4,701,590

G

patched 1

increases expression

Benzoates analog results in increased expression of PTCH1 mRNA

NCBI chr 9:95,442,980...95,516,971
Ensembl chr 9:95,442,980...95,517,057

G

peptidyl-tRNA hydrolase 2

decreases expression

Benzoates analog results in decreased expression of PTRH2 mRNA

NCBI chr17:59,697,308...59,707,430
Ensembl chr17:59,674,636...59,707,626

G

pseudouridine synthase 1

decreases expression

Benzoates analog results in decreased expression of PUS1 mRNA

NCBI chr12:131,929,276...131,945,896
Ensembl chr12:131,929,200...131,945,896

G

RAB GTPase activating protein 1 like

increases expression

Benzoates analog results in increased expression of RABGAP1L mRNA

NCBI chr 1:174,159,520...174,995,308
Ensembl chr 1:174,159,410...174,995,308

G

regulator of G protein signaling 16

affects expression

Benzoates analog affects the expression of RGS16 mRNA

NCBI chr 1:182,598,623...182,604,389
Ensembl chr 1:182,598,623...182,604,389

G

ras homolog family member H

increases expression

Benzoates analog results in increased expression of RHOH mRNA

NCBI chr 4:40,191,080...40,246,967
Ensembl chr 4:40,191,011...40,246,967

G

Ras related GTP binding D

increases expression

Benzoates analog results in increased expression of RRAGD mRNA

NCBI chr 6:89,364,616...89,412,273
Ensembl chr 6:89,364,616...89,412,273

G

SH3 domain binding glutamate rich protein like 2

increases expression

Benzoates analog results in increased expression of SH3BGRL2 mRNA

NCBI chr 6:79,537,633...79,703,655
Ensembl chr 6:79,631,329...79,703,655

G

solute carrier family 1 member 5

increases expression

Benzoates analog results in increased expression of SLC1A5 mRNA

NCBI chr19:46,774,883...46,788,594
Ensembl chr19:46,774,883...46,788,594

G

solute carrier family 2 member 3

increases expression

Benzoates analog results in increased expression of SLC2A3 mRNA

NCBI chr12:7,919,230...7,936,187
Ensembl chr12:7,919,230...8,019,007

G

solute carrier family 39 member 8

decreases expression

Benzoates analog results in decreased expression of SLC39A8 mRNA

NCBI chr 4:102,251,041...102,345,482
Ensembl chr 4:102,251,080...102,431,258

G

sphingomyelin phosphodiesterase acid like 3A

increases expression

Benzoates analog results in increased expression of SMPDL3A mRNA

NCBI chr 6:122,789,258...122,809,720
Ensembl chr 6:122,789,049...122,809,720

G

sorting nexin 9

increases expression

Benzoates analog results in increased expression of SNX9 mRNA

NCBI chr 6:157,823,246...157,945,077
Ensembl chr 6:157,700,387...157,945,077

G

suppressor of cytokine signaling 2

increases expression

Benzoates analog results in increased expression of SOCS2 mRNA

NCBI chr12:93,569,969...93,626,236
Ensembl chr12:93,569,814...93,583,487

G

sprouty related EVH1 domain containing 2

decreases expression

Benzoates analog results in decreased expression of SPRED2 mRNA

NCBI chr 2:65,307,175...65,432,599
Ensembl chr 2:65,310,851...65,432,637

G

ST3 beta-galactoside alpha-2,3-sialyltransferase 4

affects expression

Benzoates analog affects the expression of ST3GAL4 mRNA

NCBI chr11:126,355,686...126,414,638
Ensembl chr11:126,355,640...126,440,344

G

signal transducer and activator of transcription 3

multiple interactions

Benzoates analog inhibits the reaction [IL6 protein results in increased activity of STAT3 protein]

NCBI chr17:42,313,324...42,388,442
Ensembl chr17:42,313,324...42,388,568

G

signal transducer and activator of transcription 5A

multiple interactions
decreases phosphorylation

Benzoates analog inhibits the reaction [GH protein promotes the reaction [STAT5A protein binds to STAT5A protein]]; Benzoates analog inhibits the reaction [GH protein results in increased phosphorylation of STAT5A protein]; Benzoates analog inhibits the reaction [IL3 protein results in increased activity of STAT5A protein]
Benzoates analog results in decreased phosphorylation of STAT5A protein

NCBI chr17:42,287,439...42,311,943
Ensembl chr17:42,287,547...42,311,943

G

signal transducer and activator of transcription 5B

multiple interactions

Benzoates analog binds to and results in decreased phosphorylation of STAT5B protein

NCBI chr17:42,199,177...42,288,370
Ensembl chr17:42,199,176...42,288,633

G

switching B cell complex subunit SWAP70

increases expression

Benzoates analog results in increased expression of SWAP70 mRNA

NCBI chr11:9,664,077...9,752,993
Ensembl chr11:9,664,077...9,752,993

G

synaptotagmin 11

increases expression

Benzoates analog results in increased expression of SYT11 mRNA

NCBI chr 1:155,859,567...155,885,199
Ensembl chr 1:155,859,567...155,885,199

G

transglutaminase 2

decreases expression

Benzoates analog results in decreased expression of TGM2 mRNA

NCBI chr20:38,127,385...38,168,475
Ensembl chr20:38,127,385...38,166,578

G

TIAM Rac1 associated GEF 1

decreases expression

Benzoates analog results in decreased expression of TIAM1 mRNA

NCBI chr21:31,118,418...31,559,087
Ensembl chr21:31,118,416...31,559,977

G

TNF receptor superfamily member 1B

decreases expression

Benzoates analog results in decreased expression of TNFRSF1B mRNA

NCBI chr 1:12,166,991...12,209,220
Ensembl chr 1:12,166,991...12,209,228

G

TNF receptor superfamily member 21

decreases expression

Benzoates analog results in decreased expression of TNFRSF21 mRNA

NCBI chr 6:47,231,532...47,309,905
Ensembl chr 6:47,231,532...47,309,905

G

TNF receptor associated factor 1

increases expression

Benzoates analog results in increased expression of TRAF1 mRNA

NCBI chr 9:120,902,393...120,929,171
Ensembl chr 9:120,902,393...120,929,173

G

tetratricopeptide repeat domain 39B

increases expression

Benzoates analog results in increased expression of TTC39B mRNA

NCBI chr 9:15,163,622...15,307,216
Ensembl chr 9:15,163,622...15,307,360

G

uridine-cytidine kinase 2

decreases expression

Benzoates analog results in decreased expression of UCK2 mRNA

NCBI chr 1:165,827,614...165,911,618
Ensembl chr 1:165,827,614...165,911,618

G

uridine monophosphate synthetase

decreases expression

Benzoates analog results in decreased expression of UMPS mRNA

NCBI chr 3:124,730,452...124,749,273
Ensembl chr 3:124,730,433...124,749,273

G

X-box binding protein 1

increases expression

Benzoates analog results in increased expression of XBP1 mRNA

NCBI chr22:28,794,560...28,800,569
Ensembl chr22:28,794,555...28,800,597

eosin YS dye

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

iodotyrosine deiodinase

multiple interactions

Eosine Yellowish-(YS) inhibits the reaction [IYD protein results in increased metabolism of Monoiodotyrosine]

NCBI chr 6:150,369,012...150,405,969
Ensembl chr 6:150,368,892...150,405,969

erythrosin B

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

ATP binding cassette subfamily B member 1

decreases activity

Erythrosine results in decreased activity of ABCB1 protein

NCBI chr 7:87,503,017...87,713,295
Ensembl chr 7:87,503,017...87,713,323

G

caspase 9

multiple interactions

[Tartrazine co-treated with Erythrosine] affects the expression of CASP9 mRNA

NCBI chr 1:15,491,401...15,524,912
Ensembl chr 1:15,490,832...15,526,534

G

cyclin D1

increases expression

Erythrosine results in increased expression of CCND1 protein

NCBI chr11:69,641,156...69,654,474
Ensembl chr11:69,641,156...69,654,474

G

cyclin dependent kinase 2

increases activity

Erythrosine results in increased activity of CDK2 protein

PMID:8927716 PMID:9168006

NCBI chr12:55,966,830...55,972,789
Ensembl chr12:55,966,781...55,972,789

G

cytochrome P450 family 19 subfamily A member 1

decreases activity

Erythrosine results in decreased activity of CYP19A1 protein

NCBI chr15:51,208,057...51,338,596
Ensembl chr15:51,208,057...51,338,601

G

cytochrome P450 family 3 subfamily A member 4

decreases activity

Erythrosine results in decreased activity of CYP3A4 protein

NCBI chr 7:99,756,967...99,784,184
Ensembl chr 7:99,756,960...99,784,248

G

FOS like 1, AP-1 transcription factor subunit

increases expression

Erythrosine results in increased expression of FOSL1 protein

NCBI chr11:65,892,049...65,900,545
Ensembl chr11:65,892,049...65,900,573

G

glutathione S-transferase pi 1

multiple interactions

Erythrosine inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]

NCBI chr11:67,583,812...67,586,653
Ensembl chr11:67,583,742...67,586,656

G

hepatitis A virus cellular receptor 1

multiple interactions

[Tartrazine co-treated with Erythrosine] affects the expression of HAVCR1 mRNA

NCBI chr 5:157,029,413...157,069,407
Ensembl chr 5:157,026,742...157,069,396

G

hematopoietic prostaglandin D synthase

decreases activity

Erythrosine results in decreased activity of HPGDS protein

NCBI chr 4:94,298,535...94,342,836
Ensembl chr 4:94,298,535...94,342,876

G

iodotyrosine deiodinase

decreases activity

Erythrosine results in decreased activity of IYD protein

NCBI chr 6:150,369,012...150,405,969
Ensembl chr 6:150,368,892...150,405,969

G

Jun proto-oncogene, AP-1 transcription factor subunit

increases expression

Erythrosine results in increased expression of JUN protein

NCBI chr 1:58,780,791...58,784,047
Ensembl chr 1:58,776,845...58,784,048

G

orosomucoid 1

increases expression

Erythrosine results in increased expression of ORM1 protein

NCBI chr 9:114,323,098...114,326,479
Ensembl chr 9:114,323,098...114,326,479

G

phosphate regulating endopeptidase X-linked

increases expression

Erythrosine results in increased expression of PHEX protein

NCBI chr X:22,032,325...22,251,310
Ensembl chr X:22,032,325...22,494,713

G

tumor necrosis factor

multiple interactions

[Tartrazine co-treated with Erythrosine] results in increased expression of TNF mRNA

NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336

G

tumor protein p53

increases activity

Erythrosine results in increased activity of TP53 protein

NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,538

G

thyrotropin releasing hormone

multiple interactions

Erythrosine promotes the reaction [TRH protein results in increased expression of TSHB protein]

NCBI chr 3:129,974,720...129,977,935
Ensembl chr 3:129,974,688...129,977,935

G

thyroid stimulating hormone subunit beta

multiple interactions

Erythrosine promotes the reaction [TRH protein results in increased expression of TSHB protein]

NCBI chr 1:115,029,826...115,034,309
Ensembl chr 1:115,029,826...115,034,302

G

UDP glucuronosyltransferase family 1 member A6

decreases activity

Erythrosine results in decreased activity of UGT1A6 protein

NCBI chr 2:233,691,702...233,773,300
Ensembl chr 2:233,691,607...233,773,300

G

UDP glucuronosyltransferase family 2 member B7

decreases activity

Erythrosine results in decreased activity of UGT2B7 protein

NCBI chr 4:69,051,375...69,112,987
Ensembl chr 4:69,051,363...69,112,987

G

vascular endothelial growth factor A

increases expression

Erythrosine results in increased expression of VEGFA protein

NCBI chr 6:43,770,211...43,786,487
Ensembl chr 6:43,770,184...43,786,487

merbromin

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

carbonic anhydrase 2

decreases activity

Merbromin results in decreased activity of CA2 protein

NCBI chr 8:85,464,007...85,481,493
Ensembl chr 8:85,463,968...85,481,493

G

glutathione S-transferase alpha 3

multiple interactions

Merbromin inhibits the reaction [GSTA3 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]

NCBI chr 6:52,896,646...52,909,698
Ensembl chr 6:52,896,639...52,909,698

G

glutathione S-transferase pi 1

multiple interactions

Merbromin inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]

NCBI chr11:67,583,812...67,586,653
Ensembl chr11:67,583,742...67,586,656

physostigmine salicylate

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

acetylcholinesterase (Yt blood group)

decreases activity

physostigmine salicylate results in decreased activity of ACHE protein

NCBI chr 7:100,889,994...100,896,994
Ensembl chr 7:100,889,994...100,896,974

sodium benzoate

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

acetylcholinesterase (Yt blood group)

multiple interactions
increases activity

Ascorbic Acid inhibits the reaction [Sodium Benzoate results in increased activity of ACHE protein]

NCBI chr 7:100,889,994...100,896,994
Ensembl chr 7:100,889,994...100,896,974

G

aryl hydrocarbon receptor

multiple interactions

Sodium Benzoate inhibits the reaction [[DAO protein results in increased activity of AHR protein] which results in increased expression of CYP1A1 mRNA]

NCBI chr 7:17,298,652...17,346,147
Ensembl chr 7:16,916,359...17,346,152

G

calcium/calmodulin dependent protein kinase II alpha

multiple interactions

Sodium Benzoate promotes the reaction [Cocaine results in increased phosphorylation of and results in increased activity of CAMK2A protein]

NCBI chr 5:150,219,491...150,290,130
Ensembl chr 5:150,219,491...150,290,093

G

caspase 3

multiple interactions
increases expression
increases activity

Sodium Benzoate inhibits the reaction [Asbestos, Amosite results in increased activity of CASP3 protein]
Sodium Benzoate results in increased expression of CASP3 protein
Ascorbic Acid inhibits the reaction [Sodium Benzoate results in increased expression of CASP3 protein]
Sodium Benzoate results in increased activity of CASP3 protein

PMID:11329530 PMID:32911041 PMID:35187746

NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062

G

caspase 9

multiple interactions

Sodium Benzoate inhibits the reaction [Asbestos, Amosite results in increased activity of CASP9 protein]

NCBI chr 1:15,491,401...15,524,912
Ensembl chr 1:15,490,832...15,526,534

G

catalase

decreases activity
multiple interactions

Sodium Benzoate results in decreased activity of CAT protein
Ascorbic Acid inhibits the reaction [Sodium Benzoate results in decreased activity of CAT protein]

PMID:32911041 PMID:35187746

NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060

G

cytochrome P450 family 1 subfamily A member 1

multiple interactions

Sodium Benzoate inhibits the reaction [[DAO protein results in increased activity of AHR protein] which results in increased expression of CYP1A1 mRNA]

NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536

G

D-amino acid oxidase

multiple interactions
decreases activity

Sodium Benzoate inhibits the reaction [[DAO protein results in increased activity of AHR protein] which results in increased expression of CYP1A1 mRNA]
Sodium Benzoate results in decreased activity of DAO protein

PMID:19860415 PMID:20952482

NCBI chr12:108,880,092...108,901,043
Ensembl chr12:108,858,932...108,901,043

G

estrogen receptor 1

decreases activity

Sodium Benzoate results in decreased activity of ESR1 protein

NCBI chr 6:151,656,672...152,129,619
Ensembl chr 6:151,656,691...152,129,619

G

follicle stimulating hormone subunit beta

increases expression

Sodium Benzoate results in increased expression of FSHB protein

NCBI chr11:30,231,014...30,235,194
Ensembl chr11:30,231,014...30,235,261

G

interferon gamma

multiple interactions

Sodium Benzoate inhibits the reaction [Lipopolysaccharides results in increased secretion of IFNG protein]
[Food Preservatives results in increased abundance of Sodium Benzoate] which results in increased expression of IFNG mRNA

PMID:26706697 PMID:32179172

NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740

G

interleukin 10

multiple interactions

[Food Preservatives results in increased abundance of Sodium Benzoate] which results in increased expression of IL10 mRNA

NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541

G

interleukin 1 beta

multiple interactions

[Food Preservatives results in increased abundance of Sodium Benzoate] which results in increased expression of IL1B mRNA

NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816

G

interleukin 6

multiple interactions
increases expression

Sodium Benzoate inhibits the reaction [Lipopolysaccharides results in increased secretion of IL6 protein]
[Food Preservatives results in increased abundance of Sodium Benzoate] which results in increased expression of IL6 mRNA
Sodium Benzoate results in increased expression of IL6 protein

PMID:26706697 PMID:32179172 PMID:32911041

NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002

G

luteinizing hormone subunit beta

increases expression

Sodium Benzoate results in increased expression of LHB protein

NCBI chr19:49,015,980...49,019,498
Ensembl chr19:49,015,980...49,017,091

G

macrophage scavenger receptor 1

multiple interactions

Sodium Benzoate inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MSR1 mRNA alternative form]; Sodium Benzoate inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MSR1 mRNA]

NCBI chr 8:16,107,881...16,192,651
Ensembl chr 8:16,107,878...16,567,490

G

ornithine transcarbamylase

multiple interactions

Sodium Benzoate affects the reaction [OTC gene mutant form affects the abundance of Hydroxyindoleacetic Acid]; Sodium Benzoate affects the reaction [OTC gene mutant form affects the metabolism of Glycine]; Sodium Benzoate affects the reaction [OTC gene mutant form affects the metabolism of Serotonin]; Sodium Benzoate affects the reaction [OTC gene mutant form results in increased abundance of Ammonium Compounds]

PMID:3091026 PMID:3374991

NCBI chr X:38,327,684...38,422,928
Ensembl chr X:38,352,586...38,421,446

G

transcription factor A, mitochondrial

increases expression

Sodium Benzoate results in increased expression of TFAM protein

NCBI chr10:58,385,410...58,399,220
Ensembl chr10:58,385,345...58,399,220

G

tumor necrosis factor

multiple interactions
increases expression

Sodium Benzoate inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein]
[Food Preservatives results in increased abundance of Sodium Benzoate] which results in increased expression of TNF mRNA; Ascorbic Acid inhibits the reaction [Sodium Benzoate results in increased expression of TNF protein]

PMID:26706697 PMID:32179172 PMID:32911041 PMID:35187746

NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336

G

tumor protein p53

multiple interactions
increases expression

Sodium Benzoate inhibits the reaction [Asbestos, Amosite results in increased expression of TP53 mRNA]
Sodium Benzoate results in increased expression of TP53 protein

PMID:16357363 PMID:32911041

NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,538

G

uncoupling protein 2

increases expression

Sodium Benzoate results in increased expression of UCP2 protein

NCBI chr11:73,974,672...73,983,202
Ensembl chr11:73,974,672...73,982,843

G

xanthine dehydrogenase

increases activity

Sodium Benzoate results in increased activity of XDH protein

NCBI chr 2:31,334,321...31,414,742
Ensembl chr 2:31,334,321...31,414,742

thimerosal

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

abhydrolase domain containing 17B, depalmitoylase

increases expression

Thimerosal results in increased expression of ABHD17B mRNA

NCBI chr 9:71,862,452...71,911,193
Ensembl chr 9:71,862,452...71,911,193

G

ankyrin repeat and BTB domain containing 3

multiple interactions

[NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ABTB3 mRNA

NCBI chr12:107,318,434...107,659,642
Ensembl chr12:107,318,421...107,659,642

G

acetyl-CoA carboxylase beta

decreases expression

Thimerosal results in decreased expression of ACACB mRNA

NCBI chr12:109,111,189...109,268,226
Ensembl chr12:109,116,587...109,268,226

G

acyl-CoA synthetase long chain family member 4

increases expression

Thimerosal results in increased expression of ACSL4 mRNA

NCBI chr X:109,641,335...109,733,257
Ensembl chr X:109,624,244...109,733,403

G

actin maturation protease

decreases expression

Thimerosal results in decreased expression of ACTMAP mRNA

NCBI chr19:40,740,861...40,750,477
Ensembl chr19:40,740,856...40,751,553

G

actin related protein 2

decreases expression

Thimerosal results in decreased expression of ACTR2 mRNA

NCBI chr 2:65,227,831...65,271,253
Ensembl chr 2:65,227,788...65,271,253

G

adenosine deaminase 2

decreases expression

Thimerosal results in decreased expression of ADA2 mRNA

NCBI chr22:17,178,790...17,221,848
Ensembl chr22:17,178,790...17,258,235

G

adenylate cyclase 7

decreases expression

Thimerosal results in decreased expression of ADCY7 mRNA

NCBI chr16:50,244,699...50,318,135
Ensembl chr16:50,246,137...50,318,135

G

adhesion G protein-coupled receptor B2

decreases expression

Thimerosal results in decreased expression of ADGRB2 mRNA

NCBI chr 1:31,727,117...31,764,340
Ensembl chr 1:31,727,117...31,764,893

G

adhesion G protein-coupled receptor L3

increases expression

Thimerosal results in increased expression of ADGRL3 mRNA

NCBI chr 4:61,200,326...62,078,335
Ensembl chr 4:61,200,326...62,078,335

G

adhesion G protein-coupled receptor V1

increases expression

Thimerosal results in increased expression of ADGRV1 mRNA

NCBI chr 5:90,558,797...91,164,437
Ensembl chr 5:90,529,344...91,164,437

G

alcohol dehydrogenase 1B (class I), beta polypeptide

decreases expression

Thimerosal results in decreased expression of ADH1B mRNA

NCBI chr 4:99,304,971...99,321,401
Ensembl chr 4:99,304,971...99,321,401

G

adrenomedullin

decreases expression

Thimerosal results in decreased expression of ADM mRNA

NCBI chr11:10,305,073...10,307,397
Ensembl chr11:10,305,073...10,307,397

G

adenylosuccinate synthase 1

decreases expression

Thimerosal results in decreased expression of ADSS1 mRNA

NCBI chr14:104,724,229...104,747,325
Ensembl chr14:104,724,174...104,747,325

G

actin filament associated protein 1 like 1

decreases expression

Thimerosal results in decreased expression of AFAP1L1 mRNA

NCBI chr 5:149,271,859...149,343,637
Ensembl chr 5:149,271,859...149,343,637

G

ALF transcription elongation factor 4

decreases expression

Thimerosal results in decreased expression of AFF4 mRNA

NCBI chr 5:132,875,395...132,963,634
Ensembl chr 5:132,875,395...132,963,634

G

AGBL carboxypeptidase 5

decreases expression

Thimerosal results in decreased expression of AGBL5 mRNA

NCBI chr 2:27,050,364...27,070,618
Ensembl chr 2:27,042,364...27,070,622

G

ArfGAP with FG repeats 1

decreases expression

Thimerosal results in decreased expression of AGFG1 mRNA

NCBI chr 2:227,472,156...227,561,217
Ensembl chr 2:227,472,152...227,561,217

G

argonaute RISC component 1

decreases expression

Thimerosal results in decreased expression of AGO1 mRNA

NCBI chr 1:35,869,761...35,930,532
Ensembl chr 1:35,869,808...35,930,532

G

1-acylglycerol-3-phosphate O-acyltransferase 1

decreases expression

Thimerosal results in decreased expression of AGPAT1 mRNA

NCBI chr 6:32,168,212...32,178,108
Ensembl chr 6:32,168,212...32,178,096

G

adenosylhomocysteinase

decreases expression

Thimerosal results in decreased expression of AHCY mRNA

NCBI chr20:34,231,981...34,311,836
Ensembl chr20:34,280,268...34,311,802

G

AHNAK nucleoprotein 2

decreases expression

Thimerosal results in decreased expression of AHNAK2 mRNA

NCBI chr14:104,937,253...104,978,374
Ensembl chr14:104,937,244...104,978,374

G

apoptosis inducing factor mitochondria associated 1

increases secretion

Thimerosal results in increased secretion of AIFM1 protein

NCBI chr X:130,129,362...130,165,841
Ensembl chr X:130,124,666...130,165,879

G

adenylate kinase 4

decreases expression

Thimerosal results in decreased expression of AK4 mRNA

NCBI chr 1:65,147,552...65,232,145
Ensembl chr 1:65,147,549...65,232,145

G

A-kinase anchoring protein 11

increases expression

Thimerosal results in increased expression of AKAP11 mRNA

NCBI chr13:42,271,477...42,323,261
Ensembl chr13:42,272,152...42,323,261

G

A-kinase anchoring protein 8 like

increases expression

Thimerosal results in increased expression of AKAP8L mRNA

NCBI chr19:15,380,050...15,418,988
Ensembl chr19:15,380,050...15,419,141

G

A-kinase anchoring protein 9

increases expression

Thimerosal results in increased expression of AKAP9 mRNA

NCBI chr 7:91,940,862...92,110,673
Ensembl chr 7:91,940,840...92,110,673

G

AKT serine/threonine kinase 1

multiple interactions
decreases phosphorylation

Thimerosal promotes the reaction [wortmannin results in decreased phosphorylation of AKT1 protein]; wortmannin promotes the reaction [Thimerosal results in decreased phosphorylation of AKT1 protein]

NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,751

G

AKT serine/threonine kinase 3

decreases expression

Thimerosal results in decreased expression of AKT3 mRNA

NCBI chr 1:243,488,233...243,851,079
Ensembl chr 1:243,488,233...243,851,079

G

5'-aminolevulinate synthase 1

decreases expression

Thimerosal results in decreased expression of ALAS1 mRNA

NCBI chr 3:52,198,083...52,214,327
Ensembl chr 3:52,198,086...52,214,327

G

albumin

affects binding

Thimerosal binds to ALB protein

NCBI chr 4:73,404,287...73,421,482
Ensembl chr 4:73,397,114...73,421,482

G

aldehyde dehydrogenase 3 family member A2

decreases expression

Thimerosal results in decreased expression of ALDH3A2 mRNA

NCBI chr17:19,648,136...19,677,596
Ensembl chr17:19,648,136...19,685,760

G

aldehyde dehydrogenase 5 family member A1

decreases expression

Thimerosal results in decreased expression of ALDH5A1 mRNA

NCBI chr 6:24,494,969...24,537,207
Ensembl chr 6:24,494,867...24,537,207

G

aldehyde dehydrogenase 6 family member A1

decreases expression

Thimerosal results in decreased expression of ALDH6A1 mRNA

NCBI chr14:74,056,847...74,084,453
Ensembl chr14:74,056,847...74,084,492

G

aldolase, fructose-bisphosphate A

decreases expression

Thimerosal results in decreased expression of ALDOA mRNA

NCBI chr16:30,064,279...30,070,420
Ensembl chr16:30,064,164...30,070,457

G

aldolase, fructose-bisphosphate C

decreases expression

Thimerosal results in decreased expression of ALDOC mRNA

NCBI chr17:28,573,120...28,576,895
Ensembl chr17:28,573,115...28,576,948

G

ALG13 UDP-N-acetylglucosaminyltransferase subunit

increases expression

Thimerosal results in increased expression of ALG13 mRNA

NCBI chr X:111,681,170...111,760,649
Ensembl chr X:111,665,811...111,760,649

G

ALMS1 intronic transcript 1

decreases expression

Thimerosal results in decreased expression of ALMS1-IT1 mRNA

NCBI chr 2:73,457,103...73,459,482
Ensembl chr 2:73,456,764...73,459,482

G

arachidonate 5-lipoxygenase

decreases expression

Thimerosal results in decreased expression of ALOX5 mRNA

NCBI chr10:45,374,216...45,446,117
Ensembl chr10:45,374,176...45,446,119

G

angiopoietin 1

decreases expression

Thimerosal results in decreased expression of ANGPT1 mRNA

NCBI chr 8:107,249,482...107,497,918
Ensembl chr 8:107,249,482...107,498,055

G

ankyrin 2

increases expression

Thimerosal results in increased expression of ANK2 mRNA

NCBI chr 4:112,705,622...113,383,736
Ensembl chr 4:112,818,032...113,384,221

G

ankyrin repeat and death domain containing 1A

decreases expression

Thimerosal results in decreased expression of ANKDD1A mRNA

NCBI chr15:64,911,902...64,958,691
Ensembl chr15:64,911,902...64,958,691

G

ankyrin repeat and EF-hand domain containing 1

decreases expression

Thimerosal results in decreased expression of ANKEF1 mRNA

NCBI chr20:10,034,987...10,058,303
Ensembl chr20:9,986,126...10,058,303

G

ankyrin repeat domain 10

increases expression

Thimerosal results in increased expression of ANKRD10 mRNA

NCBI chr13:110,878,540...110,915,069
Ensembl chr13:110,878,540...110,915,069

G

ankyrin repeat domain 35

decreases expression

Thimerosal results in decreased expression of ANKRD35 mRNA

NCBI chr 1:145,866,564...145,885,866
Ensembl chr 1:145,866,560...145,885,866

G

ankyrin repeat domain 37

decreases expression

Thimerosal results in decreased expression of ANKRD37 mRNA

NCBI chr 4:185,396,841...185,400,723
Ensembl chr 4:185,396,021...185,400,628

G

ankyrin repeat domain 44

increases expression

Thimerosal results in increased expression of ANKRD44 mRNA

PMID:24675092 PMID:27188386

NCBI chr 2:196,967,014...197,310,780
Ensembl chr 2:196,967,017...197,311,173

G

ankyrin repeat domain 9

decreases expression

Thimerosal results in decreased expression of ANKRD9 mRNA

NCBI chr14:102,501,767...102,509,776
Ensembl chr14:102,501,767...102,509,799

G

anoctamin 4

decreases expression

Thimerosal results in decreased expression of ANO4 mRNA

NCBI chr12:100,717,261...101,128,641
Ensembl chr12:100,717,526...101,128,641

G

acidic nuclear phosphoprotein 32 family member B

decreases expression

Thimerosal results in decreased expression of ANP32B mRNA

NCBI chr 9:97,983,341...98,015,943
Ensembl chr 9:97,983,341...98,015,943

G

alanyl aminopeptidase, membrane

decreases expression

Thimerosal results in decreased expression of ANPEP mRNA

NCBI chr15:89,784,895...89,814,852
Ensembl chr15:89,784,895...89,815,401

G

APC regulator of WNT signaling pathway

increases expression

Thimerosal results in increased expression of APC mRNA

NCBI chr 5:112,707,498...112,846,239
Ensembl chr 5:112,707,518...112,846,239

G

apolipoprotein H

multiple interactions

[NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of APOH mRNA

NCBI chr17:66,212,033...66,229,415
Ensembl chr17:66,212,033...66,256,525

G

adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 2

decreases expression

Thimerosal results in decreased expression of APPL2 mRNA

NCBI chr12:105,173,300...105,236,174
Ensembl chr12:105,173,297...105,236,203

G

ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3

decreases expression

Thimerosal results in decreased expression of ARAP3 mRNA

NCBI chr 5:141,653,402...141,682,230
Ensembl chr 5:141,653,401...141,682,230

G

ARB2 cotranscriptional regulator A

decreases expression

Thimerosal results in decreased expression of ARB2A mRNA

NCBI chr 5:93,617,725...94,111,699
Ensembl chr 5:93,617,725...94,111,699

G

activity regulated cytoskeleton associated protein

increases expression

Thimerosal results in increased expression of ARC mRNA

NCBI chr 8:142,611,049...142,614,479
Ensembl chr 8:142,611,049...142,614,479

G

ARFGEF family member 3

decreases expression

Thimerosal results in decreased expression of ARFGEF3 mRNA

NCBI chr 6:138,161,939...138,344,663
Ensembl chr 6:138,161,939...138,344,663

G

arginine and glutamate rich 1

decreases expression

Thimerosal results in decreased expression of ARGLU1 mRNA

NCBI chr13:106,541,673...106,568,137
Ensembl chr13:106,541,673...106,568,137

G

Rho GTPase activating protein 18

decreases expression

Thimerosal results in decreased expression of ARHGAP18 mRNA

NCBI chr 6:129,576,132...129,710,177
Ensembl chr 6:129,576,132...129,710,177

G

Rho GTPase activating protein 5

increases expression

Thimerosal results in increased expression of ARHGAP5 mRNA

NCBI chr14:32,077,304...32,159,728
Ensembl chr14:32,076,114...32,159,728

G

Rho guanine nucleotide exchange factor 10

decreases expression

Thimerosal results in decreased expression of ARHGEF10 mRNA

NCBI chr 8:1,823,300...1,958,641
Ensembl chr 8:1,823,926...1,958,641

G

Rho guanine nucleotide exchange factor 12

increases expression

Thimerosal results in increased expression of ARHGEF12 mRNA

NCBI chr11:120,336,413...120,489,937
Ensembl chr11:120,336,413...120,489,937

G

Rho guanine nucleotide exchange factor 4

decreases expression

Thimerosal results in decreased expression of ARHGEF4 mRNA

NCBI chr 2:130,836,914...131,047,253
Ensembl chr 2:130,836,914...131,047,263

G

armadillo repeat containing 7

decreases expression

Thimerosal results in decreased expression of ARMC7 mRNA

NCBI chr17:75,109,969...75,130,272
Ensembl chr17:75,109,952...75,130,272

G

armadillo repeat containing X-linked 5

increases expression

Thimerosal results in increased expression of ARMCX5 mRNA

NCBI chr X:102,599,206...102,604,159
Ensembl chr X:102,599,168...102,604,159

G

aryl hydrocarbon receptor nuclear translocator

decreases expression

Thimerosal results in decreased expression of ARNT mRNA

NCBI chr 1:150,809,713...150,876,599
Ensembl chr 1:150,809,713...150,876,708

G

actin related protein 2/3 complex subunit 1B

decreases expression

Thimerosal results in decreased expression of ARPC1B mRNA

NCBI chr 7:99,374,259...99,394,816
Ensembl chr 7:99,374,249...99,394,816

G

arrestin domain containing 3

increases expression

Thimerosal results in increased expression of ARRDC3 mRNA

NCBI chr 5:91,368,631...91,383,317
Ensembl chr 5:91,368,631...91,383,317

G

arylsulfatase family member K

decreases expression

Thimerosal results in decreased expression of ARSK mRNA

NCBI chr 5:95,555,101...95,605,102
Ensembl chr 5:95,555,101...95,605,102

G

anti-silencing function 1A histone chaperone

increases expression

Thimerosal results in increased expression of ASF1A mRNA

NCBI chr 6:118,894,152...118,909,171
Ensembl chr 6:118,894,152...118,909,171

G

acetylserotonin O-methyltransferase like

decreases expression

Thimerosal results in decreased expression of ASMTL mRNA

NCBI chr  X:1,403,139...1,453,756
NCBI chr  Y:1,403,139...1,453,756
Ensembl chr  Y:1,403,139...1,453,762
Ensembl chr  X:1,403,139...1,453,762

G

assembly factor for spindle microtubules

decreases expression

Thimerosal results in decreased expression of ASPM mRNA

NCBI chr 1:197,084,127...197,146,669
Ensembl chr 1:197,084,121...197,146,694

G

ATPase family AAA domain containing 2B

increases expression

Thimerosal results in increased expression of ATAD2B mRNA

NCBI chr 2:23,677,969...23,927,123
Ensembl chr 2:23,748,664...23,927,123

G

activating transcription factor 3

increases expression

Thimerosal results in increased expression of ATF3 mRNA

NCBI chr 1:212,565,407...212,620,777
Ensembl chr 1:212,565,334...212,620,777

G

activating transcription factor 7 interacting protein

increases expression

Thimerosal results in increased expression of ATF7IP mRNA

NCBI chr12:14,365,682...14,502,930
Ensembl chr12:14,365,676...14,502,931

G

autophagy related 10

increases expression

Thimerosal results in increased expression of ATG10 mRNA

NCBI chr 5:81,972,023...82,256,133
Ensembl chr 5:81,972,023...82,276,857

G

autophagy related 13

decreases expression

Thimerosal results in decreased expression of ATG13 mRNA

NCBI chr11:46,617,553...46,674,518
Ensembl chr11:46,617,527...46,674,818

G

autophagy related 2B

decreases expression

Thimerosal results in decreased expression of ATG2B mRNA

NCBI chr14:96,279,195...96,363,341
Ensembl chr14:96,279,195...96,363,341

G

ATM serine/threonine kinase

increases expression

Thimerosal results in increased expression of ATM mRNA

NCBI chr11:108,223,067...108,369,102
Ensembl chr11:108,222,823...108,369,102

G

ATPase phospholipid transporting 11B (putative)

decreases expression

Thimerosal results in decreased expression of ATP11B mRNA

NCBI chr 3:182,793,504...182,921,629
Ensembl chr 3:182,793,503...182,921,629

G

ATPase 13A3

decreases expression

Thimerosal results in decreased expression of ATP13A3 mRNA

NCBI chr 3:194,402,677...194,494,334
Ensembl chr 3:194,402,672...194,498,364

G

ATPase Na+/K+ transporting subunit beta 2

decreases expression

Thimerosal results in decreased expression of ATP1B2 mRNA

NCBI chr17:7,646,627...7,657,770
Ensembl chr17:7,646,627...7,657,770

G

ATP synthase F1 subunit delta

decreases expression

Thimerosal results in decreased expression of ATP5F1D mRNA

NCBI chr19:1,241,751...1,244,825
Ensembl chr19:1,241,746...1,244,825

G

ATP synthase F1 subunit epsilon

increases expression

Thimerosal results in increased expression of ATP5F1E mRNA

NCBI chr20:59,025,475...59,032,335
Ensembl chr20:59,025,475...59,032,345

G

ATP synthase inhibitory factor subunit 1

decreases expression

Thimerosal results in decreased expression of ATP5IF1 mRNA

NCBI chr 1:28,236,124...28,238,100
Ensembl chr 1:28,236,109...28,246,906

G

ATPase H+ transporting V1 subunit D

increases expression

Thimerosal results in increased expression of ATP6V1D mRNA

NCBI chr14:67,337,872...67,359,804
Ensembl chr14:67,294,371...67,360,265

G

ATPase phospholipid transporting 8B3

decreases expression

Thimerosal results in decreased expression of ATP8B3 mRNA

NCBI chr19:1,782,075...1,812,276
Ensembl chr19:1,782,075...1,812,276

G

ATRX chromatin remodeler

decreases expression

Thimerosal results in decreased expression of ATRX mRNA

NCBI chr X:77,504,880...77,786,216
Ensembl chr X:77,504,880...77,786,233

G

ataxin 1

decreases expression

Thimerosal results in decreased expression of ATXN1 mRNA

NCBI chr 6:16,299,112...16,761,460
Ensembl chr 6:16,299,112...16,761,491

G

ataxin 7 like 3B

decreases expression

Thimerosal results in decreased expression of ATXN7L3B mRNA

NCBI chr12:74,537,835...74,545,430
Ensembl chr12:74,537,835...74,545,430

G

5-azacytidine induced 2

increases expression

Thimerosal results in increased expression of AZI2 mRNA

NCBI chr 3:28,321,047...28,348,824
Ensembl chr 3:28,315,003...28,349,050

G

beta-1,3-N-acetylgalactosaminyltransferase 2

increases expression

Thimerosal results in increased expression of B3GALNT2 mRNA

NCBI chr 1:235,439,796...235,504,452
Ensembl chr 1:235,447,190...235,504,452

G

beta-secretase 1

decreases expression

Thimerosal results in decreased expression of BACE1 mRNA

NCBI chr11:117,285,698...117,316,256
Ensembl chr11:117,285,232...117,316,259

G

beta-secretase 2

decreases expression

Thimerosal results in decreased expression of BACE2 mRNA

NCBI chr21:41,168,160...41,282,530
Ensembl chr21:41,167,801...41,282,530

G

BAG cochaperone 3

increases expression

Thimerosal results in increased expression of BAG3 mRNA

NCBI chr10:119,651,380...119,677,819
Ensembl chr10:119,651,380...119,677,819

G

BAG cochaperone 4

decreases expression

Thimerosal results in decreased expression of BAG4 mRNA

NCBI chr 8:38,176,855...38,213,301
Ensembl chr 8:38,176,533...38,213,301

G

BAIAP2 divergent transcript

decreases expression

Thimerosal results in decreased expression of BAIAP2-DT mRNA

NCBI chr17:81,029,133...81,034,719
Ensembl chr17:81,029,130...81,034,881

G

BCL2 associated X, apoptosis regulator

increases expression

Thimerosal results in increased expression of BAX

NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798

G

BBSome interacting protein 1

increases expression

Thimerosal results in increased expression of BBIP1 mRNA

NCBI chr10:110,898,730...110,919,366
Ensembl chr10:110,898,730...110,919,201

G

bublin coiled coil protein

decreases expression

Thimerosal results in decreased expression of BBLN mRNA

NCBI chr 9:128,160,265...128,163,924
Ensembl chr 9:128,160,265...128,163,924

G

BCAS3 microtubule associated cell migration factor

decreases expression

Thimerosal results in decreased expression of BCAS3 mRNA

NCBI chr17:60,677,851...61,392,831
Ensembl chr17:60,677,453...61,392,838

G

branched chain amino acid transaminase 2

decreases expression

Thimerosal results in decreased expression of BCAT2 mRNA

NCBI chr19:48,795,064...48,811,029
Ensembl chr19:48,795,062...48,811,029

G

BCL6B transcription repressor

decreases expression

Thimerosal results in decreased expression of BCL6B mRNA

NCBI chr17:7,023,050...7,029,644
Ensembl chr17:7,023,050...7,030,290

G

BCL2 associated transcription factor 1

increases expression

Thimerosal results in increased expression of BCLAF1 mRNA

NCBI chr 6:136,256,627...136,289,846
Ensembl chr 6:136,256,627...136,289,851

G

BCL6 corepressor

decreases expression

Thimerosal results in decreased expression of BCOR mRNA

NCBI chr X:40,051,246...40,177,329
Ensembl chr X:40,049,815...40,177,329

G

B double prime 1, subunit of RNA polymerase III transcription initiation factor IIIB

decreases expression

Thimerosal results in decreased expression of BDP1 mRNA

NCBI chr 5:71,455,651...71,578,288
Ensembl chr 5:71,455,651...71,567,820

G

basic helix-loop-helix family member e40

decreases expression

Thimerosal results in decreased expression of BHLHE40 mRNA

NCBI chr 3:4,979,437...4,985,323
Ensembl chr 3:4,979,437...4,985,323

G

baculoviral IAP repeat containing 3

multiple interactions
decreases expression

Glutathione inhibits the reaction [Thimerosal results in decreased expression of BIRC3 protein]

NCBI chr11:102,317,484...102,339,403
Ensembl chr11:102,317,484...102,339,403

G

baculoviral IAP repeat containing 5

multiple interactions
decreases expression

BIRC5 mutant form promotes the reaction [Thimerosal results in increased cleavage of CASP3 protein]; BIRC5 mutant form promotes the reaction [Thimerosal results in increased cleavage of CASP9 protein]; BIRC5 protein inhibits the reaction [Thimerosal results in increased cleavage of CASP3 protein]; BIRC5 protein inhibits the reaction [Thimerosal results in increased cleavage of CASP9 protein]; IGF1 protein inhibits the reaction [Thimerosal results in decreased expression of BIRC5 protein]; Thimerosal promotes the reaction [BIRC5 mutant form results in increased cleavage of CASP3 protein]; Thimerosal promotes the reaction [BIRC5 mutant form results in increased cleavage of CASP9 protein]

NCBI chr17:78,214,253...78,225,635
Ensembl chr17:78,214,186...78,225,636

G

BH3-like motif containing, cell death inducer

decreases expression

Thimerosal results in decreased expression of BLID mRNA

NCBI chr11:122,115,340...122,116,215
Ensembl chr11:122,115,340...122,116,215

G

biogenesis of lysosomal organelles complex 1 subunit 3

decreases expression

Thimerosal results in decreased expression of BLOC1S3 mRNA

NCBI chr19:45,178,784...45,217,083
Ensembl chr19:45,178,784...45,216,933

G

bridge-like lipid transfer protein family member 3A

decreases expression

Thimerosal results in decreased expression of BLTP3A mRNA

NCBI chr 6:34,792,083...34,877,514
Ensembl chr 6:34,792,083...34,877,514

G

BMP2 inducible kinase

increases expression

Thimerosal results in increased expression of BMP2K mRNA

NCBI chr 4:78,776,350...78,916,365
Ensembl chr 4:78,776,342...78,916,365

G

BCL2 interacting protein 3

decreases expression

Thimerosal results in decreased expression of BNIP3 mRNA

NCBI chr10:131,967,684...131,981,923
Ensembl chr10:131,967,684...131,981,967

G

biorientation of chromosomes in cell division 1 like 1

decreases expression

Thimerosal results in decreased expression of BOD1L1 mRNA

NCBI chr 4:13,568,738...13,627,725
Ensembl chr 4:13,568,738...13,627,725

G

BCL2 family apoptosis regulator BOK

decreases expression

Thimerosal results in decreased expression of BOK mRNA

NCBI chr 2:241,551,393...241,574,131
Ensembl chr 2:241,551,424...241,574,131

G

bolA family member 2

increases expression

Thimerosal results in increased expression of BOLA2 mRNA

NCBI chr16:29,453,588...29,454,964
Ensembl chr16:30,192,932...30,194,306
Ensembl chr16:30,192,932...30,194,306

G

BRCA2 DNA repair associated

increases expression

Thimerosal results in increased expression of BRCA2 mRNA

NCBI chr13:32,315,508...32,400,268
Ensembl chr13:32,315,086...32,400,268

G

bromodomain and WD repeat domain containing 1

increases expression

Thimerosal results in increased expression of BRWD1 mRNA

NCBI chr21:39,184,176...39,321,212
Ensembl chr21:39,184,176...39,321,559

G

bromodomain and WD repeat domain containing 3

decreases expression

Thimerosal results in decreased expression of BRWD3 mRNA

NCBI chr X:80,669,503...80,809,877
Ensembl chr X:80,669,503...80,809,877

G

BTG anti-proliferation factor 3

increases expression

Thimerosal results in increased expression of BTG3 mRNA

NCBI chr21:17,593,653...17,612,901
Ensembl chr21:17,593,653...17,612,945

G

butyrophilin subfamily 3 member A2

decreases expression

Thimerosal results in decreased expression of BTN3A2 mRNA

NCBI chr 6:26,365,169...26,378,320
Ensembl chr 6:26,365,159...26,378,320

G

chromosome 1 open reading frame 115

decreases expression

Thimerosal results in decreased expression of C1ORF115 mRNA

NCBI chr 1:220,690,363...220,699,153
Ensembl chr 1:220,690,363...220,699,153

G

chromosome 1 open reading frame 174

increases expression

Thimerosal results in increased expression of C1ORF174 mRNA

NCBI chr 1:3,889,133...3,900,272
Ensembl chr 1:3,889,125...3,900,293

G

chromosome 1 open reading frame 53

increases expression

Thimerosal results in increased expression of C1ORF53 mRNA

NCBI chr 1:197,902,630...197,907,362
Ensembl chr 1:197,902,630...197,907,367

G

C1q and TNF related 3

decreases expression

Thimerosal results in decreased expression of C1QTNF3 mRNA

NCBI chr 5:34,017,858...34,244,724
Ensembl chr 5:34,017,858...34,043,213

G

C1q and TNF related 4

decreases expression

Thimerosal results in decreased expression of C1QTNF4 mRNA

NCBI chr11:47,589,667...47,595,304
Ensembl chr11:47,589,667...47,594,411

G

complement C1r subcomponent like

decreases expression

Thimerosal results in decreased expression of C1RL mRNA

NCBI chr12:7,094,554...7,109,214
Ensembl chr12:7,089,587...7,109,238

G

C2 calcium dependent domain containing 2

decreases expression

Thimerosal results in decreased expression of C2CD2 mRNA

NCBI chr21:41,885,112...41,954,018
Ensembl chr21:41,885,112...41,954,018

G

chromosome 2 open reading frame 76

increases expression

Thimerosal results in increased expression of C2ORF76 mRNA

NCBI chr 2:119,281,130...119,367,151
Ensembl chr 2:119,302,225...119,366,834

G

chromosome 3 open reading frame 38

increases expression

Thimerosal results in increased expression of C3ORF38 mRNA

NCBI chr 3:88,149,959...88,157,965
Ensembl chr 3:88,149,959...88,168,729

G

chromosome 5 open reading frame 24

decreases expression

Thimerosal results in decreased expression of C5ORF24 mRNA

NCBI chr 5:134,833,602...134,859,735
Ensembl chr 5:134,845,680...134,859,735

G

chromosome 6 open reading frame 136

decreases expression

Thimerosal results in decreased expression of C6ORF136 mRNA

NCBI chr 6:30,647,133...30,653,207
Ensembl chr 6:30,647,039...30,653,210

G

chromosome 8 open reading frame 48

increases expression

Thimerosal results in increased expression of C8ORF48 mRNA

NCBI chr 8:13,566,869...13,568,288
Ensembl chr 8:13,566,869...13,568,288

G

chromosome 8 open reading frame 58

decreases expression

Thimerosal results in decreased expression of C8ORF58 mRNA

NCBI chr 8:22,599,599...22,604,142
Ensembl chr 8:22,599,599...22,604,150

G

chromosome 8 open reading frame 82

decreases expression

Thimerosal results in decreased expression of C8ORF82 mRNA

NCBI chr 8:144,525,733...144,529,111
Ensembl chr 8:144,525,733...144,529,132

G

carbonic anhydrase 10

increases expression

Thimerosal results in increased expression of CA10 mRNA

NCBI chr17:51,630,313...52,160,023
Ensembl chr17:51,630,313...52,160,017

G

carbonic anhydrase 14

decreases expression

Thimerosal results in decreased expression of CA14 mRNA

NCBI chr 1:150,257,774...150,265,078
Ensembl chr 1:150,257,251...150,265,078

G

cell adhesion molecule 2

increases expression

Thimerosal results in increased expression of CADM2 mRNA

NCBI chr 3:84,958,989...86,074,429
Ensembl chr 3:84,958,989...86,074,429

G

cell adhesion molecule 3

decreases expression

Thimerosal results in decreased expression of CADM3 mRNA

NCBI chr 1:159,171,615...159,203,313
Ensembl chr 1:159,171,609...159,203,313

G

calmodulin 3

decreases expression

Thimerosal results in decreased expression of CALM3 mRNA

NCBI chr19:46,601,074...46,610,782
Ensembl chr19:46,601,074...46,610,782

G

calmodulin like 4

multiple interactions

[NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CALML4 mRNA

NCBI chr15:68,190,705...68,206,110
Ensembl chr15:68,190,705...68,206,079

G

calpain 5

multiple interactions

[NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CAPN5 mRNA

NCBI chr11:77,066,971...77,126,155
Ensembl chr11:77,066,961...77,126,155

G

calpain 9

increases expression

Thimerosal results in increased expression of CAPN9 mRNA

NCBI chr 1:230,747,388...230,801,989
Ensembl chr 1:230,747,384...230,802,003

G

caspase recruitment domain family member 10

decreases expression

Thimerosal results in decreased expression of CARD10 mRNA

NCBI chr22:37,490,362...37,519,415
Ensembl chr22:37,490,362...37,519,542

G

CARD8 antisense RNA 1

increases expression

Thimerosal results in increased expression of CARD8-AS1 mRNA

NCBI chr19:48,255,675...48,258,194
Ensembl chr19:48,255,675...48,258,199

G

coactivator associated arginine methyltransferase 1

decreases expression

Thimerosal results in decreased expression of CARM1 mRNA

NCBI chr19:10,871,553...10,923,075
Ensembl chr19:10,871,553...10,923,075

G

caspase 3

increases cleavage
multiple interactions
increases activity

Thimerosal results in increased cleavage of CASP3 protein
MC1568 inhibits the reaction [Thimerosal results in increased cleavage of and results in increased activity of CASP3 protein]; Thimerosal results in increased cleavage of and results in increased activity of CASP3 protein
benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone inhibits the reaction [Thimerosal results in increased cleavage of CASP3 protein]; benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone inhibits the reaction [Thimerosal results in increased cleavage of CASP3 protein]; BIRC5 mutant form promotes the reaction [Thimerosal results in increased cleavage of CASP3 protein]; BIRC5 protein inhibits the reaction [Thimerosal results in increased cleavage of CASP3 protein]; IGF1 protein inhibits the reaction [Thimerosal results in increased cleavage of CASP3 protein]; Thimerosal promotes the reaction [BIRC5 mutant form results in increased cleavage of CASP3 protein]; Thimerosal promotes the reaction [wortmannin results in increased cleavage of CASP3 protein]; wortmannin promotes the reaction [Thimerosal results in increased cleavage of CASP3 protein]
Thimerosal results in increased activity of CASP3 protein
[[Thimerosal results in increased abundance of Reactive Oxygen Species] which results in increased activity of CASP3 protein] which results in increased cleavage of PTK2 protein; [SOD1 protein results in increased susceptibility to Thimerosal] which results in increased cleavage of CASP3 protein; [Thimerosal results in increased abundance of Reactive Oxygen Species] which results in increased activity of CASP3 protein; Acetylcysteine inhibits the reaction [[[Thimerosal results in increased abundance of Reactive Oxygen Species] which results in increased activity of CASP3 protein] which results in increased cleavage of PTK2 protein]; benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [[[Thimerosal results in increased abundance of Reactive Oxygen Species] which results in increased activity of CASP3 protein] which results in increased cleavage of PTK2 protein]; Glutathione inhibits the reaction [Thimerosal results in increased activity of CASP3 protein]; Resveratrol inhibits the reaction [[SOD1 protein results in increased susceptibility to Thimerosal] which results in increased cleavage of CASP3 protein]; SB 203580 inhibits the reaction [Thimerosal results in increased activity of CASP3 protein]

PMID:12140745 PMID:15869795 PMID:16649253 PMID:17698513 PMID:17888894 More...

NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062

G

caspase 9

increases cleavage
multiple interactions
increases activity

Thimerosal results in increased cleavage of CASP9 protein
benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone inhibits the reaction [Thimerosal results in increased cleavage of CASP9 protein]; BIRC5 mutant form promotes the reaction [Thimerosal results in increased cleavage of CASP9 protein]; BIRC5 protein inhibits the reaction [Thimerosal results in increased cleavage of CASP9 protein]; IGF1 protein inhibits the reaction [Thimerosal results in increased cleavage of CASP9 protein]; Thimerosal promotes the reaction [BIRC5 mutant form results in increased cleavage of CASP9 protein]; Thimerosal promotes the reaction [wortmannin results in increased cleavage of CASP9 protein]; wortmannin promotes the reaction [Thimerosal results in increased cleavage of CASP9 protein]
Thimerosal results in increased activity of CASP9 protein
Glutathione inhibits the reaction [Thimerosal results in increased activity of CASP9 protein]

PMID:12140745 PMID:15869795 PMID:23145070

NCBI chr 1:15,491,401...15,524,912
Ensembl chr 1:15,490,832...15,526,534

G

Cbl proto-oncogene

decreases expression

Thimerosal results in decreased expression of CBL mRNA

NCBI chr11:119,206,339...119,308,149
Ensembl chr11:119,206,298...119,313,926

G

chromobox 3

increases expression

Thimerosal results in increased expression of CBX3 mRNA

NCBI chr 7:26,201,443...26,213,607
Ensembl chr 7:26,201,162...26,213,607

G

chromobox 5

decreases expression

Thimerosal results in decreased expression of CBX5 mRNA

NCBI chr12:54,230,942...54,280,122
Ensembl chr12:54,230,942...54,280,133

G

chromobox 7

decreases expression

Thimerosal results in decreased expression of CBX7 mRNA

NCBI chr22:39,130,772...39,152,680
Ensembl chr22:39,120,167...39,152,680

G

coiled-coil and C2 domain containing 2B

decreases expression

Thimerosal results in decreased expression of CC2D2B mRNA

NCBI chr10:95,907,671...96,033,745
Ensembl chr10:95,907,603...96,033,745

G

coiled-coil domain containing 126

increases expression

Thimerosal results in increased expression of CCDC126 mRNA

NCBI chr 7:23,597,382...23,644,708
Ensembl chr 7:23,597,382...23,644,708

G

coiled-coil domain containing 183

decreases expression

Thimerosal results in decreased expression of CCDC183 mRNA

NCBI chr 9:136,796,338...136,807,741
Ensembl chr 9:136,796,338...136,807,741

G

coiled-coil domain containing 186

decreases expression

Thimerosal results in decreased expression of CCDC186 mRNA

NCBI chr10:114,120,862...114,174,220
Ensembl chr10:114,120,862...114,174,232

G

coiled-coil domain containing 66

increases expression

Thimerosal results in increased expression of CCDC66 mRNA

NCBI chr 3:56,557,156...56,621,837
Ensembl chr 3:56,557,161...56,621,837

G

coiled-coil domain containing 71 like

decreases expression

Thimerosal results in decreased expression of CCDC71L mRNA

NCBI chr 7:106,654,360...106,661,158
Ensembl chr 7:106,654,360...106,661,158

G

coiled-coil domain containing 82

increases expression

Thimerosal results in increased expression of CCDC82 mRNA

NCBI chr11:96,352,773...96,389,912
Ensembl chr11:96,349,241...96,389,956

G

coiled-coil domain containing 85B

decreases expression

Thimerosal results in decreased expression of CCDC85B mRNA

NCBI chr11:65,890,673...65,891,635
Ensembl chr11:65,890,673...65,891,635

G

CCM2 like scaffold protein

decreases expression

Thimerosal results in decreased expression of CCM2L mRNA

NCBI chr20:32,010,438...32,032,180
Ensembl chr20:32,010,438...32,032,180

G

cellular communication network factor 1

increases expression

Thimerosal results in increased expression of CCN1 mRNA

NCBI chr 1:85,580,761...85,583,950
Ensembl chr 1:85,580,761...85,584,589

G

cyclin B1

multiple interactions

Thimerosal results in increased expression of and results in increased activity of CCNB1 protein

NCBI chr 5:69,167,150...69,178,245
Ensembl chr 5:69,167,135...69,178,245

G

cyclin D1

decreases expression

Thimerosal results in decreased expression of CCND1 mRNA

NCBI chr11:69,641,156...69,654,474
Ensembl chr11:69,641,156...69,654,474

G

cyclin D2

decreases expression

Thimerosal results in decreased expression of CCND2 mRNA

NCBI chr12:4,273,762...4,305,353
Ensembl chr12:4,269,771...4,305,353

G

cyclin T1

decreases expression

Thimerosal results in decreased expression of CCNT1 mRNA

NCBI chr12:48,688,458...48,716,707
Ensembl chr12:48,688,458...48,716,998

G

cyclin T2

increases expression

Thimerosal results in increased expression of CCNT2 mRNA

NCBI chr 2:134,918,822...134,959,342
Ensembl chr 2:134,918,235...134,959,342

G

coiled-coil serine rich protein 1

increases expression

Thimerosal results in increased expression of CCSER1 mRNA

NCBI chr 4:90,127,394...91,605,295
Ensembl chr 4:90,127,394...91,605,295

G

chaperonin containing TCP1 subunit 6B

increases expression

Thimerosal results in increased expression of CCT6B mRNA

NCBI chr17:34,927,861...34,961,460
Ensembl chr17:34,927,859...34,981,078

G

CCZ1 homolog B, vacuolar protein trafficking and biogenesis associated

increases expression

Thimerosal results in increased expression of CCZ1B mRNA

NCBI chr 7:6,798,937...6,826,275
Ensembl chr 7:6,794,134...6,826,770

G

CD28 molecule

affects response to substance

CD28 affects the susceptibility to Thimerosal

NCBI chr 2:203,706,482...203,738,912
Ensembl chr 2:203,706,475...203,738,912

G

CD40 molecule

decreases expression

Thimerosal results in decreased expression of CD40 mRNA

NCBI chr20:46,118,314...46,129,858
Ensembl chr20:46,118,271...46,129,863

G

CD6 molecule

decreases expression

Thimerosal results in decreased expression of CD6 mRNA

NCBI chr11:60,971,680...61,020,377
Ensembl chr11:60,971,680...61,020,377

G

CD79b molecule

increases expression

Thimerosal results in increased expression of CD79B mRNA

NCBI chr17:63,928,740...63,932,331
Ensembl chr17:63,928,738...63,932,336

G

CD81 molecule

decreases expression

Thimerosal results in decreased expression of CD81 mRNA

NCBI chr11:2,376,180...2,397,397
Ensembl chr11:2,376,177...2,397,802

G

CD86 molecule

multiple interactions
increases expression

Acetylcysteine inhibits the reaction [Thimerosal results in increased expression of CD86 protein]; Cysteine inhibits the reaction [Thimerosal results in increased expression of CD86 protein]; Glutathione inhibits the reaction [Thimerosal results in increased expression of CD86 protein]; Vitamin E inhibits the reaction [Thimerosal results in increased expression of CD86 protein]

PMID:15737199 PMID:20417223 PMID:20457211

NCBI chr 3:122,055,362...122,121,136
Ensembl chr 3:122,055,362...122,121,139

G

CD99 molecule (Xg blood group)

decreases expression

Thimerosal results in decreased expression of CD99 mRNA

NCBI chr  X:2,691,295...2,741,309
NCBI chr  Y:2,691,295...2,741,309
Ensembl chr  Y:2,691,187...2,741,309
Ensembl chr  X:2,691,187...2,741,309

G

cell division cycle 20B

increases expression

Thimerosal results in increased expression of CDC20B mRNA

NCBI chr 5:55,112,971...55,173,177
Ensembl chr 5:55,112,971...55,173,177

G

cell division cycle 27

decreases expression

Thimerosal results in decreased expression of CDC27 mRNA

NCBI chr17:47,117,703...47,189,295
Ensembl chr17:47,117,703...47,189,422

G

cell division cycle 37 like 1, HSP90 cochaperone

increases expression

Thimerosal results in increased expression of CDC37L1 mRNA

NCBI chr 9:4,679,569...4,708,399
Ensembl chr 9:4,679,559...4,708,399

G

CDC42 small effector 2

increases expression

Thimerosal results in increased expression of CDC42SE2 mRNA

NCBI chr 5:131,210,052...131,394,672
Ensembl chr 5:131,245,493...131,398,447

G

cell division cycle associated 2

decreases expression

Thimerosal results in decreased expression of CDCA2 mRNA

NCBI chr 8:25,458,931...25,507,917
Ensembl chr 8:25,459,199...25,507,911

G

cadherin 8

increases expression

Thimerosal results in increased expression of CDH8 mRNA

NCBI chr16:61,647,250...62,036,438
Ensembl chr16:61,647,242...62,037,035

G

cadherin related family member 1

increases expression

Thimerosal results in increased expression of CDHR1 mRNA

NCBI chr10:84,194,537...84,219,621
Ensembl chr10:84,194,537...84,219,621

G

cyclin dependent kinase 1

increases expression

Thimerosal results in increased expression of CDK1 mRNA

NCBI chr10:60,778,331...60,794,852
Ensembl chr10:60,778,331...60,794,852

G

cyclin dependent kinase 14

affects expression

Thimerosal affects the expression of CDK14 mRNA

NCBI chr 7:90,596,321...91,210,590
Ensembl chr 7:90,466,424...91,210,590

G

cyclin dependent kinase 16

decreases expression

Thimerosal results in decreased expression of CDK16 mRNA

NCBI chr X:47,218,303...47,229,997
Ensembl chr X:47,217,860...47,229,997

G

cyclin dependent kinase 4

decreases expression

Thimerosal results in decreased expression of CDK4 protein

NCBI chr12:57,747,727...57,752,310
Ensembl chr12:57,747,727...57,756,013

G

cyclin dependent kinase 6

decreases expression

Thimerosal results in decreased expression of CDK6 mRNA

NCBI chr 7:92,604,921...92,836,573
Ensembl chr 7:92,604,921...92,836,573

G

cyclin dependent kinase inhibitor 1C

decreases expression

Thimerosal results in decreased expression of CDKN1C mRNA

NCBI chr11:2,883,218...2,885,775
Ensembl chr11:2,883,213...2,885,775

G

chromatin licensing and DNA replication factor 1

decreases expression

Thimerosal results in decreased expression of CDT1 mRNA

NCBI chr16:88,803,789...88,809,258
Ensembl chr16:88,803,789...88,809,258

G

centromere protein N

increases expression

Thimerosal results in increased expression of CENPN mRNA

NCBI chr16:81,007,214...81,033,107
Ensembl chr16:81,006,552...81,033,114

G

centromere protein Q

increases expression

Thimerosal results in increased expression of CENPQ mRNA

NCBI chr 6:49,463,370...49,493,107
Ensembl chr 6:49,463,370...49,493,107

G

centromere protein U

increases expression

Thimerosal results in increased expression of CENPU mRNA

NCBI chr 4:184,694,085...184,734,096
Ensembl chr 4:184,694,085...184,734,130

G

centrosomal protein 126

decreases expression

Thimerosal results in decreased expression of CEP126 mRNA

NCBI chr11:101,915,010...102,001,062
Ensembl chr11:101,915,010...102,001,062

G

centrosomal protein 350

decreases expression

Thimerosal results in decreased expression of CEP350 mRNA

NCBI chr 1:179,954,810...180,114,875
Ensembl chr 1:179,954,674...180,114,880

G

centrosomal protein 89

decreases expression

Thimerosal results in decreased expression of CEP89 mRNA

NCBI chr19:32,875,925...32,971,958
Ensembl chr19:32,875,925...32,971,991

G

cilia and flagella associated protein 263

decreases expression

Thimerosal results in decreased expression of CFAP263 mRNA

NCBI chr16:58,249,936...58,283,836
Ensembl chr16:58,231,157...58,283,836

G

cilia and flagella associated protein 300

increases expression

Thimerosal results in increased expression of CFAP300 mRNA

NCBI chr11:102,047,437...102,084,554
Ensembl chr11:102,047,437...102,084,554

G

cilia and flagella associated protein 44

increases expression

Thimerosal results in increased expression of CFAP44 mRNA

NCBI chr 3:113,286,930...113,441,514
Ensembl chr 3:113,286,930...113,441,610

G

cilia and flagella associated protein 96

decreases expression

Thimerosal results in decreased expression of CFAP96 mRNA

NCBI chr 4:185,408,434...185,449,826
Ensembl chr 4:185,426,249...185,449,826

G

complement factor properdin

decreases expression

Thimerosal results in decreased expression of CFP mRNA

NCBI chr X:47,623,282...47,630,305
Ensembl chr X:47,623,172...47,630,305

G

glycoprotein hormones, alpha polypeptide

increases expression

Thimerosal results in increased expression of CGA mRNA

NCBI chr 6:87,085,498...87,095,106
Ensembl chr 6:87,085,498...87,095,106

G

coiled-coil-helix-coiled-coil-helix domain containing 10

decreases expression

Thimerosal results in decreased expression of CHCHD10 mRNA

NCBI chr22:23,765,834...23,767,972
Ensembl chr22:23,765,834...23,767,972

G

chromodomain helicase DNA binding protein 4

decreases expression

Thimerosal results in decreased expression of CHD4 mRNA

NCBI chr12:6,570,082...6,607,379
Ensembl chr12:6,570,082...6,614,524

G

chromodomain helicase DNA binding protein 9

increases expression

Thimerosal results in increased expression of CHD9 mRNA

NCBI chr16:53,054,991...53,327,497
Ensembl chr16:53,054,991...53,329,150

G

charged multivesicular body protein 5

increases expression

Thimerosal results in increased expression of CHMP5 mRNA

NCBI chr 9:33,265,049...33,282,070
Ensembl chr 9:33,264,879...33,282,070

G

chimerin 2

increases expression

Thimerosal results in increased expression of CHN2 mRNA

NCBI chr 7:29,146,591...29,514,328
Ensembl chr 7:29,146,547...29,514,328

G

choline phosphotransferase 1

increases expression

Thimerosal results in increased expression of CHPT1 mRNA

NCBI chr12:101,697,640...101,729,074
Ensembl chr12:101,696,947...101,744,140

G

calcium and integrin binding family member 2

decreases expression

Thimerosal results in decreased expression of CIB2 mRNA

NCBI chr15:78,104,606...78,131,535
Ensembl chr15:78,104,606...78,131,535

G

CBY1 interacting BAR domain containing 1

decreases expression

Thimerosal results in decreased expression of CIBAR1 mRNA

NCBI chr 8:93,700,550...93,731,527
Ensembl chr 8:93,698,561...93,731,527

G

cartilage intermediate layer protein 2

decreases expression

Thimerosal results in decreased expression of CILP2 mRNA

NCBI chr19:19,538,265...19,546,659
Ensembl chr19:19,538,248...19,546,659

G

CDGSH iron sulfur domain 2

increases expression

Thimerosal results in increased expression of CISD2 mRNA

NCBI chr 4:102,868,992...102,892,807
Ensembl chr 4:102,868,974...102,892,807

G

Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 2

increases expression

Thimerosal results in increased expression of CITED2 mRNA

NCBI chr 6:139,371,807...139,374,648
Ensembl chr 6:139,371,807...139,374,648

G

cytoplasmic linker associated protein 2

increases expression

Thimerosal results in increased expression of CLASP2 mRNA

NCBI chr 3:33,496,245...33,718,254
Ensembl chr 3:33,496,245...33,718,356

G

CDC like kinase 4

increases expression

Thimerosal results in increased expression of CLK4 mRNA

NCBI chr 5:178,602,664...178,627,050
Ensembl chr 5:178,602,664...178,630,615

G

cleavage factor polyribonucleotide kinase subunit 1

increases expression

Thimerosal results in increased expression of CLP1 mRNA

NCBI chr11:57,657,762...57,661,865
Ensembl chr11:57,648,188...57,661,865

G

clusterin

increases expression
decreases expression

Thimerosal results in increased expression of CLU mRNA
Thimerosal results in decreased expression of CLU mRNA

PMID:16870260 PMID:27188386

NCBI chr 8:27,596,917...27,614,700
Ensembl chr 8:27,596,917...27,614,700

G

c-Maf inducing protein

decreases expression

Thimerosal results in decreased expression of CMIP mRNA

NCBI chr16:81,444,808...81,711,762
Ensembl chr16:81,444,808...81,711,762

G

cornifelin

decreases expression

Thimerosal results in decreased expression of CNFN mRNA

NCBI chr19:42,387,019...42,390,297
Ensembl chr19:42,387,019...42,390,297

G

CCR4-NOT transcription complex subunit 7

increases expression

Thimerosal results in increased expression of CNOT7 mRNA

NCBI chr 8:17,224,966...17,246,857
Ensembl chr 8:17,224,966...17,246,878

G

CCR4-NOT transcription complex subunit 9

increases expression

Thimerosal results in increased expression of CNOT9 mRNA

NCBI chr 2:218,568,839...218,597,080
Ensembl chr 2:218,568,580...218,597,080

G

canopy FGF signaling regulator 2

decreases expression

Thimerosal results in decreased expression of CNPY2 mRNA

NCBI chr12:56,309,844...56,316,346
Ensembl chr12:56,309,842...56,316,119

G

contactin associated protein 2

decreases expression

Thimerosal results in decreased expression of CNTNAP2 mRNA

NCBI chr 7:146,116,801...148,420,998
Ensembl chr 7:146,116,002...148,420,998

G

CNTNAP3 pseudogene 2

decreases expression

Thimerosal results in decreased expression of CNTNAP3P2 mRNA

NCBI chr 9:67,059,460...67,297,156
Ensembl chr 9:67,059,560...67,293,468

G

cordon-bleu WH2 repeat protein like 1

increases expression

Thimerosal results in increased expression of COBLL1 mRNA

NCBI chr 2:164,657,931...164,842,076
Ensembl chr 2:164,653,624...164,843,679

G

component of oligomeric golgi complex 3

increases expression

Thimerosal results in increased expression of COG3 mRNA

NCBI chr13:45,464,939...45,536,701
Ensembl chr13:45,464,898...45,536,701

G

collagen type XXI alpha 1 chain

increases expression

Thimerosal results in increased expression of COL21A1 mRNA

NCBI chr 6:56,056,590...56,394,128
Ensembl chr 6:56,056,590...56,394,094

G

collagen type XXII alpha 1 chain

decreases expression

Thimerosal results in decreased expression of COL22A1 mRNA

NCBI chr 8:138,588,235...138,914,041
Ensembl chr 8:138,588,235...138,914,041

G

collagen type IV alpha 6 chain

increases expression

Thimerosal results in increased expression of COL4A6 mRNA

NCBI chr X:108,155,614...108,439,458
Ensembl chr X:108,155,607...108,439,497

G

collagen type IX alpha 2 chain

decreases expression

Thimerosal results in decreased expression of COL9A2 mRNA

NCBI chr 1:40,300,489...40,317,286
Ensembl chr 1:40,300,489...40,317,813

G

COP9 signalosome subunit 7B

increases expression

Thimerosal results in increased expression of COPS7B mRNA

NCBI chr 2:231,781,671...231,809,253
Ensembl chr 2:231,781,671...231,809,254

G

cytochrome c oxidase assembly homolog COX15

decreases expression

Thimerosal results in decreased expression of COX15 mRNA

NCBI chr10:99,694,293...99,732,127
Ensembl chr10:99,710,868...99,732,127

G

cytochrome c oxidase subunit 4I1

increases expression

Thimerosal results in increased expression of COX4I1 mRNA

NCBI chr16:85,799,695...85,807,068
Ensembl chr16:85,798,633...85,807,068

G

cytoplasmic polyadenylation element binding protein 2

multiple interactions
increases expression

[NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CPEB2 mRNA
Thimerosal results in increased expression of CPEB2 mRNA

NCBI chr 4:15,002,481...15,070,151
Ensembl chr 4:15,002,481...15,070,153

G

cytoplasmic polyadenylation element binding protein 3

increases expression

Thimerosal results in increased expression of CPEB3 mRNA

NCBI chr10:92,046,692...92,291,233
Ensembl chr10:92,046,692...92,291,078

G

copine 3

decreases expression

Thimerosal results in decreased expression of CPNE3 mRNA

NCBI chr 8:86,514,435...86,561,498
Ensembl chr 8:86,514,435...86,561,498

G

carbamoyl-phosphate synthase 1

decreases expression

Thimerosal results in decreased expression of CPS1 mRNA

NCBI chr 2:210,477,685...210,679,107
Ensembl chr 2:210,477,682...210,679,107

G

CGRP receptor component

decreases expression

Thimerosal results in decreased expression of CRCP mRNA

NCBI chr 7:66,114,818...66,154,568
Ensembl chr 7:66,114,604...66,154,568

G

cAMP responsive element binding protein 1

decreases expression

Thimerosal results in decreased expression of CREB1 mRNA

NCBI chr 2:207,529,962...207,605,988
Ensembl chr 2:207,529,737...207,605,988

G

cysteine rich protein 3

decreases expression

Thimerosal results in decreased expression of CRIP3 mRNA

NCBI chr 6:43,305,472...43,308,826
Ensembl chr 6:43,299,710...43,308,826

G

crystallin alpha B

increases expression

Thimerosal results in increased expression of CRYAB mRNA

NCBI chr11:111,908,564...111,923,740
Ensembl chr11:111,908,564...111,923,722

G

citrate synthase

decreases expression

Thimerosal results in decreased expression of CS mRNA

NCBI chr12:56,271,699...56,300,330
Ensembl chr12:56,271,699...56,300,391

G

centrosome and spindle pole associated protein 1

increases expression

Thimerosal results in increased expression of CSPP1 mRNA

NCBI chr 8:67,064,368...67,196,614
Ensembl chr 8:67,062,417...67,196,778

G

CTD small phosphatase like 2

increases expression

Thimerosal results in increased expression of CTDSPL2 mRNA

NCBI chr15:44,427,629...44,529,038
Ensembl chr15:44,427,622...44,529,038

G

catenin alpha 1

decreases expression

Thimerosal results in decreased expression of CTNNA1 mRNA

NCBI chr 5:138,753,425...138,935,034
Ensembl chr 5:138,610,967...138,935,034

G

cortexin 3

increases expression

Thimerosal results in increased expression of CTXN3 mRNA

NCBI chr 5:127,649,082...127,658,630
Ensembl chr 5:127,649,082...127,658,630

G

C-X-C motif chemokine ligand 8

multiple interactions
increases secretion

Acetylcysteine inhibits the reaction [Thimerosal results in increased secretion of CXCL8 protein]; Glutathione inhibits the reaction [Thimerosal results in increased secretion of CXCL8 protein]

PMID:18495191 PMID:19729060 PMID:20417223 PMID:20457211

NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716

G

chromosome X open reading frame 38

decreases expression

Thimerosal results in decreased expression of CXORF38 mRNA

NCBI chr X:40,626,921...40,647,561
Ensembl chr X:40,626,921...40,647,561

G

cytochrome b5 reductase 3

decreases expression

Thimerosal results in decreased expression of CYB5R3 mRNA

NCBI chr22:42,617,840...42,649,392
Ensembl chr22:42,615,730...42,720,870

G

cytochrome b5 reductase 4

increases expression

Thimerosal results in increased expression of CYB5R4 mRNA

NCBI chr 6:83,859,689...83,967,423
Ensembl chr 6:83,859,656...83,967,423

G

cytochrome P450 family 39 subfamily A member 1

increases expression

Thimerosal results in increased expression of CYP39A1 mRNA

NCBI chr 6:46,549,580...46,652,818
Ensembl chr 6:46,549,580...46,652,830

G

dishevelled binding antagonist of beta catenin 3

decreases expression

Thimerosal results in decreased expression of DACT3 mRNA

NCBI chr19:46,647,551...46,661,182
Ensembl chr19:46,647,551...46,661,182

G

drebrin 1

decreases expression

Thimerosal results in decreased expression of DBN1 mRNA

NCBI chr 5:177,456,610...177,473,634
Ensembl chr 5:177,456,608...177,474,401

G

DDB1 and CUL4 associated factor 13

increases expression

Thimerosal results in increased expression of DCAF13 mRNA

NCBI chr 8:103,415,386...103,443,453
Ensembl chr 8:103,414,714...103,443,453

G

DDB1 and CUL4 associated factor 16

decreases expression

Thimerosal results in decreased expression of DCAF16 mRNA

NCBI chr 4:17,793,446...17,810,757
Ensembl chr 4:17,800,655...17,810,758

G

DDB1 and CUL4 associated factor 4

decreases expression

Thimerosal results in decreased expression of DCAF4 mRNA

NCBI chr14:72,926,464...72,962,098
Ensembl chr14:72,926,377...72,959,703

G

DDB1 and CUL4 associated factor 7

decreases expression

Thimerosal results in decreased expression of DCAF7 mRNA

NCBI chr17:63,550,477...63,594,266
Ensembl chr17:63,550,222...63,594,286

G

DCC netrin 1 receptor

increases expression

Thimerosal results in increased expression of DCC mRNA

NCBI chr18:52,340,197...53,535,899
Ensembl chr18:52,340,197...53,535,899

G

defective in cullin neddylation 1 domain containing 1

increases expression

Thimerosal results in increased expression of DCUN1D1 mRNA

NCBI chr 3:182,938,074...182,985,918
Ensembl chr 3:182,938,074...182,985,953

G

doublecortin

increases expression

Thimerosal results in increased expression of DCX mRNA

NCBI chr X:111,293,779...111,412,192
Ensembl chr X:111,293,779...111,412,429

G

DExD-box helicase 39B

decreases expression

Thimerosal results in decreased expression of DDX39B mRNA

NCBI chr 6:31,530,226...31,542,003
Ensembl chr 6:31,530,219...31,542,448

G

DEAD-box helicase 6

decreases expression

Thimerosal results in decreased expression of DDX6 mRNA

NCBI chr11:118,747,763...118,791,744
Ensembl chr11:118,747,763...118,791,164

G

DENN domain containing 1B

increases expression

Thimerosal results in increased expression of DENND1B mRNA

NCBI chr 1:197,504,748...197,782,150
Ensembl chr 1:197,504,748...197,775,696

G

Dexi homolog

decreases expression

Thimerosal results in decreased expression of DEXI mRNA

NCBI chr16:10,928,891...10,942,468
Ensembl chr16:10,928,891...10,942,468

G

diacylglycerol O-acyltransferase 1

decreases expression

Thimerosal results in decreased expression of DGAT1 mRNA

NCBI chr 8:144,314,584...144,326,852
Ensembl chr 8:144,314,584...144,326,910

G

24-dehydrocholesterol reductase

decreases expression

Thimerosal results in decreased expression of DHCR24 mRNA

NCBI chr 1:54,849,627...54,887,195
Ensembl chr 1:54,849,627...54,887,195

G

7-dehydrocholesterol reductase

decreases expression

Thimerosal results in decreased expression of DHCR7 mRNA

NCBI chr11:71,434,411...71,448,393
Ensembl chr11:71,428,193...71,452,868

G

dehydrogenase/reductase 1

decreases expression

Thimerosal results in decreased expression of DHRS1 mRNA

NCBI chr14:24,290,598...24,299,780
Ensembl chr14:24,290,598...24,299,780

G

DEAH-box helicase 36

increases expression

Thimerosal results in increased expression of DHX36 mRNA

NCBI chr 3:154,272,546...154,324,487
Ensembl chr 3:154,272,546...154,324,487

G

DExH-box helicase 9

decreases expression

Thimerosal results in decreased expression of DHX9 mRNA

NCBI chr 1:182,839,347...182,887,982
Ensembl chr 1:182,839,347...182,887,982

G

DICER1 antisense RNA 1

decreases expression

Thimerosal results in decreased expression of DICER1-AS1 mRNA

NCBI chr14:95,157,688...95,179,933
Ensembl chr14:95,157,645...95,181,475

G

dickkopf like acrosomal protein 1

decreases expression

Thimerosal results in decreased expression of DKKL1 mRNA

NCBI chr19:49,360,515...49,375,116
Ensembl chr19:49,361,783...49,375,116

G

deleted in lymphocytic leukemia 2

increases expression

Thimerosal results in increased expression of DLEU2 mRNA

NCBI chr13:49,982,549...50,125,541
Ensembl chr13:49,956,670...50,125,720

G

discs large MAGUK scaffold protein 1

decreases expression

Thimerosal results in decreased expression of DLG1 mRNA

NCBI chr 3:197,042,560...197,299,321
Ensembl chr 3:197,042,560...197,299,330

G

DLX6 antisense RNA 1

increases expression

Thimerosal results in increased expression of DLX6OS1 mRNA

NCBI chr 7:96,968,515...97,014,065
Ensembl chr 7:96,955,141...97,014,088

G

DnaJ heat shock protein family (Hsp40) member B1

increases expression

Thimerosal results in increased expression of DNAJB1 mRNA

NCBI chr19:14,514,769...14,560,391
Ensembl chr19:14,514,769...14,560,391

G

DnaJ heat shock protein family (Hsp40) member B4

increases expression

Thimerosal results in increased expression of DNAJB4 mRNA

NCBI chr 1:77,979,175...78,017,964
Ensembl chr 1:77,979,175...78,017,964

G

DnaJ heat shock protein family (Hsp40) member C13

decreases expression

Thimerosal results in decreased expression of DNAJC13 mRNA

NCBI chr 3:132,417,502...132,539,032
Ensembl chr 3:132,417,502...132,539,032

G

DnaJ heat shock protein family (Hsp40) member C4

decreases expression

Thimerosal results in decreased expression of DNAJC4 mRNA

NCBI chr11:64,230,432...64,234,281
Ensembl chr11:64,230,278...64,234,286

G

deoxyribonuclease 1

decreases expression

Thimerosal results in decreased expression of DNASE1 mRNA

NCBI chr16:3,611,760...3,665,461
Ensembl chr16:3,611,728...3,680,143

G

DNA methyltransferase 3 alpha

decreases expression

Thimerosal results in decreased expression of DNMT3A mRNA

NCBI chr 2:25,227,874...25,342,590
Ensembl chr 2:25,227,855...25,342,590

G

dedicator of cytokinesis 11

decreases expression

Thimerosal results in decreased expression of DOCK11 mRNA

NCBI chr X:118,495,815...118,686,147
Ensembl chr X:118,495,815...118,686,163

G

dedicator of cytokinesis 4

increases expression

Thimerosal results in increased expression of DOCK4 mRNA

NCBI chr 7:111,726,110...112,206,399
Ensembl chr 7:111,726,110...112,206,407

G

dedicator of cytokinesis 6

decreases expression

Thimerosal results in decreased expression of DOCK6 mRNA

NCBI chr19:11,199,295...11,262,524
Ensembl chr19:11,199,295...11,262,524

G

dystonin

affects expression

Thimerosal affects the expression of DST mRNA

NCBI chr 6:56,457,996...56,954,830
Ensembl chr 6:56,457,987...56,954,830

G

DPPA2 upstream binding RNA

decreases expression

Thimerosal results in decreased expression of DUBR mRNA

NCBI chr 3:107,240,692...107,326,964
Ensembl chr 3:107,220,744...107,348,464

G

dual specificity phosphatase 1

increases expression

Thimerosal results in increased expression of DUSP1 mRNA

NCBI chr 5:172,768,096...172,771,195
Ensembl chr 5:172,768,096...172,771,195

G

dual specificity phosphatase 7

decreases expression

Thimerosal results in decreased expression of DUSP7 mRNA

NCBI chr 3:52,048,919...52,056,571
Ensembl chr 3:52,048,919...52,056,571

G

dynein light chain Tctex-type 2B

increases expression

Thimerosal results in increased expression of DYNLT2B mRNA

NCBI chr 3:196,291,219...196,318,240
Ensembl chr 3:196,291,219...196,318,299

G

enoyl-CoA hydratase domain containing 2

decreases expression

Thimerosal results in decreased expression of ECHDC2 mRNA

NCBI chr 1:52,895,910...52,921,774
Ensembl chr 1:52,895,910...52,927,212

G

ECRG4 augurin precursor

decreases expression

Thimerosal results in decreased expression of ECRG4 mRNA

NCBI chr 2:106,063,241...106,078,155
Ensembl chr 2:106,063,246...106,078,155

G

endothelin receptor type B

decreases expression

Thimerosal results in decreased expression of EDNRB mRNA

NCBI chr13:77,895,481...77,975,527
Ensembl chr13:77,895,481...77,975,529

G

early endosome antigen 1

decreases expression

Thimerosal results in decreased expression of EEA1 mRNA

NCBI chr12:92,770,637...92,929,295
Ensembl chr12:92,770,637...92,929,331

G

eukaryotic translation elongation factor 1 alpha 2

decreases expression

Thimerosal results in decreased expression of EEF1A2 mRNA

NCBI chr20:63,488,014...63,499,083
Ensembl chr20:63,488,013...63,499,239

G

EEF1A lysine methyltransferase 3

decreases expression

Thimerosal results in decreased expression of EEF1AKMT3 mRNA

NCBI chr12:57,772,614...57,782,541
Ensembl chr12:57,771,492...57,782,541

G

EF-hand calcium binding domain 14

decreases expression

Thimerosal results in decreased expression of EFCAB14 mRNA

NCBI chr 1:46,675,159...46,719,114
Ensembl chr 1:46,674,659...46,719,146

G

EGF like domain multiple 7

decreases expression

Thimerosal results in decreased expression of EGFL7 mRNA

PMID:24675092 PMID:27188386

NCBI chr 9:136,658,856...136,672,678
Ensembl chr 9:136,658,856...136,672,678

G

egl-9 family hypoxia inducible factor 1

decreases expression

Thimerosal results in decreased expression of EGLN1 mRNA

NCBI chr 1:231,363,756...231,422,287
Ensembl chr 1:231,363,751...231,422,287

G

egl-9 family hypoxia inducible factor 3

decreases expression

Thimerosal results in decreased expression of EGLN3 mRNA

NCBI chr14:33,924,227...33,951,074
Ensembl chr14:33,924,227...34,462,774

G

EH domain binding protein 1

decreases expression

Thimerosal results in decreased expression of EHBP1 mRNA

NCBI chr 2:62,673,878...63,046,487
Ensembl chr 2:62,673,851...63,046,487

G

EH domain containing 4

decreases expression

Thimerosal results in decreased expression of EHD4 mRNA

NCBI chr15:41,895,933...41,972,557
Ensembl chr15:41,895,933...41,972,557

G

euchromatic histone lysine methyltransferase 1

decreases expression

Thimerosal results in decreased expression of EHMT1 mRNA

NCBI chr 9:137,619,005...137,836,127
Ensembl chr 9:137,618,992...137,870,016

G

eukaryotic translation initiation factor 3 subunit F

decreases expression

Thimerosal results in decreased expression of EIF3F mRNA

NCBI chr11:7,987,337...8,001,852
Ensembl chr11:7,970,251...8,001,862

G

eukaryotic translation initiation factor 4B

decreases expression

Thimerosal results in decreased expression of EIF4B mRNA

NCBI chr12:53,006,456...53,042,215
Ensembl chr12:53,006,282...53,042,215

G

eukaryotic translation initiation factor 4 gamma 1

decreases expression

Thimerosal results in decreased expression of EIF4G1 mRNA

NCBI chr 3:184,314,606...184,335,358
Ensembl chr 3:184,314,495...184,335,358

G

eukaryotic translation initiation factor 5A2

decreases expression

Thimerosal results in decreased expression of EIF5A2 mRNA

NCBI chr 3:170,888,418...170,908,637
Ensembl chr 3:170,888,418...170,908,644

G

elaC ribonuclease Z 1

increases expression

Thimerosal results in increased expression of ELAC1 mRNA

NCBI chr18:50,968,040...50,988,121
Ensembl chr18:50,967,991...50,988,121

G

engulfment and cell motility 1

decreases expression

Thimerosal results in decreased expression of ELMO1 mRNA

NCBI chr 7:36,852,906...37,449,326
Ensembl chr 7:36,852,906...37,449,223

G

elongin A

decreases expression

Thimerosal results in decreased expression of ELOA mRNA

NCBI chr 1:23,743,471...23,762,059
Ensembl chr 1:23,743,448...23,762,059

G

EMAP like 5

increases expression

Thimerosal results in increased expression of EML5 mRNA

NCBI chr14:88,612,431...88,792,953
Ensembl chr14:88,612,431...88,792,953

G

enolase 1

decreases expression

Thimerosal results in decreased expression of ENO1 mRNA

NCBI chr 1:8,861,000...8,878,686
Ensembl chr 1:8,861,000...8,879,190

G

enolase 2

decreases expression

Thimerosal results in decreased expression of ENO2 mRNA

NCBI chr12:6,914,580...6,923,697
Ensembl chr12:6,913,745...6,923,698

G

enolase 3

decreases expression

Thimerosal results in decreased expression of ENO3 mRNA

NCBI chr17:4,948,710...4,957,129
Ensembl chr17:4,948,092...4,957,131

G

ectonucleotide pyrophosphatase/phosphodiesterase family member 5

decreases expression

Thimerosal results in decreased expression of ENPP5 mRNA

NCBI chr 6:46,159,185...46,170,980
Ensembl chr 6:46,159,185...46,170,980

G

E1A binding protein p400

decreases expression

Thimerosal results in decreased expression of EP400 mRNA

NCBI chr12:131,949,942...132,080,460
Ensembl chr12:131,949,942...132,080,460

G

erythrocyte membrane protein band 4.1 like 1

decreases expression

Thimerosal results in decreased expression of EPB41L1 mRNA

NCBI chr20:36,091,414...36,232,799
Ensembl chr20:36,091,504...36,232,799

G

erythrocyte membrane protein band 4.1 like 4A

decreases expression

Thimerosal results in decreased expression of EPB41L4A mRNA

NCBI chr 5:112,141,829...112,419,935
Ensembl chr 5:112,142,441...112,419,313

G

erythrocyte membrane protein band 4.1 like 5

decreases expression

Thimerosal results in decreased expression of EPB41L5 mRNA

NCBI chr 2:120,013,077...120,179,119
Ensembl chr 2:120,013,077...120,179,119

G

enhancer of polycomb homolog 1

increases expression

Thimerosal results in increased expression of EPC1 mRNA

NCBI chr10:32,267,751...32,378,769
Ensembl chr10:32,267,751...32,378,798

G

epithelial cell adhesion molecule

increases expression

Thimerosal results in increased expression of EPCAM mRNA

NCBI chr 2:47,369,311...47,387,020
Ensembl chr 2:47,345,158...47,387,601

G

elongin BC and polycomb repressive complex 2 associated protein

decreases expression

Thimerosal results in decreased expression of EPOP mRNA

NCBI chr17:38,671,703...38,674,957
Ensembl chr17:38,671,703...38,674,957

G

glutamyl-prolyl-tRNA synthetase 1

decreases expression

Thimerosal results in decreased expression of EPRS1 mRNA

NCBI chr 1:219,968,600...220,046,505
Ensembl chr 1:219,968,600...220,046,530

G

ELKS/RAB6-interacting/CAST family member 1

decreases expression

Thimerosal results in decreased expression of ERC1 mRNA

NCBI chr12:989,959...1,495,933
Ensembl chr12:990,509...1,495,933

G

ERCC excision repair 2, TFIIH core complex helicase subunit

decreases expression

Thimerosal results in decreased expression of ERCC2 mRNA

NCBI chr19:45,349,837...45,370,573
Ensembl chr19:45,349,837...45,370,918

G

ERCC6L2 antisense RNA 1

increases expression

Thimerosal results in increased expression of ERCC6L2-AS1 mRNA

NCBI chr 9:95,806,088...95,875,977
Ensembl chr 9:95,759,231...95,876,049

G

endoplasmic reticulum-golgi intermediate compartment 1

decreases expression

Thimerosal results in decreased expression of ERGIC1 mRNA

NCBI chr 5:172,834,251...172,952,683
Ensembl chr 5:172,834,251...172,952,792

G

ERGIC and golgi 2

increases expression

Thimerosal results in increased expression of ERGIC2 mRNA

NCBI chr12:29,337,352...29,381,172
Ensembl chr12:29,337,352...29,381,189

G

establishment of sister chromatid cohesion N-acetyltransferase 1

decreases expression

Thimerosal results in decreased expression of ESCO1 mRNA

NCBI chr18:21,529,284...21,600,704
Ensembl chr18:21,529,284...21,600,884

G

establishment of sister chromatid cohesion N-acetyltransferase 2

decreases expression

Thimerosal results in decreased expression of ESCO2 mRNA

NCBI chr 8:27,771,974...27,819,660
Ensembl chr 8:27,771,949...27,812,640

G

ESF1 nucleolar pre-rRNA processing protein homolog

increases expression

Thimerosal results in increased expression of ESF1 mRNA

NCBI chr20:13,714,325...13,784,919
Ensembl chr20:13,714,322...13,784,919

G

ethanolamine kinase 1

increases expression

Thimerosal results in increased expression of ETNK1 mRNA

NCBI chr12:22,625,171...22,690,665
Ensembl chr12:22,625,075...22,690,665

G

EvC ciliary complex subunit 2

decreases expression

Thimerosal results in decreased expression of EVC2 mRNA

NCBI chr 4:5,529,011...5,709,548
Ensembl chr 4:5,542,772...5,709,548

G

ecotropic viral integration site 5

decreases expression

Thimerosal results in decreased expression of EVI5 mRNA

NCBI chr 1:92,508,696...92,792,410
Ensembl chr 1:92,508,696...92,792,404

G

exonuclease 3'-5' domain containing 3

decreases expression

Thimerosal results in decreased expression of EXD3 mRNA

NCBI chr 9:137,306,896...137,423,162
Ensembl chr 9:137,306,896...137,423,211

G

exocyst complex component 6

increases expression

Thimerosal results in increased expression of EXOC6 mRNA

NCBI chr10:92,826,831...93,059,490
Ensembl chr10:92,826,831...93,059,493

G

coagulation factor XII

decreases expression

Thimerosal results in decreased expression of F12 mRNA

NCBI chr 5:177,402,141...177,409,564
Ensembl chr 5:177,402,133...177,416,583

G

fatty acid binding protein 7

increases expression

Thimerosal results in increased expression of FABP7 mRNA

NCBI chr 6:122,749,201...122,784,074
Ensembl chr 6:122,779,716...122,784,074

G

fatty acid desaturase 1

decreases expression

Thimerosal results in decreased expression of FADS1 mRNA

NCBI chr11:61,799,627...61,817,003
Ensembl chr11:61,799,627...61,829,318

G

fatty acid desaturase 2

decreases expression

Thimerosal results in decreased expression of FADS2 mRNA

NCBI chr11:61,816,203...61,867,354
Ensembl chr11:61,792,980...61,867,354

G

Fas associated factor family member 2

decreases expression

Thimerosal results in decreased expression of FAF2 mRNA

NCBI chr 5:176,448,385...176,510,074
Ensembl chr 5:176,447,628...176,510,074

G

fumarylacetoacetate hydrolase

decreases expression

Thimerosal results in decreased expression of FAH mRNA

NCBI chr15:80,152,789...80,186,949
Ensembl chr15:80,152,490...80,186,946

G

FAM111 trypsin like peptidase B

decreases expression

Thimerosal results in decreased expression of FAM111B mRNA

NCBI chr11:59,107,237...59,127,412
Ensembl chr11:59,107,185...59,127,412

G

family with sequence similarity 124 member B

decreases expression

Thimerosal results in decreased expression of FAM124B mRNA

NCBI chr 2:224,378,698...224,402,107
Ensembl chr 2:224,378,698...224,402,107

G

family with sequence similarity 135 member A

affects expression

Thimerosal affects the expression of FAM135A mRNA

NCBI chr 6:70,413,508...70,561,174
Ensembl chr 6:70,412,941...70,561,174

G

family with sequence similarity 149 member A

decreases expression

Thimerosal results in decreased expression of FAM149A mRNA

NCBI chr 4:186,104,704...186,175,337
Ensembl chr 4:186,104,419...186,175,337

G

family with sequence similarity 162 member A

decreases expression

Thimerosal results in decreased expression of FAM162A mRNA

NCBI chr 3:122,384,182...122,412,334
Ensembl chr 3:122,384,161...122,412,334

G

family with sequence similarity 168 member B

decreases expression

Thimerosal results in decreased expression of FAM168B mRNA

NCBI chr 2:131,047,876...131,093,460
Ensembl chr 2:131,047,876...131,093,460

G

family with sequence similarity 234 member B

decreases expression

Thimerosal results in decreased expression of FAM234B mRNA

NCBI chr12:13,044,381...13,083,449
Ensembl chr12:13,044,381...13,142,521

G

FAM3 metabolism regulating signaling molecule C

increases expression

Thimerosal results in increased expression of FAM3C mRNA

NCBI chr 7:121,348,878...121,396,396
Ensembl chr 7:121,348,878...121,396,364

G

family with sequence similarity 76 member B

increases expression

Thimerosal results in increased expression of FAM76B mRNA

NCBI chr11:95,768,953...95,789,782
Ensembl chr11:95,768,953...95,790,409

G

family with sequence similarity 81 member B

increases expression

Thimerosal results in increased expression of FAM81B mRNA

NCBI chr 5:95,391,366...95,450,441
Ensembl chr 5:95,391,366...95,450,454

G

family with sequence similarity 85 member A

decreases expression

Thimerosal results in decreased expression of FAM85A mRNA

NCBI chr 8:12,185,736...12,202,526

G

FA complementation group F

decreases expression

Thimerosal results in decreased expression of FANCF mRNA

NCBI chr11:22,622,533...22,625,823
Ensembl chr11:22,622,533...22,625,823

G

Fas cell surface death receptor

increases expression

Thimerosal results in increased expression of FAS mRNA

NCBI chr10:88,964,050...89,017,059
Ensembl chr10:88,953,813...89,029,605

G

fatty acid synthase

decreases expression

Thimerosal results in decreased expression of FASN mRNA

NCBI chr17:82,078,338...82,098,236
Ensembl chr17:82,078,338...82,098,294

G

FAST kinase domains 2

increases expression

Thimerosal results in increased expression of FASTKD2 mRNA

NCBI chr 2:206,765,606...206,796,189
Ensembl chr 2:206,765,357...206,796,189

G

fibulin 2

decreases expression

Thimerosal results in decreased expression of FBLN2 mRNA

NCBI chr 3:13,549,125...13,638,404
Ensembl chr 3:13,549,125...13,638,422

G

fibrillin 1

decreases expression

Thimerosal results in decreased expression of FBN1 mRNA

NCBI chr15:48,408,313...48,645,709
Ensembl chr15:48,408,313...48,645,721

G

F-box protein 3

increases expression

Thimerosal results in increased expression of FBXO3 mRNA

NCBI chr11:33,740,944...33,774,520
Ensembl chr11:33,740,939...33,774,543

G

F-box protein 7

decreases expression

Thimerosal results in decreased expression of FBXO7 mRNA

NCBI chr22:32,474,811...32,498,829
Ensembl chr22:32,474,676...32,498,829

G

F-box protein 9

increases expression

Thimerosal results in increased expression of FBXO9 mRNA

NCBI chr 6:53,064,998...53,100,873
Ensembl chr 6:53,051,991...53,100,873

G

FER tyrosine kinase

increases expression

Thimerosal results in increased expression of FER mRNA

NCBI chr 5:108,747,897...109,196,841
Ensembl chr 5:108,747,841...109,196,841

G

fer-1 like family member 4 (pseudogene)

decreases expression

Thimerosal results in decreased expression of FER1L4 mRNA

NCBI chr20:35,558,737...35,607,562
Ensembl chr20:35,558,866...35,607,494

G

FYVE, RhoGEF and PH domain containing 6

increases expression

Thimerosal results in increased expression of FGD6 mRNA

NCBI chr12:95,076,749...95,217,467
Ensembl chr12:95,076,749...95,217,482

G

fibroblast growth factor 11

decreases expression

Thimerosal results in decreased expression of FGF11 mRNA

NCBI chr17:7,438,298...7,444,937
Ensembl chr17:7,438,273...7,444,937

G

fibroblast growth factor binding protein 3

decreases expression

Thimerosal results in decreased expression of FGFBP3 mRNA

NCBI chr10:91,906,584...91,909,486
Ensembl chr10:91,906,584...91,909,486

G

FGFR1 oncogene partner 2

increases expression

Thimerosal results in increased expression of FGFR1OP2 mRNA

NCBI chr12:26,938,470...26,966,648
Ensembl chr12:26,938,470...26,966,650

G

fibroblast growth factor receptor 2

decreases expression

Thimerosal results in decreased expression of FGFR2 mRNA

NCBI chr10:121,478,330...121,598,458
Ensembl chr10:121,478,332...121,598,458

G

FKBP prolyl isomerase 10

decreases expression

Thimerosal results in decreased expression of FKBP10 mRNA

NCBI chr17:41,813,004...41,823,213
Ensembl chr17:41,812,680...41,823,213

G

folliculin

multiple interactions

[NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FLCN mRNA

NCBI chr17:17,212,212...17,237,330
Ensembl chr17:17,212,212...17,237,188

G

formin like 2

decreases expression

Thimerosal results in decreased expression of FMNL2 mRNA

NCBI chr 2:152,335,174...152,649,826
Ensembl chr 2:152,335,174...152,649,826

G

fibronectin 1

increases secretion

Thimerosal results in increased secretion of FN1 protein

NCBI chr 2:215,360,865...215,436,068
Ensembl chr 2:215,360,440...215,436,073

G

formin binding protein 4

decreases expression

Thimerosal results in decreased expression of FNBP4 mRNA

NCBI chr11:47,716,494...47,767,341
Ensembl chr11:47,716,494...47,767,443

G

fibronectin type III domain containing 10

decreases expression

Thimerosal results in decreased expression of FNDC10 mRNA

NCBI chr 1:1,598,012...1,600,135
Ensembl chr 1:1,598,012...1,600,135

G

fibronectin type III domain containing 11

decreases expression

Thimerosal results in decreased expression of FNDC11 mRNA

NCBI chr20:63,553,020...63,556,708
Ensembl chr20:63,547,891...63,556,695

G

fibronectin type III domain containing 4

decreases expression

Thimerosal results in decreased expression of FNDC4 mRNA

NCBI chr 2:27,491,883...27,495,200
Ensembl chr 2:27,491,883...27,495,200

G

folate receptor alpha

decreases expression

Thimerosal results in decreased expression of FOLR1 mRNA

NCBI chr11:72,189,709...72,196,323
Ensembl chr11:72,189,558...72,196,323

G

Fos proto-oncogene, AP-1 transcription factor subunit

increases expression

Thimerosal results in increased expression of FOS mRNA

NCBI chr14:75,278,828...75,282,230
Ensembl chr14:75,278,826...75,282,230

G

FosB proto-oncogene, AP-1 transcription factor subunit

increases expression

Thimerosal results in increased expression of FOSB mRNA

NCBI chr19:45,467,996...45,475,179
Ensembl chr19:45,467,995...45,475,179

G

forkhead box C1

decreases expression

Thimerosal results in decreased expression of FOXC1 mRNA

NCBI chr 6:1,609,915...1,613,897
Ensembl chr 6:1,609,915...1,613,897

G

forkhead box P2

increases expression

Thimerosal results in increased expression of FOXP2 mRNA

NCBI chr 7:114,086,327...114,693,765
Ensembl chr 7:114,086,327...114,693,772

G

FRA10A associated CGG repeat 1

multiple interactions

[NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FRA10AC1 mRNA

NCBI chr10:93,667,883...93,702,959
Ensembl chr10:93,667,883...93,702,592

G

FERM domain containing 7

increases expression

Thimerosal results in increased expression of FRMD7 mRNA

NCBI chr X:132,076,990...132,128,020
Ensembl chr X:132,076,990...132,128,020

G

FERM and PDZ domain containing 3

increases expression

Thimerosal results in increased expression of FRMPD3 mRNA

NCBI chr X:107,449,652...107,605,251
Ensembl chr X:107,449,652...107,605,255

G

fibroblast growth factor receptor substrate 2

increases expression

Thimerosal results in increased expression of FRS2 mRNA

NCBI chr12:69,470,388...69,579,793
Ensembl chr12:69,470,349...69,579,793

G

follicle stimulating hormone subunit beta

increases expression

Thimerosal results in increased expression of FSHB mRNA; Thimerosal results in increased expression of FSHB protein

NCBI chr11:30,231,014...30,235,194
Ensembl chr11:30,231,014...30,235,261

G

fibrous sheath interacting protein 2

increases expression

Thimerosal results in increased expression of FSIP2 mRNA

NCBI chr 2:185,737,134...185,833,290
Ensembl chr 2:185,738,804...185,833,290

G

fucosyltransferase 1 (H blood group)

decreases expression

Thimerosal results in decreased expression of FUT1 mRNA

NCBI chr19:48,748,011...48,755,358
Ensembl chr19:48,748,011...48,755,390

G

fucosyltransferase 11

decreases expression

Thimerosal results in decreased expression of FUT11 mRNA

NCBI chr10:73,772,276...73,780,254
Ensembl chr10:73,772,276...73,780,251

G

FXYD domain containing ion transport regulator 6

decreases expression

Thimerosal results in decreased expression of FXYD6 mRNA

NCBI chr11:117,836,981...117,877,430
Ensembl chr11:117,836,976...117,877,486

G

frizzled class receptor 2

decreases expression

Thimerosal results in decreased expression of FZD2 mRNA

NCBI chr17:44,557,484...44,561,262
Ensembl chr17:44,557,484...44,561,262

G

frizzled class receptor 7

decreases expression

Thimerosal results in decreased expression of FZD7 mRNA

NCBI chr 2:202,033,855...202,038,441
Ensembl chr 2:202,033,855...202,038,441

G

G3BP stress granule assembly factor 1

affects expression

Thimerosal affects the expression of G3BP1 mRNA

NCBI chr 5:151,771,954...151,812,785
Ensembl chr 5:151,771,045...151,812,911

G

glucose-6-phosphate dehydrogenase

decreases expression

Thimerosal results in decreased expression of G6PD mRNA

NCBI chr X:154,531,390...154,547,569
Ensembl chr X:154,517,825...154,547,572

G

gamma-aminobutyric acid type A receptor subunit alpha1

increases expression

Thimerosal results in increased expression of GABRA1 mRNA

NCBI chr 5:161,847,191...161,899,971
Ensembl chr 5:161,847,063...161,899,981

G

gamma-aminobutyric acid type A receptor subunit rho1

increases expression

Thimerosal results in increased expression of GABRR1 mRNA

NCBI chr 6:89,177,504...89,231,288
Ensembl chr 6:89,177,504...89,231,278

G

growth arrest and DNA damage inducible gamma

increases expression

Thimerosal results in increased expression of GADD45G mRNA

NCBI chr 9:89,605,012...89,606,555
Ensembl chr 9:89,605,012...89,606,555

G

GTPase activating protein and VPS9 domains 1

decreases expression

Thimerosal results in decreased expression of GAPVD1 mRNA

NCBI chr 9:125,261,826...125,367,207
Ensembl chr 9:125,261,794...125,367,207

G

GRB2 associated regulator of MAPK1 subtype 1

decreases expression

Thimerosal results in decreased expression of GAREM1 mRNA

NCBI chr18:32,263,522...32,470,882
Ensembl chr18:32,124,877...32,470,882

G

GRB2 associated regulator of MAPK1 subtype 2

decreases expression

Thimerosal results in decreased expression of GAREM2 mRNA

NCBI chr 2:26,173,088...26,204,304
Ensembl chr 2:26,173,088...26,189,663

G

growth arrest specific 2 like 1

decreases expression

Thimerosal results in decreased expression of GAS2L1 mRNA

NCBI chr22:29,306,650...29,312,787
Ensembl chr22:29,306,618...29,312,787

G

1,4-alpha-glucan branching enzyme 1

decreases expression

Thimerosal results in decreased expression of GBE1 mRNA

NCBI chr 3:81,489,703...81,761,645
Ensembl chr 3:81,489,703...81,761,645

G

germ cell nuclear acidic peptidase

increases expression

Thimerosal results in increased expression of GCNA mRNA

NCBI chr X:71,578,437...71,613,583
Ensembl chr X:71,578,437...71,613,583

G

gem nuclear organelle associated protein 4

decreases expression

Thimerosal results in decreased expression of GEMIN4 mRNA

NCBI chr17:744,421...754,410
Ensembl chr17:744,421...753,999

G

G elongation factor mitochondrial 1

increases expression

Thimerosal results in increased expression of GFM1 mRNA

NCBI chr 3:158,644,527...158,695,581
Ensembl chr 3:158,644,527...158,695,581

G

growth hormone 1

increases expression

Thimerosal results in increased expression of GH mRNA

NCBI chr17:63,917,203...63,918,839
Ensembl chr17:63,917,200...63,918,839

G

growth hormone releasing hormone receptor

increases expression

Thimerosal results in increased expression of GHRHR mRNA

NCBI chr 7:30,963,953...30,979,528
Ensembl chr 7:30,938,669...30,993,254

G

GRB10 interacting GYF protein 1

increases expression

Thimerosal results in increased expression of GIGYF1 mRNA

NCBI chr 7:100,679,507...100,694,250
Ensembl chr 7:100,679,507...100,694,250

G

gypsy retrotransposon integrase 1

increases expression

Thimerosal results in increased expression of GIN1 mRNA

NCBI chr 5:103,086,000...103,120,138
Ensembl chr 5:103,086,000...103,120,138

G

GIT ArfGAP 2

decreases expression

Thimerosal results in decreased expression of GIT2 mRNA

NCBI chr12:109,929,804...110,000,164
Ensembl chr12:109,929,804...109,996,389

G

gap junction protein alpha 4

decreases expression

Thimerosal results in decreased expression of GJA4 mRNA

NCBI chr 1:34,792,999...34,795,747
Ensembl chr 1:34,792,999...34,795,747

G

glycosylated lysosomal membrane protein

decreases expression

Thimerosal results in decreased expression of GLMP mRNA

NCBI chr 1:156,292,688...156,295,679
Ensembl chr 1:156,290,089...156,295,689

G

glutaminase

increases expression

Thimerosal results in increased expression of GLS mRNA

NCBI chr 2:190,880,821...190,965,552
Ensembl chr 2:190,880,821...190,965,552

G

ganglioside GM2 activator

decreases expression

Thimerosal results in decreased expression of GM2A mRNA

NCBI chr 5:151,253,185...151,270,440
Ensembl chr 5:151,212,150...151,270,440

G

GDP-mannose 4,6-dehydratase

decreases expression

Thimerosal results in decreased expression of GMDS mRNA

NCBI chr 6:1,623,806...2,245,605
Ensembl chr 6:1,623,806...2,245,605

G

G protein subunit alpha L

decreases expression

Thimerosal results in decreased expression of GNAL mRNA

NCBI chr18:11,689,264...11,885,685
Ensembl chr18:11,689,264...11,885,685

G

G protein subunit beta 1

decreases expression

Thimerosal results in decreased expression of GNB1 mRNA

NCBI chr 1:1,785,286...1,891,087
Ensembl chr 1:1,785,285...1,892,292

G

G protein subunit gamma 4

increases expression

Thimerosal results in increased expression of GNG4 mRNA

NCBI chr 1:235,547,685...235,650,608
Ensembl chr 1:235,547,685...235,650,754

G

G protein subunit gamma 7

decreases expression

Thimerosal results in decreased expression of GNG7 mRNA

NCBI chr19:2,511,219...2,702,694
Ensembl chr19:2,511,219...2,702,694

G

gonadotropin releasing hormone receptor

increases expression

Thimerosal results in increased expression of GNRHR mRNA

NCBI chr 4:67,737,118...67,754,388
Ensembl chr 4:67,737,118...67,754,388

G

golgin A8 family member A

decreases expression

Thimerosal results in decreased expression of GOLGA8A mRNA

NCBI chr15:34,379,068...34,437,808
Ensembl chr15:34,378,935...34,437,808

G

gon-4 like

decreases expression

Thimerosal results in decreased expression of GON4L mRNA

NCBI chr 1:155,745,112...155,859,431
Ensembl chr 1:155,749,659...155,859,400

G

glycerophosphocholine phosphodiesterase 1

increases expression

Thimerosal results in increased expression of GPCPD1 mRNA

NCBI chr20:5,544,439...5,611,006
Ensembl chr20:5,544,439...5,611,006

G

glucose-6-phosphate isomerase

decreases expression

Thimerosal results in decreased expression of GPI mRNA

NCBI chr19:34,359,718...34,402,413
Ensembl chr19:34,359,480...34,402,413

G

G protein-coupled receptor 135

decreases expression

Thimerosal results in decreased expression of GPR135 mRNA

NCBI chr14:59,452,783...59,465,380
Ensembl chr14:59,429,022...59,465,380

G

G protein-coupled receptor 22

increases expression

Thimerosal results in increased expression of GPR22 mRNA

NCBI chr 7:107,470,057...107,477,845
Ensembl chr 7:107,470,018...107,475,684

G

gremlin 2, DAN family BMP antagonist

decreases expression

Thimerosal results in decreased expression of GREM2 mRNA

NCBI chr 1:240,489,573...240,612,155
Ensembl chr 1:240,489,573...240,612,155

G

glutamate ionotropic receptor kainate type subunit 2

increases expression

Thimerosal results in increased expression of GRIK2 mRNA

NCBI chr 6:101,393,708...102,070,083
Ensembl chr 6:100,962,701...102,081,622

G

glutamate ionotropic receptor kainate type subunit 5

affects expression

Thimerosal affects the expression of GRIK5 protein

NCBI chr19:41,998,324...42,070,206
Ensembl chr19:41,998,321...42,070,206

G

glutamate ionotropic receptor NMDA type subunit 1

decreases expression

Thimerosal results in decreased expression of GRIN1 protein

NCBI chr 9:137,139,154...137,168,756
Ensembl chr 9:137,138,346...137,168,756

G

glutamate ionotropic receptor NMDA type subunit 2B

decreases expression

Thimerosal results in decreased expression of GRIN2B protein

NCBI chr12:13,537,337...13,982,134
Ensembl chr12:13,437,942...13,982,002

G

G protein-coupled receptor kinase 3

decreases expression

Thimerosal results in decreased expression of GRK3 mRNA

NCBI chr22:25,564,675...25,729,294
Ensembl chr22:25,564,675...25,729,294

G

glutathione S-transferase mu 1

affects response to substance

GSTM1 affects the susceptibility to Thimerosal

NCBI chr 1:109,687,817...109,693,745
Ensembl chr 1:109,687,814...109,709,039

G

glutathione S-transferase mu 2

decreases expression

Thimerosal results in decreased expression of GSTM2 mRNA

NCBI chr 1:109,668,057...109,683,997
Ensembl chr 1:109,668,022...109,709,551

G

glutathione S-transferase theta 1

affects response to substance
decreases expression

GSTT1 affects the susceptibility to Thimerosal
Thimerosal results in decreased expression of GSTT1 mRNA

PMID:11007341 PMID:27188386

G

general transcription factor IIA subunit 1

decreases expression

Thimerosal results in decreased expression of GTF2A1 mRNA

NCBI chr14:81,175,452...81,221,390
Ensembl chr14:81,175,452...81,221,377

G

general transcription factor IIB

increases expression

Thimerosal results in increased expression of GTF2B mRNA

NCBI chr 1:88,852,633...88,891,567
Ensembl chr 1:88,852,633...88,891,944

G

general transcription factor IIF subunit 1

decreases expression

Thimerosal results in decreased expression of GTF2F1 mRNA

NCBI chr19:6,379,572...6,393,164
Ensembl chr19:6,379,572...6,393,981

G

guanylate cyclase activator 1A

decreases expression

Thimerosal results in decreased expression of GUCA1A mRNA

NCBI chr 6:42,173,364...42,180,056
Ensembl chr 6:42,173,364...42,181,338

G

GULP PTB domain containing engulfment adaptor 1

increases expression

Thimerosal results in increased expression of GULP1 mRNA

NCBI chr 2:188,291,874...188,595,926
Ensembl chr 2:188,291,669...188,595,931

G

glucoside xylosyltransferase 1

decreases expression

Thimerosal results in decreased expression of GXYLT1 mRNA

NCBI chr12:42,081,845...42,144,874
Ensembl chr12:42,081,845...42,144,874

G

glycophorin B (MNS blood group)

increases expression

Thimerosal results in increased expression of GYPB mRNA

NCBI chr 4:143,995,188...144,019,380
Ensembl chr 4:143,996,104...144,019,380

G

H1.0 linker histone

decreases expression

Thimerosal results in decreased expression of H1-0 mRNA

NCBI chr22:37,805,229...37,807,432
Ensembl chr22:37,805,229...37,807,432

G

H1.10 linker histone

decreases expression

Thimerosal results in decreased expression of H1-10 mRNA

NCBI chr 3:129,314,771...129,316,286
Ensembl chr 3:129,314,771...129,316,286

G

H1.3 linker histone, cluster member

decreases expression

Thimerosal results in decreased expression of H1-3 mRNA

NCBI chr 6:26,234,212...26,234,987
Ensembl chr 6:26,234,212...26,234,987

G

H1.4 linker histone, cluster member

decreases expression

Thimerosal results in decreased expression of H1-4 mRNA

NCBI chr 6:26,156,329...26,157,115
Ensembl chr 6:26,156,329...26,157,115

G

H3 clustered histone 2

increases expression

Thimerosal results in increased expression of H3C2 mRNA

NCBI chr 6:26,031,589...26,032,099
Ensembl chr 6:26,031,589...26,032,099

G

H3 clustered histone 8

increases expression

Thimerosal results in increased expression of H3C8 mRNA

NCBI chr 6:26,270,918...26,271,413
Ensembl chr 6:26,270,918...26,271,413

G

H4 clustered histone 11

increases expression

Thimerosal results in increased expression of H4C11 mRNA

NCBI chr 6:27,824,092...27,824,480
Ensembl chr 6:27,824,092...27,824,480

G

H4 clustered histone 8

increases expression

Thimerosal results in increased expression of H4C8 mRNA

NCBI chr 6:26,285,126...26,285,534
Ensembl chr 6:26,277,609...26,285,638

G

3-hydroxyacyl-CoA dehydratase 2

decreases expression

Thimerosal results in decreased expression of HACD2 mRNA

NCBI chr 3:123,491,554...123,585,053
Ensembl chr 3:123,490,820...123,585,053

G

hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha

decreases expression

Thimerosal results in decreased expression of HADHA mRNA

NCBI chr 2:26,190,635...26,244,632
Ensembl chr 2:26,190,635...26,244,672

G

histone acetyltransferase 1

increases expression

Thimerosal results in increased expression of HAT1 mRNA

NCBI chr 2:171,922,461...171,983,686
Ensembl chr 2:171,922,448...171,983,686

G

heparin binding EGF like growth factor

increases expression

Thimerosal results in increased expression of HBEGF mRNA

NCBI chr 5:140,332,843...140,346,603
Ensembl chr 5:140,332,843...140,346,603

G

HBS1 like translational GTPase

increases expression

Thimerosal results in increased expression of HBS1L mRNA

NCBI chr 6:134,960,378...135,054,822
Ensembl chr 6:134,960,378...135,103,056

G

host cell factor C1 regulator 1

decreases expression

Thimerosal results in decreased expression of HCFC1R1 mRNA

NCBI chr16:3,022,620...3,024,286
Ensembl chr16:3,022,625...3,024,286

G

histone deacetylase 4

multiple interactions
increases expression

MC1568 inhibits the reaction [Thimerosal results in increased expression of HDAC4 protein]

NCBI chr 2:239,048,168...239,401,649
Ensembl chr 2:239,048,168...239,401,654

G

highly divergent homeobox

increases expression

Thimerosal results in increased expression of HDX mRNA

NCBI chr X:84,317,878...84,502,453
Ensembl chr X:84,317,874...84,502,479

G

HEAT repeat containing 1

decreases expression

Thimerosal results in decreased expression of HEATR1 mRNA

NCBI chr 1:236,549,005...236,604,516
Ensembl chr 1:236,549,005...236,604,516

G

heme binding protein 1

decreases expression

Thimerosal results in decreased expression of HEBP1 mRNA

NCBI chr12:12,974,870...13,000,265
Ensembl chr12:12,974,870...13,000,265

G

HECT domain E3 ubiquitin protein ligase 1

decreases expression

Thimerosal results in decreased expression of HECTD1 mRNA

NCBI chr14:31,100,117...31,207,793
Ensembl chr14:31,100,117...31,207,804

G

HECT domain E3 ubiquitin protein ligase 2

increases expression

Thimerosal results in increased expression of HECTD2 mRNA

NCBI chr10:91,409,235...91,514,820
Ensembl chr10:91,409,280...91,514,829

G

HECT, C2 and WW domain containing E3 ubiquitin protein ligase 1

increases expression

Thimerosal results in increased expression of HECW1 mRNA

NCBI chr 7:43,112,647...43,566,001
Ensembl chr 7:43,112,629...43,566,001

G

helicase, lymphoid specific

increases expression

Thimerosal results in increased expression of HELLS mRNA

NCBI chr10:94,545,788...94,613,905
Ensembl chr10:94,545,329...94,613,905

G

HEN methyltransferase 1

increases expression

Thimerosal results in increased expression of HENMT1 mRNA

NCBI chr 1:108,648,295...108,661,474
Ensembl chr 1:108,648,290...108,661,526

G

hephaestin

decreases expression

Thimerosal results in decreased expression of HEPH mRNA

NCBI chr X:66,162,671...66,268,863
Ensembl chr X:66,162,671...66,268,867

G

hes family bHLH transcription factor 1

decreases expression

Thimerosal results in decreased expression of HES1 mRNA

NCBI chr 3:194,136,148...194,138,732
Ensembl chr 3:194,136,148...194,138,732

G

hes family bHLH transcription factor 3

decreases expression

Thimerosal results in decreased expression of HES3 mRNA

NCBI chr 1:6,244,179...6,245,578
Ensembl chr 1:6,244,179...6,245,578

G

hypoxia inducible factor 3 subunit alpha

decreases expression

Thimerosal results in decreased expression of HIF3A mRNA

NCBI chr19:46,297,042...46,343,433
Ensembl chr19:46,297,042...46,343,433

G

huntingtin interacting protein 1

decreases expression

Thimerosal results in decreased expression of HIP1 mRNA

NCBI chr 7:75,533,298...75,738,941
Ensembl chr 7:75,533,298...75,738,962

G

homeodomain interacting protein kinase 2

decreases expression

Thimerosal results in decreased expression of HIPK2 mRNA

NCBI chr 7:139,561,570...139,777,998
Ensembl chr 7:139,561,570...139,777,998

G

hexokinase 1

decreases expression

Thimerosal results in decreased expression of HK1 mRNA

NCBI chr10:69,270,000...69,401,882
Ensembl chr10:69,269,984...69,401,884

G

hexokinase 2

decreases expression

Thimerosal results in decreased expression of HK2 mRNA

NCBI chr 2:74,834,127...74,893,359
Ensembl chr 2:74,834,127...74,893,359

G

major histocompatibility complex, class I, A

decreases expression

Thimerosal results in decreased expression of HLA-A mRNA

NCBI chr 6:29,942,532...29,945,870
Ensembl chr 6:29,941,260...29,949,572

G

major histocompatibility complex, class I, B

decreases expression

Thimerosal results in decreased expression of HLA-B mRNA

NCBI chr 6:31,353,875...31,357,179
Ensembl chr 6:31,353,872...31,367,067

G

major histocompatibility complex, class II, DP beta 1

decreases expression

Thimerosal results in decreased expression of HLA-DPB1 mRNA

NCBI chr 6:33,075,990...33,089,696
Ensembl chr 6:33,075,990...33,089,696

G

major histocompatibility complex, class I, E

decreases expression

Thimerosal results in decreased expression of HLA-E mRNA

NCBI chr 6:30,489,509...30,494,194
Ensembl chr 6:30,489,509...30,494,194

G

high mobility group AT-hook 1

decreases expression

Thimerosal results in decreased expression of HMGA1 mRNA

NCBI chr 6:34,236,873...34,246,231
Ensembl chr 6:34,236,873...34,246,231

G

high mobility group box 1

increases expression

Thimerosal results in increased expression of HMGB1 mRNA

NCBI chr13:30,456,704...30,617,597
Ensembl chr13:30,456,704...30,617,597

G

high mobility group nucleosome binding domain 5

increases expression

Thimerosal results in increased expression of HMGN5 mRNA

NCBI chr X:81,113,699...81,201,913
Ensembl chr X:81,113,699...81,201,913

G

heme oxygenase 1

increases expression

Thimerosal results in increased expression of HMOX1 mRNA

NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214

G

heterogeneous nuclear ribonucleoprotein A0

decreases expression

Thimerosal results in decreased expression of HNRNPA0 mRNA

NCBI chr 5:137,745,651...137,754,363
Ensembl chr 5:137,745,651...137,754,363

G

heterogeneous nuclear ribonucleoprotein U like 2

decreases expression

Thimerosal results in decreased expression of HNRNPUL2 mRNA

NCBI chr11:62,712,630...62,727,457
Ensembl chr11:62,712,630...62,727,457

G

hydroxysteroid 17-beta dehydrogenase 6

decreases expression

Thimerosal results in decreased expression of HSD17B6 mRNA

NCBI chr12:56,763,324...56,787,790
Ensembl chr12:56,752,161...56,787,790

G

heat shock transcription factor 2

increases expression

Thimerosal results in increased expression of HSF2 mRNA

NCBI chr 6:122,399,551...122,433,119
Ensembl chr 6:122,399,551...122,433,119

G

heat shock protein 90 alpha family class B member 1

decreases expression

Thimerosal results in decreased expression of HSP90AB1 mRNA

NCBI chr 6:44,246,194...44,253,883
Ensembl chr 6:44,246,166...44,253,888

G

heat shock protein family A (Hsp70) member 13

increases expression

Thimerosal results in increased expression of HSPA13 mRNA

NCBI chr21:14,371,115...14,383,146
Ensembl chr21:14,371,115...14,383,484

G

heat shock protein family A (Hsp70) member 1A

increases expression
decreases expression

Thimerosal results in increased expression of HSPA1A mRNA
Thimerosal results in decreased expression of HSPA1A mRNA

PMID:16870260 PMID:24675092

NCBI chr 6:31,815,543...31,817,942
Ensembl chr 6:31,815,543...31,817,946

G

heat shock protein family A (Hsp70) member 1B

increases expression

Thimerosal results in increased expression of HSPA1B mRNA

NCBI chr 6:31,827,738...31,830,254
Ensembl chr 6:31,827,738...31,830,254

G

heat shock protein family A (Hsp70) member 1 like

increases expression

Thimerosal results in increased expression of HSPA1L mRNA

NCBI chr 6:31,809,619...31,815,283
Ensembl chr 6:31,809,619...31,815,283

G

heat shock protein family A (Hsp70) member 4 like

increases expression

Thimerosal results in increased expression of HSPA4L mRNA

NCBI chr 4:127,781,796...127,840,733
Ensembl chr 4:127,781,821...127,840,733

G

heat shock protein family A (Hsp70) member 6

increases expression

Thimerosal results in increased expression of HSPA6 mRNA

NCBI chr 1:161,524,540...161,526,894
Ensembl chr 1:161,524,540...161,526,894

G

heat shock protein family B (small) member 1

increases expression

Thimerosal results in increased expression of HSPB1 mRNA

NCBI chr 7:76,302,673...76,304,292
Ensembl chr 7:76,302,673...76,304,295

G

HIV-1 Tat specific factor 1

decreases expression

Thimerosal results in decreased expression of HTATSF1 mRNA

NCBI chr X:136,497,229...136,512,346
Ensembl chr X:136,497,079...136,512,346

G

5-hydroxytryptamine receptor 2C

increases expression

Thimerosal results in increased expression of HTR2C mRNA

NCBI chr X:114,584,086...114,910,061
Ensembl chr X:114,584,078...114,910,061

G

HYLS1 centriolar and ciliogenesis associated

increases expression

Thimerosal results in increased expression of HYLS1 mRNA

NCBI chr11:125,883,614...125,900,646
Ensembl chr11:125,883,614...125,900,646

G

immediate early response 5 like

decreases expression

Thimerosal results in decreased expression of IER5L mRNA

PMID:24675092 PMID:27188386

NCBI chr 9:129,175,552...129,178,261
Ensembl chr 9:129,175,552...129,178,261

G

interferon gamma inducible protein 16

decreases expression

Thimerosal results in decreased expression of IFI16 mRNA

NCBI chr 1:158,999,976...159,055,151
Ensembl chr 1:158,999,968...159,055,155

G

interferon alpha inducible protein 6

decreases expression

Thimerosal results in decreased expression of IFI6 mRNA

NCBI chr 1:27,666,064...27,672,192
Ensembl chr 1:27,666,064...27,672,212

G

interferon induced protein with tetratricopeptide repeats 5

increases expression

Thimerosal results in increased expression of IFIT5 mRNA

NCBI chr10:89,414,568...89,420,997
Ensembl chr10:89,414,568...89,421,605

G

interferon gamma

affects response to substance
multiple interactions

IFNG affects the susceptibility to Thimerosal
Glutathione inhibits the reaction [Thimerosal inhibits the reaction [Lipopolysaccharides results in increased secretion of IFNG protein]]; Thimerosal inhibits the reaction [Lipopolysaccharides results in increased secretion of IFNG protein]

PMID:15808517 PMID:17079650

NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740

G

intraflagellar transport 80

increases expression

Thimerosal results in increased expression of IFT80 mRNA

NCBI chr 3:160,256,986...160,399,225
Ensembl chr 3:160,256,986...160,399,880

G

immunoglobulin superfamily DCC subclass member 3

decreases expression

Thimerosal results in decreased expression of IGDCC3 mRNA

NCBI chr15:65,327,127...65,378,002
Ensembl chr15:65,327,127...65,378,002

G

insulin like growth factor 1

multiple interactions

Thimerosal affects the reaction [IGF1 protein results in increased activity of MTR protein]
IGF1 protein inhibits the reaction [Thimerosal results in decreased expression of BIRC5 protein]; IGF1 protein inhibits the reaction [Thimerosal results in increased cleavage of CASP3 protein]; IGF1 protein inhibits the reaction [Thimerosal results in increased cleavage of CASP9 protein]

PMID:14745455 PMID:23145070

NCBI chr12:102,395,874...102,481,839
Ensembl chr12:102,395,874...102,481,744

G

insulin like growth factor 2 mRNA binding protein 3

decreases expression

Thimerosal results in decreased expression of IGF2BP3 mRNA

NCBI chr 7:23,310,209...23,470,491
Ensembl chr 7:23,310,209...23,470,491

G

insulin like growth factor binding protein 2

decreases expression

Thimerosal results in decreased expression of IGFBP2 mRNA

NCBI chr 2:216,632,828...216,664,436
Ensembl chr 2:216,632,828...216,664,436

G

insulin like growth factor binding protein 5

decreases expression

Thimerosal results in decreased expression of IGFBP5 mRNA

NCBI chr 2:216,672,105...216,695,549
Ensembl chr 2:216,672,105...216,695,549

G

IgLON family member 5

decreases expression

Thimerosal results in decreased expression of IGLON5 mRNA

NCBI chr19:51,311,644...51,330,891
Ensembl chr19:51,311,644...51,330,891

G

IKAROS family zinc finger 1

decreases expression

Thimerosal results in decreased expression of IKZF1 mRNA

NCBI chr 7:50,303,455...50,405,101
Ensembl chr 7:50,304,068...50,405,101

G

interleukin 13

multiple interactions

[Thimerosal co-treated with Lipopolysaccharides] results in increased secretion of IL13 protein; Glutathione inhibits the reaction [[Thimerosal co-treated with Lipopolysaccharides] results in increased secretion of IL13 protein]

NCBI chr 5:132,656,522...132,661,110
Ensembl chr 5:132,656,263...132,661,110

G

interleukin 13 receptor subunit alpha 1

decreases expression

Thimerosal results in decreased expression of IL13RA1 mRNA

NCBI chr X:118,727,606...118,805,228
Ensembl chr X:118,727,133...118,794,535

G

interleukin 17 receptor A

decreases expression

Thimerosal results in decreased expression of IL17RA mRNA

NCBI chr22:17,085,000...17,115,693
Ensembl chr22:17,084,954...17,115,693

G

interleukin 27 receptor subunit alpha

decreases expression

Thimerosal results in decreased expression of IL27RA mRNA

NCBI chr19:14,031,762...14,053,218
Ensembl chr19:14,031,762...14,053,218

G

interleukin 5

multiple interactions

[Thimerosal co-treated with Lipopolysaccharides] results in increased secretion of IL5 protein

NCBI chr 5:132,541,445...132,556,815
Ensembl chr 5:132,541,445...132,556,838

G

interleukin 6

affects response to substance
multiple interactions

IL6 affects the susceptibility to Thimerosal
Glutathione inhibits the reaction [Thimerosal inhibits the reaction [Lipopolysaccharides results in increased secretion of IL6 protein]]; Thimerosal inhibits the reaction [Lipopolysaccharides results in increased secretion of IL6 protein]

PMID:15808517 PMID:17079650

NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002

G

interleukin enhancer binding factor 3

decreases expression

Thimerosal results in decreased expression of ILF3 mRNA

NCBI chr19:10,654,346...10,692,400
Ensembl chr19:10,654,304...10,692,400

G

inflammation and lipid regulator with UBA-like and NBR1-like domains

decreases expression

Thimerosal results in decreased expression of ILRUN mRNA

NCBI chr 6:34,587,288...34,696,767
Ensembl chr 6:34,587,288...34,696,859

G

inner mitochondrial membrane peptidase subunit 1

increases expression

Thimerosal results in increased expression of IMMP1L mRNA

NCBI chr11:31,432,401...31,509,622
Ensembl chr11:31,432,401...31,509,645

G

InaF motif containing 1

decreases expression

Thimerosal results in decreased expression of INAFM1 mRNA

NCBI chr19:47,274,423...47,275,723
Ensembl chr19:47,274,885...47,275,723

G

inhibitor of growth family member 3

increases expression

Thimerosal results in increased expression of ING3 mRNA

NCBI chr 7:120,950,777...120,977,216
Ensembl chr 7:120,950,763...120,977,216

G

INO80 complex subunit D

increases expression

Thimerosal results in increased expression of INO80D mRNA

NCBI chr 2:205,993,721...206,086,174
Ensembl chr 2:205,993,721...206,086,303

G

insulin induced gene 1

decreases expression

Thimerosal results in decreased expression of INSIG1 mRNA

NCBI chr 7:155,297,878...155,310,235
Ensembl chr 7:155,297,776...155,310,235

G

integrator complex subunit 10

increases expression

Thimerosal results in increased expression of INTS10 mRNA

NCBI chr 8:19,817,416...19,852,067
Ensembl chr 8:19,817,391...19,852,083

G

integrator complex subunit 14

increases expression

Thimerosal results in increased expression of INTS14 mRNA

NCBI chr15:65,578,757...65,611,131
Ensembl chr15:65,578,753...65,611,289

G

integrator complex subunit 6

increases expression

Thimerosal results in increased expression of INTS6 mRNA

NCBI chr13:51,334,405...51,453,036
Ensembl chr13:51,354,077...51,454,264

G

IQ motif containing GTPase activating protein 1

decreases expression

Thimerosal results in decreased expression of IQGAP1 mRNA

NCBI chr15:90,388,242...90,502,239
Ensembl chr15:90,388,242...90,502,239

G

inositol 1,4,5-triphosphate receptor associated 1

decreases expression

Thimerosal results in decreased expression of IRAG1 mRNA

NCBI chr11:10,573,095...10,693,755
Ensembl chr11:10,573,091...10,693,988

G

interferon regulatory factor 2 binding protein 2

decreases expression

Thimerosal results in decreased expression of IRF2BP2 mRNA

NCBI chr 1:234,604,269...234,610,178
Ensembl chr 1:234,604,269...234,610,178

G

inositol-3-phosphate synthase 1

decreases expression

Thimerosal results in decreased expression of ISYNA1 mRNA

NCBI chr19:18,434,388...18,438,133
Ensembl chr19:18,434,388...18,438,167

G

inositol 1,4,5-trisphosphate receptor type 3

decreases expression

Thimerosal results in decreased expression of ITPR3 mRNA

NCBI chr 6:33,621,322...33,696,562
Ensembl chr 6:33,620,365...33,696,574

G

ITPR interacting domain containing 2

decreases expression

Thimerosal results in decreased expression of ITPRID2 mRNA

NCBI chr 2:181,891,730...181,930,738
Ensembl chr 2:181,891,730...181,930,738

G

ITPRIP like 1

decreases expression

Thimerosal results in decreased expression of ITPRIPL1 mRNA

NCBI chr 2:96,325,317...96,330,507
Ensembl chr 2:96,325,317...96,330,517

G

ITPRIP like 2

decreases expression

Thimerosal results in decreased expression of ITPRIPL2 mRNA

NCBI chr16:19,113,964...19,121,629
Ensembl chr16:19,113,932...19,121,629

G

intersectin 2

decreases expression

Thimerosal results in decreased expression of ITSN2 mRNA

NCBI chr 2:24,202,864...24,361,368
Ensembl chr 2:24,202,864...24,360,536

G

interacts with SUPT6H, CTD assembly factor 1

decreases expression

Thimerosal results in decreased expression of IWS1 mRNA

NCBI chr 2:127,480,812...127,527,336
Ensembl chr 2:127,436,207...127,526,886

G

jumonji domain containing 1C

decreases expression

Thimerosal results in decreased expression of JMJD1C mRNA

NCBI chr10:63,167,225...63,521,890
Ensembl chr10:63,167,221...63,521,850

G

junctophilin 3

decreases expression

Thimerosal results in decreased expression of JPH3 mRNA

NCBI chr16:87,601,835...87,698,156
Ensembl chr16:87,601,835...87,698,156

G

Jun proto-oncogene, AP-1 transcription factor subunit

increases expression

Thimerosal results in increased expression of JUN mRNA

NCBI chr 1:58,780,791...58,784,047
Ensembl chr 1:58,776,845...58,784,048

G

JunD proto-oncogene, AP-1 transcription factor subunit

decreases expression

Thimerosal results in decreased expression of JUND mRNA

NCBI chr19:18,279,694...18,281,622
Ensembl chr19:18,279,694...18,281,622

G

KAT8 regulatory NSL complex subunit 1 like

increases expression

Thimerosal results in increased expression of KANSL1L mRNA

NCBI chr 2:210,021,421...210,172,760
Ensembl chr 2:210,021,421...210,171,409

G

lysine acetyltransferase 2B

increases expression

Thimerosal results in increased expression of KAT2B mRNA

NCBI chr 3:20,040,446...20,154,404
Ensembl chr 3:20,040,446...20,154,404

G

lysine acetyltransferase 6A

decreases expression

Thimerosal results in decreased expression of KAT6A mRNA

NCBI chr 8:41,929,479...42,051,987
Ensembl chr 8:41,929,479...42,051,994

G

lysine acetyltransferase 8

decreases expression

Thimerosal results in decreased expression of KAT8 mRNA

NCBI chr16:31,117,664...31,131,393
Ensembl chr16:31,114,489...31,131,393

G

kelch repeat and BTB domain containing 2

decreases expression

Thimerosal results in decreased expression of KBTBD2 mRNA

NCBI chr 7:32,868,172...32,892,166
Ensembl chr 7:32,868,172...32,894,131

G

kelch repeat and BTB domain containing 8

increases expression

Thimerosal results in increased expression of KBTBD8 mRNA

NCBI chr 3:66,998,307...67,011,210
Ensembl chr 3:66,998,307...67,011,210

G

potassium voltage-gated channel subfamily B member 2

increases expression

Thimerosal results in increased expression of KCNB2 mRNA

NCBI chr 8:72,537,225...72,938,349
Ensembl chr 8:72,537,225...72,938,349

G

potassium voltage-gated channel interacting protein 3

multiple interactions

[SOD1 protein mutant form results in increased susceptibility to Thimerosal] which results in increased acetylation of and results in increased ubiquitination of KCNIP3 protein; [SOD1 protein results in increased susceptibility to Thimerosal] which results in decreased expression of KCNIP3 protein; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [[SOD1 protein results in increased susceptibility to Thimerosal] which results in decreased expression of KCNIP3 protein]; Resveratrol inhibits the reaction [[SOD1 protein mutant form results in increased susceptibility to Thimerosal] which results in increased acetylation of and results in increased ubiquitination of KCNIP3 protein]; Resveratrol inhibits the reaction [[SOD1 protein results in increased susceptibility to Thimerosal] which results in decreased expression of KCNIP3 protein]; SIRT1 protein affects the reaction [Resveratrol inhibits the reaction [[SOD1 protein results in increased susceptibility to Thimerosal] which results in decreased expression of KCNIP3 protein]]

NCBI chr 2:95,297,347...95,386,077
Ensembl chr 2:95,297,327...95,386,077

G

potassium channel regulator

increases expression

Thimerosal results in increased expression of KCNRG mRNA

NCBI chr13:50,015,444...50,020,922
Ensembl chr13:50,015,254...50,020,922

G

KDEL endoplasmic reticulum protein retention receptor 1

decreases expression

Thimerosal results in decreased expression of KDELR1 mRNA

NCBI chr19:48,382,575...48,397,412
Ensembl chr19:48,382,575...48,391,551

G

lysine demethylase 4B

decreases expression

Thimerosal results in decreased expression of KDM4B mRNA

NCBI chr19:4,969,113...5,153,598
Ensembl chr19:4,969,113...5,153,598

G

lysine demethylase 6A

decreases expression

Thimerosal results in decreased expression of KDM6A mRNA

NCBI chr X:44,873,188...45,112,779
Ensembl chr X:44,873,188...45,112,779

G

ketohexokinase

decreases expression

Thimerosal results in decreased expression of KHK mRNA

NCBI chr 2:27,086,772...27,100,762
Ensembl chr 2:27,086,772...27,100,762

G

KIAA1586

increases expression

Thimerosal results in increased expression of KIAA1586 mRNA

NCBI chr 6:57,046,693...57,066,898
Ensembl chr 6:57,046,532...57,055,239

G

kinesin family member 1A

decreases expression

Thimerosal results in decreased expression of KIF1A mRNA

NCBI chr 2:240,713,767...240,821,403
Ensembl chr 2:240,713,761...240,824,293

G

kinesin family member 21B

decreases expression

Thimerosal results in decreased expression of KIF21B mRNA

NCBI chr 1:200,969,390...201,023,714
Ensembl chr 1:200,969,390...201,023,714

G

kinesin family member 22

decreases expression

Thimerosal results in decreased expression of KIF22 mRNA

NCBI chr16:29,790,751...29,805,385
Ensembl chr16:29,790,727...29,805,385

G

KISS1 receptor

decreases expression

Thimerosal results in decreased expression of KISS1R mRNA

NCBI chr19:917,333...921,005
Ensembl chr19:917,287...921,005

G

KLF transcription factor 12

increases expression

Thimerosal results in increased expression of KLF12 mRNA

NCBI chr13:73,686,089...74,306,045
Ensembl chr13:73,686,089...74,134,404

G

KLF transcription factor 13

decreases expression

Thimerosal results in decreased expression of KLF13 mRNA

NCBI chr15:31,326,835...31,435,665
Ensembl chr15:31,326,835...31,435,665

G

KLF transcription factor 15

increases expression

Thimerosal results in increased expression of KLF15 mRNA

NCBI chr 3:126,288,125...126,357,408
Ensembl chr 3:126,342,635...126,357,408

G

KLF transcription factor 4

increases expression

Thimerosal results in increased expression of KLF4 mRNA

NCBI chr 9:107,484,852...107,489,769
Ensembl chr 9:107,484,852...107,490,482

G

kelch domain containing 10

decreases expression

Thimerosal results in decreased expression of KLHDC10 mRNA

NCBI chr 7:130,070,534...130,135,705
Ensembl chr 7:130,070,534...130,135,705

G

kelch like family member 24

decreases expression

Thimerosal results in decreased expression of KLHL24 mRNA

NCBI chr 3:183,635,623...183,684,519
Ensembl chr 3:183,635,610...183,684,519

G

kelch like family member 3

decreases expression

Thimerosal results in decreased expression of KLHL3 mRNA

NCBI chr 5:137,617,500...137,736,089
Ensembl chr 5:137,617,500...137,736,089

G

kelch like family member 41

increases expression

Thimerosal results in increased expression of KLHL41 mRNA

NCBI chr 2:169,509,702...169,526,258
Ensembl chr 2:169,509,702...169,526,258

G

lysine methyltransferase 2A

decreases expression

Thimerosal results in decreased expression of KMT2A mRNA

NCBI chr11:118,436,492...118,526,832
Ensembl chr11:118,436,456...118,526,832

G

kinetochore scaffold 1

decreases expression

Thimerosal results in decreased expression of KNL1 mRNA

NCBI chr15:40,594,249...40,664,342
Ensembl chr15:40,594,020...40,664,342

G

KRAS proto-oncogene, GTPase

decreases expression

Thimerosal results in decreased expression of KRAS mRNA

NCBI chr12:25,205,246...25,250,929
Ensembl chr12:25,205,246...25,250,936

G

lysine rich coiled-coil 1

increases expression

Thimerosal results in increased expression of KRCC1 mRNA

NCBI chr 2:88,027,205...88,055,783
Ensembl chr 2:88,027,205...88,064,252

G

KRR1 small subunit processome component homolog

increases expression

Thimerosal results in increased expression of KRR1 mRNA

NCBI chr12:75,490,863...75,511,609
Ensembl chr12:75,490,863...75,511,636

G

KRTAP5-1/KRTAP5-2 antisense RNA 1

increases expression

Thimerosal results in increased expression of KRTAP5-AS1 mRNA

NCBI chr11:1,572,741...1,599,184
Ensembl chr11:1,571,353...1,599,184

G

La ribonucleoprotein 1B

increases expression

Thimerosal results in increased expression of LARP1B mRNA

NCBI chr 4:128,060,789...128,222,926
Ensembl chr 4:128,061,286...128,222,931

G

La ribonucleoprotein 4

decreases expression

Thimerosal results in decreased expression of LARP4 mRNA

NCBI chr12:50,400,885...50,480,004
Ensembl chr12:50,392,383...50,480,004

G

La ribonucleoprotein 7, transcriptional regulator

increases expression

Thimerosal results in increased expression of LARP7 mRNA

NCBI chr 4:112,637,143...112,657,586
Ensembl chr 4:112,637,077...112,657,696

G

leucyl-tRNA synthetase 1

decreases expression

Thimerosal results in decreased expression of LARS1 mRNA

NCBI chr 5:146,113,034...146,182,650
Ensembl chr 5:146,110,566...146,182,696

G

ligand dependent nuclear receptor corepressor like

increases expression

Thimerosal results in increased expression of LCORL mRNA

NCBI chr 4:17,841,187...18,021,875
Ensembl chr 4:17,841,187...18,021,876

G

lactate dehydrogenase A

decreases expression

Thimerosal results in decreased expression of LDHA mRNA

NCBI chr11:18,394,563...18,408,425
Ensembl chr11:18,394,560...18,408,425

G

galectin 3 binding protein

decreases expression

Thimerosal results in decreased expression of LGALS3BP mRNA

NCBI chr17:78,971,255...78,979,923
Ensembl chr17:78,971,238...78,979,947

G

galectin like

decreases expression

Thimerosal results in decreased expression of LGALSL mRNA

NCBI chr 2:64,454,162...64,461,381
Ensembl chr 2:64,453,969...64,461,381

G

leucine rich repeat containing G protein-coupled receptor 5

increases expression

Thimerosal results in increased expression of LGR5 mRNA

NCBI chr12:71,439,129...71,586,310
Ensembl chr12:71,439,798...71,586,310

G

leucine rich repeat containing G protein-coupled receptor 6

increases expression

Thimerosal results in increased expression of LGR6 mRNA

NCBI chr 1:202,193,799...202,319,761
Ensembl chr 1:202,193,799...202,319,781

G

luteinizing hormone subunit beta

increases expression

Thimerosal results in increased expression of LHB mRNA; Thimerosal results in increased expression of LHB protein

NCBI chr19:49,015,980...49,019,498
Ensembl chr19:49,015,980...49,017,091

G

LIM homeobox 9

decreases expression

Thimerosal results in decreased expression of LHX9 mRNA

NCBI chr 1:197,912,464...197,935,478
Ensembl chr 1:197,911,902...197,935,478

G

LIM domain and actin binding 1

decreases expression

Thimerosal results in decreased expression of LIMA1 mRNA

NCBI chr12:50,175,788...50,283,520
Ensembl chr12:50,175,788...50,283,520

G

LIM zinc finger domain containing 1

increases expression

Thimerosal results in increased expression of LIMS1 mRNA

NCBI chr 2:108,533,671...108,687,246
Ensembl chr 2:108,533,671...108,687,246

G

lin-7 homolog C, crumbs cell polarity complex component

increases expression

Thimerosal results in increased expression of LIN7C mRNA

NCBI chr11:27,494,418...27,506,769
Ensembl chr11:27,494,418...27,506,769

G

lin-9 DREAM MuvB core complex component

increases expression

Thimerosal results in increased expression of LIN9 mRNA

NCBI chr 1:226,231,149...226,309,767
Ensembl chr 1:226,231,149...226,309,869

G

long intergenic non-protein coding RNA 115

decreases expression

Thimerosal results in decreased expression of LINC00115 mRNA

NCBI chr 1:826,206...827,522
Ensembl chr 1:824,228...827,539

G

long intergenic non-protein coding RNA 342

increases expression

Thimerosal results in increased expression of LINC00342 mRNA

NCBI chr 2:95,807,052...95,826,981
Ensembl chr 2:95,807,052...95,835,003

G

long intergenic non-protein coding RNA 622

increases expression

Thimerosal results in increased expression of LINC00622 mRNA

NCBI chr 1:119,597,702...119,599,291
Ensembl chr 1:119,597,702...119,599,271

G

long intergenic non-protein coding RNA 645

increases expression

Thimerosal results in increased expression of LINC00645 mRNA

NCBI chr14:27,612,588...27,639,636
Ensembl chr14:27,612,577...27,639,636

G

long intergenic non-protein coding RNA 663

decreases expression

Thimerosal results in decreased expression of LINC00663 mRNA

NCBI chr19:19,756,371...19,776,413
Ensembl chr19:19,757,366...19,776,423

G

long intergenic non-protein coding RNA 1000

increases expression

Thimerosal results in increased expression of LINC01000 mRNA

NCBI chr 7:128,641,241...128,660,998

G

long intergenic non-protein coding RNA 1252

increases expression

Thimerosal results in increased expression of LINC01252 mRNA

NCBI chr12:11,548,030...11,564,403
Ensembl chr12:11,548,030...11,590,369

G

lipopolysaccharide induced TNF factor

decreases expression

Thimerosal results in decreased expression of LITAF mRNA

NCBI chr16:11,547,722...11,640,317
Ensembl chr16:11,547,722...11,636,381

G

limb and CNS expressed 1 like

decreases expression

Thimerosal results in decreased expression of LIX1L mRNA

NCBI chr 1:145,933,423...145,958,017
Ensembl chr 1:145,933,423...145,958,017

G

LMBR1 domain containing 2

increases expression

Thimerosal results in increased expression of LMBRD2 mRNA

NCBI chr 5:36,098,407...36,151,887
Ensembl chr 5:36,098,407...36,151,887

G

lipase maturation factor 1

decreases expression

Thimerosal results in decreased expression of LMF1 mRNA

NCBI chr16:853,634...981,613
Ensembl chr16:853,634...981,318

G

leucyl and cystinyl aminopeptidase

multiple interactions

[NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LNPEP mRNA

NCBI chr 5:96,936,080...97,037,513
Ensembl chr 5:96,935,394...97,037,513

G

LOXL1 antisense RNA 1

decreases expression

Thimerosal results in decreased expression of LOXL1-AS1 mRNA

NCBI chr15:73,917,468...73,928,248
Ensembl chr15:73,908,071...73,928,248

G

lysophosphatidylcholine acyltransferase 1

increases expression

Thimerosal results in increased expression of LPCAT1 mRNA

NCBI chr 5:1,461,427...1,523,960
Ensembl chr 5:1,456,480...1,523,962

G

lysophosphatidylglycerol acyltransferase 1

decreases expression

Thimerosal results in decreased expression of LPGAT1 mRNA

NCBI chr 1:211,743,457...211,830,763
Ensembl chr 1:211,743,457...211,830,763

G

LDL receptor related protein 6

decreases expression

Thimerosal results in decreased expression of LRP6 mRNA

NCBI chr12:12,116,025...12,267,044
Ensembl chr12:12,116,025...12,267,044

G

leucine rich pentatricopeptide repeat containing

increases expression

Thimerosal results in increased expression of LRPPRC mRNA

NCBI chr 2:43,886,224...43,996,265
Ensembl chr 2:43,886,224...43,996,226

G

leucine rich repeat containing 26

decreases expression

Thimerosal results in decreased expression of LRRC26 mRNA

NCBI chr 9:137,168,758...137,170,051
Ensembl chr 9:137,168,758...137,170,051

G

leucine rich repeat containing 37 member A2

decreases expression

Thimerosal results in decreased expression of LRRC37A2 mRNA

NCBI chr17:46,372,792...47,049,128
Ensembl chr17:46,511,508...46,556,910

G

leucine rich repeat containing 7

increases expression

Thimerosal results in increased expression of LRRC7 mRNA

NCBI chr 1:69,567,922...70,144,364
Ensembl chr 1:69,567,922...70,151,945

G

leucine rich repeat containing 75B

decreases expression

Thimerosal results in decreased expression of LRRC75B mRNA

NCBI chr22:24,585,635...24,593,073
Ensembl chr22:24,585,620...24,593,208

G

LSM12 homolog

decreases expression

Thimerosal results in decreased expression of LSM12 mRNA

NCBI chr17:44,034,328...44,067,587
Ensembl chr17:44,034,328...44,067,619

G

LSM family member 14B

decreases expression

Thimerosal results in decreased expression of LSM14B mRNA

NCBI chr20:62,122,475...62,135,374
Ensembl chr20:62,122,461...62,135,374

G

LSM5 homolog, U6 small nuclear RNA and mRNA degradation associated

increases expression

Thimerosal results in increased expression of LSM5 mRNA

NCBI chr 7:32,485,338...32,495,283
Ensembl chr 7:32,485,338...32,495,283

G

lanosterol synthase

decreases expression

Thimerosal results in decreased expression of LSS mRNA

NCBI chr21:46,188,446...46,228,774
Ensembl chr21:46,188,141...46,228,824

G

leukotriene A4 hydrolase

decreases expression

Thimerosal results in decreased expression of LTA4H mRNA

NCBI chr12:96,000,753...96,043,520
Ensembl chr12:96,000,753...96,043,520

G

latent transforming growth factor beta binding protein 2

decreases expression

Thimerosal results in decreased expression of LTBP2 mRNA

NCBI chr14:74,498,183...74,612,237
Ensembl chr14:74,498,183...74,612,378

G

listerin E3 ubiquitin protein ligase 1

decreases expression

Thimerosal results in decreased expression of LTN1 mRNA

NCBI chr21:28,928,144...28,992,877
Ensembl chr21:28,928,144...28,992,956

G

leucine zipper protein 1

decreases expression

Thimerosal results in decreased expression of LUZP1 mRNA

NCBI chr 1:23,083,642...23,178,122
Ensembl chr 1:23,084,030...23,177,808

G

LY86 antisense RNA 1

increases expression

Thimerosal results in increased expression of LY86-AS1 mRNA

NCBI chr 6:6,346,465...6,622,826
Ensembl chr 6:6,346,465...6,622,771

G

LysM domain containing 4

decreases expression

Thimerosal results in decreased expression of LYSMD4 mRNA

NCBI chr15:99,715,697...99,733,444
Ensembl chr15:99,715,697...99,733,561

G

MAF bZIP transcription factor B

increases expression

Thimerosal results in increased expression of MAFB mRNA

NCBI chr20:40,685,848...40,689,236
Ensembl chr20:40,685,848...40,689,236

G

MAF bZIP transcription factor F

decreases expression

Thimerosal results in decreased expression of MAFF mRNA

NCBI chr22:38,201,994...38,216,511
Ensembl chr22:38,200,767...38,216,507

G

MAGE family member L2

decreases expression

Thimerosal results in decreased expression of MAGEL2 mRNA

NCBI chr15:23,643,549...23,647,867
Ensembl chr15:23,643,549...23,647,867

G

membrane associated guanylate kinase, WW and PDZ domain containing 2

decreases expression

Thimerosal results in decreased expression of MAGI2 mRNA

NCBI chr 7:78,017,055...79,453,667
Ensembl chr 7:78,017,055...79,453,667

G

metastasis associated lung adenocarcinoma transcript 1

decreases expression

Thimerosal results in decreased expression of MALAT1 mRNA

NCBI chr11:65,497,738...65,506,516
Ensembl chr11:65,497,640...65,508,073

G

MANSC domain containing 1

decreases expression

Thimerosal results in decreased expression of MANSC1 mRNA

NCBI chr12:12,326,056...12,350,242
Ensembl chr12:12,326,056...12,350,242

G

monoamine oxidase A

multiple interactions

[NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAOA mRNA

NCBI chr X:43,655,006...43,746,817
Ensembl chr X:43,654,907...43,746,817

G

microtubule associated protein 1 light chain 3 gamma

multiple interactions

[NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MAP1LC3C mRNA

NCBI chr 1:241,995,490...242,001,393
Ensembl chr 1:241,995,490...241,999,098

G

mitogen-activated protein kinase kinase 2

decreases expression

Thimerosal results in decreased expression of MAP2K2 mRNA

NCBI chr19:4,090,321...4,124,122
Ensembl chr19:4,090,321...4,124,122

G

mitogen-activated protein kinase kinase kinase 11

decreases expression

Thimerosal results in decreased expression of MAP3K11 mRNA

NCBI chr11:65,597,757...65,614,221
Ensembl chr11:65,597,756...65,615,382

G

mitogen-activated protein kinase kinase kinase 3

decreases expression

Thimerosal results in decreased expression of MAP3K3 mRNA

NCBI chr17:63,622,417...63,696,305
Ensembl chr17:63,622,415...63,696,305

G

mitogen-activated protein kinase kinase kinase 6

decreases expression

Thimerosal results in decreased expression of MAP3K6 mRNA

NCBI chr 1:27,355,184...27,366,961
Ensembl chr 1:27,355,184...27,366,961

G

microtubule associated protein 4

decreases expression

Thimerosal results in decreased expression of MAP4 mRNA

NCBI chr 3:47,850,695...48,088,848
Ensembl chr 3:47,850,690...48,089,272

G

mitogen-activated protein kinase kinase kinase kinase 1

decreases expression

Thimerosal results in decreased expression of MAP4K1 mRNA

NCBI chr19:38,587,641...38,617,953
Ensembl chr19:38,587,641...38,618,882

G

mitogen-activated protein kinase kinase kinase kinase 5

decreases expression

Thimerosal results in decreased expression of MAP4K5 mRNA

NCBI chr14:50,418,521...50,561,126
Ensembl chr14:50,418,501...50,561,126

G

microtubule associated protein 9

increases expression

Thimerosal results in increased expression of MAP9 mRNA

NCBI chr 4:155,342,658...155,376,965
Ensembl chr 4:155,342,658...155,376,970

G

mitogen-activated protein kinase 1

multiple interactions
decreases phosphorylation

Acetylcysteine inhibits the reaction [Thimerosal results in decreased phosphorylation of MAPK1 protein]; SB 203580 inhibits the reaction [Thimerosal results in decreased phosphorylation of MAPK1 protein]

NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680

G

mitogen-activated protein kinase 14

increases phosphorylation
decreases expression

Thimerosal results in increased phosphorylation of MAPK14 protein
Thimerosal results in decreased expression of MAPK14 mRNA

PMID:15737199 PMID:27188386

NCBI chr 6:36,027,808...36,124,214
Ensembl chr 6:36,027,782...36,111,236

G

mitogen-activated protein kinase 3

decreases phosphorylation
increases phosphorylation
multiple interactions

Thimerosal results in decreased phosphorylation of MAPK3 protein
Thimerosal results in increased phosphorylation of MAPK3 protein
Acetylcysteine inhibits the reaction [Thimerosal results in decreased phosphorylation of MAPK3 protein]; SB 203580 inhibits the reaction [Thimerosal results in decreased phosphorylation of MAPK3 protein]

PMID:17698513 PMID:18495191

NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506

G

mitogen-activated protein kinase 8

increases phosphorylation
increases expression

Thimerosal results in increased phosphorylation of MAPK8 protein
Thimerosal results in increased expression of MAPK8 mRNA

PMID:18495191 PMID:27188386

NCBI chr10:48,306,677...48,439,360
Ensembl chr10:48,306,639...48,439,360

G

mitogen-activated protein kinase 9

increases phosphorylation

Thimerosal results in increased phosphorylation of MAPK9 protein

NCBI chr 5:180,233,143...180,292,083
Ensembl chr 5:180,233,143...180,292,099

G

MAPK activated protein kinase 2

decreases expression

Thimerosal results in decreased expression of MAPKAPK2 mRNA

NCBI chr 1:206,684,905...206,734,281
Ensembl chr 1:206,684,905...206,734,281

G

membrane associated ring-CH-type finger 1

increases expression

Thimerosal results in increased expression of MARCHF1 mRNA

NCBI chr 4:163,524,298...164,384,019
Ensembl chr 4:163,524,298...164,384,050

G

microtubule affinity regulating kinase 4

decreases expression

Thimerosal results in decreased expression of MARK4 mRNA

NCBI chr19:45,251,271...45,305,284
Ensembl chr19:45,079,288...45,305,284

G

methyl-CpG binding domain protein 2

decreases expression

Thimerosal results in decreased expression of MBD2 mRNA

NCBI chr18:54,151,606...54,224,669
Ensembl chr18:54,151,606...54,224,669

G

muscleblind like splicing regulator 2

decreases expression

Thimerosal results in decreased expression of MBNL2 mRNA

NCBI chr13:97,141,834...97,394,120
Ensembl chr13:97,221,434...97,394,120

G

membrane bound O-acyltransferase domain containing 7

decreases expression

Thimerosal results in decreased expression of MBOAT7 mRNA

NCBI chr19:54,173,415...54,189,580
Ensembl chr19:54,173,412...54,189,882

G

microcephalin 1

increases expression

Thimerosal results in increased expression of MCPH1 mRNA

NCBI chr 8:6,406,627...6,648,508
Ensembl chr 8:6,406,592...6,648,508

G

malate dehydrogenase 2

decreases expression

Thimerosal results in decreased expression of MDH2 mRNA

NCBI chr 7:76,048,106...76,067,508
Ensembl chr 7:76,048,051...76,067,508

G

MTOR associated protein, eak-7 homolog

decreases expression

Thimerosal results in decreased expression of MEAK7 mRNA

NCBI chr16:84,476,355...84,504,659
Ensembl chr16:84,476,355...84,554,033

G

MDS1 and EVI1 complex locus

increases expression

Thimerosal results in increased expression of MECOM mRNA

NCBI chr 3:169,083,507...169,663,712
Ensembl chr 3:169,083,499...169,663,775

G

mediator complex subunit 13

decreases expression

Thimerosal results in decreased expression of MED13 mRNA

NCBI chr17:61,942,605...62,065,278
Ensembl chr17:61,942,605...62,065,278

G

mediator complex subunit 13L

increases expression

Thimerosal results in increased expression of MED13L mRNA

NCBI chr12:115,958,576...116,277,693
Ensembl chr12:115,957,905...116,277,693

G

mediator complex subunit 16

decreases expression

Thimerosal results in decreased expression of MED16 mRNA

NCBI chr19:867,963...893,187
Ensembl chr19:867,630...893,218

G

mediator complex subunit 17

increases expression

Thimerosal results in increased expression of MED17 mRNA

NCBI chr11:93,784,282...93,814,963
Ensembl chr11:93,784,227...93,814,963

G

mediator complex subunit 18

decreases expression

Thimerosal results in decreased expression of MED18 mRNA

NCBI chr 1:28,329,040...28,335,965
Ensembl chr 1:28,329,002...28,335,965

G

mediator complex subunit 21

increases expression

Thimerosal results in increased expression of MED21 mRNA

NCBI chr12:27,022,558...27,038,951
Ensembl chr12:27,022,546...27,066,343

G

mediator complex subunit 25

decreases expression

Thimerosal results in decreased expression of MED25 mRNA

NCBI chr19:49,818,289...49,840,384
Ensembl chr19:49,818,282...49,840,383

G

mesenteric estrogen dependent adipogenesis

multiple interactions

[NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MEDAG mRNA

NCBI chr13:30,906,271...30,925,572
Ensembl chr13:30,906,271...30,925,572

G

multiple EGF like domains 6

decreases expression

Thimerosal results in decreased expression of MEGF6 mRNA

NCBI chr 1:3,487,951...3,624,786
Ensembl chr 1:3,487,951...3,611,508

G

methyltransferase 18, RPL3 N3(tau)-histidine

increases expression

Thimerosal results in increased expression of METTL18 mRNA

NCBI chr 1:169,792,529...169,794,907
Ensembl chr 1:169,792,529...169,794,963

G

O-6-methylguanine-DNA methyltransferase

decreases expression

Thimerosal results in decreased expression of MGMT mRNA

NCBI chr10:129,467,241...129,770,983
Ensembl chr10:129,467,190...129,770,983

G

MIA SH3 domain ER export factor 3

increases expression

Thimerosal results in increased expression of MIA3 mRNA

NCBI chr 1:222,618,097...222,668,007
Ensembl chr 1:222,618,097...222,668,007

G

MHC class I polypeptide-related sequence A

decreases expression

Thimerosal results in decreased expression of MICA mRNA

NCBI chr 6:31,400,711...31,415,315
Ensembl chr 6:31,399,784...31,415,315

G

midline 1

decreases expression

Thimerosal results in decreased expression of MID1 mRNA

NCBI chr X:10,445,310...10,833,683
Ensembl chr X:10,445,310...10,833,654

G

MIER family member 3

increases expression

Thimerosal results in increased expression of MIER3 mRNA

NCBI chr 5:56,919,603...56,952,209
Ensembl chr 5:56,919,602...56,971,675

G

MIR210 host gene

decreases expression

Thimerosal results in decreased expression of MIR210HG mRNA

NCBI chr11:565,657...568,457
Ensembl chr11:565,657...568,457

G

microRNA 29c

decreases expression

Thimerosal results in decreased expression of MIR29C mRNA

NCBI chr 1:207,801,852...207,801,939
Ensembl chr 1:207,801,852...207,801,939

G

mir-99a-let-7c cluster host gene

increases expression

Thimerosal results in increased expression of MIR99AHG mRNA

NCBI chr21:16,070,488...16,631,727
Ensembl chr21:15,928,296...16,646,364

G

MIS18 binding protein 1

decreases expression

Thimerosal results in decreased expression of MIS18BP1 mRNA

NCBI chr14:45,203,190...45,253,202
Ensembl chr14:45,203,190...45,253,540

G

muskelin 1

increases expression

Thimerosal results in increased expression of MKLN1 mRNA

NCBI chr 7:131,110,094...131,496,632
Ensembl chr 7:131,110,096...131,496,632

G

makorin ring finger protein 3

decreases expression

Thimerosal results in decreased expression of MKRN3 mRNA

NCBI chr15:23,565,674...23,568,044
Ensembl chr15:23,565,674...23,630,075

G

myeloid leukemia factor 2

decreases expression

Thimerosal results in decreased expression of MLF2 mRNA

NCBI chr12:6,747,996...6,753,141
Ensembl chr12:6,747,996...6,767,475

G

matrix metallopeptidase 16

affects expression

Thimerosal affects the expression of MMP16 mRNA

NCBI chr 8:88,032,011...88,327,483
Ensembl chr 8:88,032,011...88,328,025

G

MOB kinase activator 1A

decreases expression

Thimerosal results in decreased expression of MOB1A mRNA

NCBI chr 2:74,152,528...74,178,879
Ensembl chr 2:74,152,528...74,178,898

G

mannose phosphate isomerase

decreases expression

Thimerosal results in decreased expression of MPI mRNA

NCBI chr15:74,890,042...74,902,219
Ensembl chr15:74,890,005...74,902,219

G

melanocortin 2 receptor accessory protein 2

decreases expression

Thimerosal results in decreased expression of MRAP2 mRNA

NCBI chr 6:84,033,178...84,146,282
Ensembl chr 6:84,033,772...84,090,881

G

maestro heat like repeat family member 1

decreases expression

Thimerosal results in decreased expression of MROH1 mRNA

NCBI chr 8:144,148,016...144,261,926
Ensembl chr 8:144,148,016...144,261,927

G

mitochondrial ribosomal protein L1

increases expression

Thimerosal results in increased expression of MRPL1 mRNA

NCBI chr 4:77,862,830...77,952,785
Ensembl chr 4:77,862,830...77,952,785

G

mitochondrial ribosomal protein L10

decreases expression

Thimerosal results in decreased expression of MRPL10 mRNA

NCBI chr17:47,823,272...47,831,541
Ensembl chr17:47,823,272...47,831,541

G

mitochondrial ribosomal protein L50

increases expression

Thimerosal results in increased expression of MRPL50 mRNA

NCBI chr 9:101,387,633...101,398,618
Ensembl chr 9:101,387,633...101,398,618

G

mitochondrial ribosomal protein S2

decreases expression

Thimerosal results in decreased expression of MRPS2 mRNA

NCBI chr 9:135,499,965...135,504,673
Ensembl chr 9:135,499,984...135,504,673

G

membrane spanning 4-domains A15

increases expression

Thimerosal results in increased expression of MS4A15 mRNA

NCBI chr11:60,756,867...60,776,733
Ensembl chr11:60,756,867...60,776,733

G

moesin

decreases expression

Thimerosal results in decreased expression of MSN mRNA

NCBI chr X:65,588,377...65,741,931
Ensembl chr X:65,588,377...65,741,931

G

metallothionein 1X

increases expression
affects expression

Thimerosal results in increased expression of MT1 mRNA; Thimerosal results in increased expression of MT1 protein
Thimerosal affects the expression of MT1 mRNA

PMID:19357975 PMID:19386279

NCBI chr16:56,682,470...56,684,196
Ensembl chr16:56,682,470...56,684,196

G

metallothionein 2A

increases expression

Thimerosal results in increased expression of MT2 mRNA; Thimerosal results in increased expression of MT2 protein

NCBI chr16:56,608,584...56,609,497
Ensembl chr16:56,608,584...56,609,497

G

metallothionein 3

increases expression

Thimerosal results in increased expression of MT3 mRNA

NCBI chr16:56,589,528...56,591,085
Ensembl chr16:56,589,074...56,591,088

G

metastasis associated 1

decreases expression

Thimerosal results in decreased expression of MTA1 mRNA

NCBI chr14:105,419,827...105,470,729
Ensembl chr14:105,419,820...105,470,729

G

metastasis associated 1 family member 2

decreases expression

Thimerosal results in decreased expression of MTA2 mRNA

NCBI chr11:62,593,214...62,601,865
Ensembl chr11:62,593,214...62,601,865

G

mitochondrial amidoxime reducing component 2

decreases expression

Thimerosal results in decreased expression of MTARC2 mRNA

NCBI chr 1:220,748,322...220,784,815
Ensembl chr 1:220,748,225...220,784,815

G

microtubule crosslinking factor 2

increases expression

Thimerosal results in increased expression of MTCL2 mRNA

NCBI chr20:36,777,447...36,863,538
Ensembl chr20:36,777,447...36,863,538

G

MTCL family member 3

decreases expression

Thimerosal results in decreased expression of MTCL3 mRNA

NCBI chr 6:127,472,974...127,519,335
Ensembl chr 6:127,472,806...127,519,335

G

mitochondrial fission process 1

decreases expression

Thimerosal results in decreased expression of MTFP1 mRNA

NCBI chr22:30,425,768...30,429,054
Ensembl chr22:30,425,623...30,429,054

G

methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2 like

increases expression

Thimerosal results in increased expression of MTHFD2L mRNA

NCBI chr 4:74,114,560...74,303,099
Ensembl chr 4:74,114,174...74,303,099

G

mitochondrial poly(A) polymerase

increases expression

Thimerosal results in increased expression of MTPAP mRNA

NCBI chr10:30,309,801...30,349,278
Ensembl chr10:30,309,801...30,374,448

G

5-methyltetrahydrofolate-homocysteine methyltransferase

multiple interactions
decreases expression

Glutathione inhibits the reaction [Thimerosal inhibits the reaction [[Hydroxocobalamin co-treated with S-Adenosylmethionine] results in increased activity of MTR protein alternative form]]; Thimerosal affects the reaction [IGF1 protein results in increased activity of MTR protein]; Thimerosal inhibits the reaction [[Hydroxocobalamin co-treated with S-Adenosylmethionine] results in increased activity of MTR protein alternative form]; Thimerosal inhibits the reaction [mecobalamin results in increased activity of MTR protein alternative form]
Thimerosal results in decreased expression of MTR mRNA

PMID:14745455 PMID:26989453 PMID:27188386

NCBI chr 1:236,795,281...236,903,981
Ensembl chr 1:236,795,260...236,921,278

G

multivesicular body subunit 12A

decreases expression

Thimerosal results in decreased expression of MVB12A mRNA

NCBI chr19:17,405,741...17,425,332
Ensembl chr19:17,405,722...17,433,724

G

MAX dimerization protein 1

increases expression

Thimerosal results in increased expression of MXD1 mRNA

NCBI chr 2:69,915,109...69,942,945
Ensembl chr 2:69,897,688...69,942,945

G

matrix remodeling associated 8

decreases expression

Thimerosal results in decreased expression of MXRA8 mRNA

NCBI chr 1:1,352,689...1,363,541
Ensembl chr 1:1,352,689...1,361,777

G

myoneurin

increases expression

Thimerosal results in increased expression of MYNN mRNA

NCBI chr 3:169,773,396...169,789,716
Ensembl chr 3:169,773,396...169,789,716

G

myosin IE

decreases expression

Thimerosal results in decreased expression of MYO1E mRNA

NCBI chr15:59,132,434...59,372,871
Ensembl chr15:59,132,434...59,372,871

G

myosin VA

decreases expression

Thimerosal results in decreased expression of MYO5A mRNA

NCBI chr15:52,307,283...52,529,050
Ensembl chr15:52,307,281...52,529,132

G

myosin VI

decreases expression

Thimerosal results in decreased expression of MYO6 mRNA

NCBI chr 6:75,749,239...75,919,537
Ensembl chr 6:75,749,201...75,919,537

G

myosin IXA

increases expression

Thimerosal results in increased expression of MYO9A mRNA

NCBI chr15:71,822,291...72,118,600
Ensembl chr15:71,822,291...72,118,577

G

myeloid zinc finger 1

decreases expression

Thimerosal results in decreased expression of MZF1 mRNA

NCBI chr19:58,561,932...58,573,573
Ensembl chr19:58,561,931...58,573,575

G

NEDD4 binding protein 2 like 2

increases expression

Thimerosal results in increased expression of N4BP2L2 mRNA

NCBI chr13:32,432,485...32,538,868
Ensembl chr13:32,432,417...32,538,885

G

NEDD4 binding protein 3

decreases expression

Thimerosal results in decreased expression of N4BP3 mRNA

NCBI chr 5:178,113,532...178,127,034
Ensembl chr 5:178,113,532...178,126,081

G

N-alpha-acetyltransferase 16, NatA auxiliary subunit

decreases expression

Thimerosal results in decreased expression of NAA16 mRNA

NCBI chr13:41,311,267...41,377,030
Ensembl chr13:41,311,267...41,377,030

G

N-acylethanolamine acid amidase

increases expression

Thimerosal results in increased expression of NAAA mRNA

NCBI chr 4:75,910,655...75,941,013
Ensembl chr 4:75,913,660...75,941,013

G

nicotinate phosphoribosyltransferase

decreases expression

Thimerosal results in decreased expression of NAPRT mRNA

NCBI chr 8:143,572,874...143,578,330
Ensembl chr 8:143,574,785...143,578,649

G

nuclear autoantigenic sperm protein

decreases expression

Thimerosal results in decreased expression of NASP mRNA

NCBI chr 1:45,584,041...45,618,893
Ensembl chr 1:45,583,846...45,618,904

G

N-acetyltransferase domain containing 1

decreases expression

Thimerosal results in decreased expression of NATD1 mRNA

NCBI chr17:21,238,870...21,253,410
Ensembl chr17:21,238,870...21,253,410

G

neuron navigator 3

increases expression

Thimerosal results in increased expression of NAV3 mRNA

NCBI chr12:77,571,862...78,213,010
Ensembl chr12:77,324,641...78,213,010

G

NBAS subunit of NRZ tethering complex

decreases expression

Thimerosal results in decreased expression of NBAS mRNA

NCBI chr 2:14,778,909...15,561,334
Ensembl chr 2:15,166,916...15,561,340

G

neural cell adhesion molecule 1

decreases expression

Thimerosal results in decreased expression of NCAM1 mRNA

NCBI chr11:112,961,420...113,278,436
Ensembl chr11:112,961,275...113,278,436

G

N-myc downstream regulated 1

decreases expression

Thimerosal results in decreased expression of NDRG1 mRNA

NCBI chr 8:133,237,175...133,297,252
Ensembl chr 8:133,237,175...133,302,022

G

NADH:ubiquinone oxidoreductase subunit A5

increases expression

Thimerosal results in increased expression of NDUFA5 mRNA

NCBI chr 7:123,536,997...123,601,651
Ensembl chr 7:123,536,997...123,557,904

G

NADH:ubiquinone oxidoreductase subunit A9

increases expression

Thimerosal results in increased expression of NDUFA9 mRNA

NCBI chr12:4,649,114...4,694,317
Ensembl chr12:4,649,095...4,694,317

G

NADH:ubiquinone oxidoreductase complex assembly factor 4

increases expression

Thimerosal results in increased expression of NDUFAF4 mRNA

NCBI chr 6:96,889,315...96,897,891
Ensembl chr 6:96,889,315...96,897,891

G

NADH:ubiquinone oxidoreductase subunit B7

decreases expression

Thimerosal results in decreased expression of NDUFB7 mRNA

NCBI chr19:14,566,078...14,572,066
Ensembl chr19:14,566,078...14,572,066

G

neurofilament heavy chain

decreases expression

Thimerosal results in decreased expression of NEFH mRNA

NCBI chr22:29,480,218...29,491,390
Ensembl chr22:29,480,218...29,491,390

G

neuronal growth regulator 1

decreases expression

Thimerosal results in decreased expression of NEGR1 mRNA

NCBI chr 1:71,395,943...72,282,539
Ensembl chr 1:71,395,943...72,282,539

G

nestin

decreases expression

Thimerosal results in decreased expression of NES mRNA

NCBI chr 1:156,668,763...156,677,407
Ensembl chr 1:156,668,763...156,677,407

G

neurofibromin 1

affects expression

Thimerosal affects the expression of NF1 mRNA

NCBI chr17:31,094,927...31,377,677
Ensembl chr17:31,094,927...31,382,116

G

nuclear factor of activated T cells 5

decreases expression

Thimerosal results in decreased expression of NFAT5 mRNA

NCBI chr16:69,565,966...69,704,654
Ensembl chr16:69,565,094...69,704,666

G

nuclear factor of activated T cells 2 interacting protein

decreases expression

Thimerosal results in decreased expression of NFATC2IP mRNA

NCBI chr16:28,950,937...28,967,092
Ensembl chr16:28,950,807...28,967,092

G

nuclear transcription factor Y subunit beta

increases expression

Thimerosal results in increased expression of NFYB mRNA

NCBI chr12:104,117,086...104,138,210
Ensembl chr12:104,117,086...104,138,241

G

nerve growth factor

multiple interactions
decreases response to substance

[Thimerosal co-treated with NGF protein] results in decreased phosphorylation of NTRK1 protein
NGF protein results in decreased susceptibility to Thimerosal

NCBI chr 1:115,285,917...115,338,249
Ensembl chr 1:115,285,904...115,338,770

G

NIPA like domain containing 3

decreases expression

Thimerosal results in decreased expression of NIPAL3 mRNA

NCBI chr 1:24,413,524...24,472,983
Ensembl chr 1:24,415,802...24,472,976

G

NIPBL cohesin loading factor

decreases expression

Thimerosal results in decreased expression of NIPBL mRNA

NCBI chr 5:36,876,769...37,066,413
Ensembl chr 5:36,876,769...37,066,413

G

nipsnap homolog 1

decreases expression

Thimerosal results in decreased expression of NIPSNAP1 mRNA

NCBI chr22:29,554,808...29,581,113
Ensembl chr22:29,554,808...29,581,327

G

nipsnap homolog 3B

increases expression

Thimerosal results in increased expression of NIPSNAP3B mRNA

NCBI chr 9:104,764,129...104,790,899
Ensembl chr 9:104,764,129...104,777,764

G

sodium/potassium transporting ATPase interacting 2

decreases expression

Thimerosal results in decreased expression of NKAIN2 mRNA

NCBI chr 6:123,803,865...124,825,640
Ensembl chr 6:123,803,865...124,825,640

G

NLR family member X1

decreases expression

Thimerosal results in decreased expression of NLRX1 mRNA

NCBI chr11:119,168,334...119,184,016
Ensembl chr11:119,166,568...119,184,016

G

NME/NM23 nucleoside diphosphate kinase 4

decreases expression

Thimerosal results in decreased expression of NME4 mRNA

NCBI chr16:396,729...400,754
Ensembl chr16:396,725...410,367

G

noggin

multiple interactions
decreases expression

[NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of APOH mRNA; [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CPEB2 mRNA; [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LNPEP mRNA; [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MAP1LC3C mRNA; [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MEDAG mRNA; [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PITPNM2 mRNA; [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SEPSECS mRNA; [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLCO4A1-AS1 mRNA; [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SNCAIP mRNA; [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TMC5 mRNA; [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ABTB3 mRNA; [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CALML4 mRNA; [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CAPN5 mRNA; [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FLCN mRNA; [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FRA10AC1 mRNA; [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAOA mRNA; [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of OTULINL mRNA; [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PIAS2 mRNA; [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLEKHF2 mRNA; [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of POP1 mRNA; [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SAPCD2 mRNA; [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC25A21 mRNA; [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC30A5 mRNA; [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TTC39C mRNA
Thimerosal results in decreased expression of NOG mRNA

NCBI chr17:56,593,699...56,595,611
Ensembl chr17:56,593,699...56,595,611

G

nucleolar protein 3

decreases expression

Thimerosal results in decreased expression of NOL3 mRNA

NCBI chr16:67,170,538...67,175,737
Ensembl chr16:67,170,154...67,175,737

G

NOP53 ribosome biogenesis factor

decreases expression

Thimerosal results in decreased expression of NOP53 mRNA

NCBI chr19:47,745,546...47,757,058
Ensembl chr19:47,745,546...47,757,058

G

neuronal PAS domain protein 3

increases expression

Thimerosal results in increased expression of NPAS3 mRNA

NCBI chr14:32,934,785...33,804,173
Ensembl chr14:32,934,396...33,820,863

G

nuclear protein, coactivator of histone transcription

increases expression

Thimerosal results in increased expression of NPAT mRNA

NCBI chr11:108,157,215...108,222,638
Ensembl chr11:108,157,215...108,222,638

G

nephrocystin 1

increases expression

Thimerosal results in increased expression of NPHP1 mRNA

NCBI chr 2:110,123,348...110,205,013
Ensembl chr 2:110,122,311...110,205,066

G

NPR3 like, GATOR1 complex subunit

decreases expression

Thimerosal results in decreased expression of NPRL3 mRNA

NCBI chr16:85,386...138,673
Ensembl chr16:84,271...138,677

G

NAD(P)H quinone dehydrogenase 1

increases expression

Thimerosal results in increased expression of NQO1 mRNA

NCBI chr16:69,709,401...69,726,560
Ensembl chr16:69,706,996...69,726,668

G

nuclear receptor subfamily 2 group C member 2

decreases expression

Thimerosal results in decreased expression of NR2C2 mRNA

NCBI chr 3:14,947,583...15,049,273
Ensembl chr 3:14,947,583...15,053,600

G

nuclear receptor subfamily 4 group A member 1

increases expression

Thimerosal results in increased expression of NR4A1 mRNA

NCBI chr12:52,022,832...52,059,503
Ensembl chr12:52,022,832...52,059,507

G

nuclear receptor subfamily 4 group A member 2

increases expression

Thimerosal results in increased expression of NR4A2 mRNA

NCBI chr 2:156,324,437...156,332,721
Ensembl chr 2:156,324,437...156,342,348

G

nardilysin convertase

increases expression

Thimerosal results in increased expression of NRDC mRNA

NCBI chr 1:51,789,210...51,878,727
Ensembl chr 1:51,789,191...51,878,805

G

nurim

decreases expression

Thimerosal results in decreased expression of NRM mRNA

NCBI chr 6:30,688,049...30,691,420
Ensembl chr 6:30,688,047...30,691,420

G

5'-nucleotidase domain containing 2

decreases expression

Thimerosal results in decreased expression of NT5DC2 mRNA

NCBI chr 3:52,524,387...52,535,027
Ensembl chr 3:52,524,385...52,535,054

G

neurotrophic receptor tyrosine kinase 1

multiple interactions

[Thimerosal co-treated with NGF protein] results in decreased phosphorylation of NTRK1 protein

NCBI chr 1:156,815,750...156,881,850
Ensembl chr 1:156,815,636...156,881,850

G

neurotrophic receptor tyrosine kinase 3

decreases expression

Thimerosal results in decreased expression of NTRK3 mRNA

NCBI chr15:87,859,751...88,256,739
Ensembl chr15:87,859,751...88,256,791

G

negative regulator of ubiquitin like proteins 1

decreases expression

Thimerosal results in decreased expression of NUB1 mRNA

NCBI chr 7:151,341,812...151,378,449
Ensembl chr 7:151,341,772...151,378,449

G

NYN domain and retroviral integrase containing

decreases expression

Thimerosal results in decreased expression of NYNRIN mRNA

NCBI chr14:24,399,003...24,419,283
Ensembl chr14:24,399,003...24,419,283

G

ORC ubiquitin ligase 1

increases expression

Thimerosal results in increased expression of OBI1 mRNA

NCBI chr13:78,614,289...78,659,155
Ensembl chr13:78,614,289...78,659,155

G

obscurin like cytoskeletal adaptor 1

decreases expression

Thimerosal results in decreased expression of OBSL1 mRNA

NCBI chr 2:219,547,206...219,571,539
Ensembl chr 2:219,550,728...219,571,859

G

OCIA domain containing 1

decreases expression

Thimerosal results in decreased expression of OCIAD1 mRNA

NCBI chr 4:48,805,156...48,861,815
Ensembl chr 4:48,805,212...48,861,817

G

oligodendrocyte maturation-associated long intergenic non-coding RNA

decreases expression

Thimerosal results in decreased expression of OLMALINC mRNA

NCBI chr10:100,373,576...100,388,354
Ensembl chr10:100,373,099...100,454,043

G

olfactory marker protein

increases expression

Thimerosal results in increased expression of OMP mRNA

NCBI chr11:77,102,840...77,103,331
Ensembl chr11:77,102,840...77,103,331

G

oxysterol binding protein like 8

decreases expression

Thimerosal results in decreased expression of OSBPL8 mRNA

NCBI chr12:76,351,797...76,559,771
Ensembl chr12:76,351,797...76,559,809

G

OTU deubiquitinase, ubiquitin aldehyde binding 2

decreases expression

Thimerosal results in decreased expression of OTUB2 mRNA

NCBI chr14:94,026,340...94,048,930
Ensembl chr14:94,026,340...94,048,930

G

OTU deubiquitinase 4

decreases expression

Thimerosal results in decreased expression of OTUD4 mRNA

NCBI chr 4:145,133,650...145,180,589
Ensembl chr 4:145,110,838...145,180,589

G

OTU deubiquitinase 6B

increases expression

Thimerosal results in increased expression of OTUD6B mRNA

NCBI chr 8:91,070,344...91,087,093
Ensembl chr 8:91,070,196...91,087,095

G

OTU deubiquitinase with linear linkage specificity like

multiple interactions

[NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of OTULINL mRNA

NCBI chr 5:14,581,792...14,616,180
Ensembl chr 5:14,581,792...14,616,180

G

prolyl 4-hydroxylase subunit alpha 1

decreases expression

Thimerosal results in decreased expression of P4HA1 mRNA

NCBI chr10:73,007,217...73,096,866
Ensembl chr10:73,007,217...73,096,974

G

protein kinase C and casein kinase substrate in neurons 1

decreases expression

Thimerosal results in decreased expression of PACSIN1 mRNA

NCBI chr 6:34,466,076...34,535,223
Ensembl chr 6:34,466,061...34,535,229

G

poly(A) binding protein interacting protein 2B

decreases expression

Thimerosal results in decreased expression of PAIP2B mRNA

NCBI chr 2:71,182,738...71,227,103
Ensembl chr 2:71,182,738...71,227,103

G

phosphatase domain containing paladin 1

decreases expression

Thimerosal results in decreased expression of PALD1 mRNA

NCBI chr10:70,458,485...70,568,450
Ensembl chr10:70,478,767...70,668,754

G

pantothenate kinase 2

increases expression

Thimerosal results in increased expression of PANK2 mRNA

NCBI chr20:3,888,781...3,929,887
Ensembl chr20:3,888,839...3,929,887

G

par-3 family cell polarity regulator beta

increases expression

Thimerosal results in increased expression of PARD3B mRNA

NCBI chr 2:204,545,475...205,620,162
Ensembl chr 2:204,545,475...205,620,162

G

PARP1 binding protein

increases expression

Thimerosal results in increased expression of PARPBP mRNA

NCBI chr12:102,120,183...102,197,520
Ensembl chr12:102,120,183...102,197,520

G

pyruvate carboxylase

decreases expression

Thimerosal results in decreased expression of PC mRNA

NCBI chr11:66,848,420...66,958,383
Ensembl chr11:66,848,417...66,958,386

G

prostate cancer associated transcript 6

decreases expression

Thimerosal results in decreased expression of PCAT6 mRNA

NCBI chr 1:202,810,946...202,811,913
Ensembl chr 1:202,810,850...202,812,473

G

poly(rC) binding protein 2

decreases expression

Thimerosal results in decreased expression of PCBP2 mRNA

NCBI chr12:53,452,102...53,481,162
Ensembl chr12:53,452,102...53,481,162

G

protocadherin alpha 9

increases expression

Thimerosal results in increased expression of PCDHA9 mRNA

NCBI chr 5:140,847,772...141,012,347
Ensembl chr 5:140,847,772...141,012,347

G

piccolo presynaptic cytomatrix protein

increases expression

Thimerosal results in increased expression of PCLO mRNA

NCBI chr 7:82,754,012...83,162,884
Ensembl chr 7:82,754,012...83,162,930

G

pericentriolar material 1

decreases expression

Thimerosal results in decreased expression of PCM1 mRNA

NCBI chr 8:17,922,988...18,029,948
Ensembl chr 8:17,922,842...18,029,948

G

PEST proteolytic signal containing nuclear protein

decreases expression

Thimerosal results in decreased expression of PCNP mRNA

NCBI chr 3:101,574,094...101,594,465
Ensembl chr 3:101,574,180...101,594,465

G

pecanex 1

increases expression

Thimerosal results in increased expression of PCNX1 mRNA

NCBI chr14:70,907,459...71,115,382
Ensembl chr14:70,907,405...71,115,382

G

Purkinje cell protein 4

increases expression

Thimerosal results in increased expression of PCP4 mRNA

NCBI chr21:39,867,438...39,929,392
Ensembl chr21:39,867,438...39,929,397

G

proprotein convertase subtilisin/kexin type 2

increases expression

Thimerosal results in increased expression of PCSK2 mRNA

NCBI chr20:17,226,107...17,484,578
Ensembl chr20:17,226,107...17,484,578

G

protein disulfide isomerase family A member 3

decreases expression

Thimerosal results in decreased expression of PDIA3 mRNA

NCBI chr15:43,746,438...43,773,278
Ensembl chr15:43,746,394...43,773,279

G

pyruvate dehydrogenase kinase 1

decreases expression

Thimerosal results in decreased expression of PDK1 mRNA

NCBI chr 2:172,555,373...172,724,312
Ensembl chr 2:172,555,373...172,608,669

G

PDZ and LIM domain 4

decreases expression

Thimerosal results in decreased expression of PDLIM4 mRNA

NCBI chr 5:132,257,696...132,273,454
Ensembl chr 5:132,257,696...132,273,454

G

decaprenyl diphosphate synthase subunit 2

decreases expression

Thimerosal results in decreased expression of PDSS2 mRNA

NCBI chr 6:107,152,562...107,459,564
Ensembl chr 6:107,152,562...107,459,564

G

prodynorphin

multiple interactions

[SOD1 protein mutant form results in increased susceptibility to Thimerosal] which results in increased expression of PDYN mRNA; Resveratrol inhibits the reaction [[SOD1 protein mutant form results in increased susceptibility to Thimerosal] which results in increased expression of PDYN mRNA]

NCBI chr20:1,978,756...1,994,285
Ensembl chr20:1,978,757...1,994,285

G

plasmanylethanolamine desaturase 1

decreases expression

Thimerosal results in decreased expression of PEDS1 mRNA

NCBI chr20:50,118,254...50,153,723
Ensembl chr20:50,118,254...50,153,734

G

proline, glutamate and leucine rich protein 1

decreases expression

Thimerosal results in decreased expression of PELP1 mRNA

NCBI chr17:4,669,774...4,704,137
Ensembl chr17:4,669,774...4,704,337

G

peroxisomal biogenesis factor 6

decreases expression

Thimerosal results in decreased expression of PEX6 mRNA

NCBI chr 6:42,963,865...42,979,181
Ensembl chr 6:42,963,865...42,979,181

G

prefoldin subunit 4

increases expression

Thimerosal results in increased expression of PFDN4 mRNA

NCBI chr20:54,208,087...54,219,961
Ensembl chr20:54,208,087...54,228,052

G

6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2

decreases expression

Thimerosal results in decreased expression of PFKFB2 mRNA

NCBI chr 1:207,034,416...207,081,027
Ensembl chr 1:207,034,366...207,081,024

G

6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4

decreases expression

Thimerosal results in decreased expression of PFKFB4 mRNA

NCBI chr 3:48,517,684...48,563,136
Ensembl chr 3:48,517,684...48,562,015

G

phosphofructokinase, platelet

decreases expression

Thimerosal results in decreased expression of PFKP mRNA

NCBI chr10:3,067,548...3,136,805
Ensembl chr10:3,066,333...3,137,718

G

profilin 1

decreases expression

Thimerosal results in decreased expression of PFN1 mRNA

NCBI chr17:4,945,652...4,948,530
Ensembl chr17:4,945,652...4,949,061

G

phosphoglycerate mutase 1

decreases expression

Thimerosal results in decreased expression of PGAM1 mRNA

NCBI chr10:97,426,191...97,433,444
Ensembl chr10:97,426,191...97,433,444

G

post-GPI attachment to proteins inositol deacylase 1

increases expression

Thimerosal results in increased expression of PGAP1 mRNA

NCBI chr 2:196,833,004...196,926,707
Ensembl chr 2:196,833,004...196,927,796

G

post-GPI attachment to proteins 2

decreases expression

Thimerosal results in decreased expression of PGAP2 mRNA

NCBI chr11:3,797,724...3,826,371
Ensembl chr11:3,797,724...3,826,371

G

post-GPI attachment to proteins GalNAc transferase 4

decreases expression

Thimerosal results in decreased expression of PGAP4 mRNA

NCBI chr 9:101,473,170...101,533,686
Ensembl chr 9:101,473,170...101,533,537

G

post-GPI attachment to proteins 6

decreases expression

Thimerosal results in decreased expression of PGAP6 mRNA

NCBI chr16:370,788...386,979
Ensembl chr16:370,788...387,113

G

piggyBac transposable element derived 2

increases expression

Thimerosal results in increased expression of PGBD2 mRNA

NCBI chr 1:248,872,851...248,930,191
Ensembl chr 1:248,906,196...248,919,946

G

placental growth factor

increases expression

Thimerosal results in increased expression of PGF mRNA

NCBI chr14:74,941,830...74,955,764
Ensembl chr14:74,941,834...74,955,626

G

phosphoglycerate kinase 1

decreases expression

Thimerosal results in decreased expression of PGK1 mRNA

NCBI chr X:78,104,248...78,129,295
Ensembl chr X:77,910,739...78,129,295

G

6-phosphogluconolactonase

decreases expression

Thimerosal results in decreased expression of PGLS mRNA

NCBI chr19:17,511,649...17,521,288
Ensembl chr19:17,511,636...17,521,288

G

phosphoglucomutase 1

decreases expression

Thimerosal results in decreased expression of PGM1 mRNA

NCBI chr 1:63,593,411...63,660,245
Ensembl chr 1:63,593,411...63,660,245

G

pyroglutamyl-peptidase I

decreases expression

Thimerosal results in decreased expression of PGPEP1 mRNA

NCBI chr19:18,340,598...18,369,950
Ensembl chr19:18,340,598...18,369,950

G

phosphorylated adaptor for RNA export

increases expression

Thimerosal results in increased expression of PHAX mRNA

NCBI chr 5:126,600,947...126,627,252
Ensembl chr 5:126,600,925...126,627,252

G

PHD finger protein 20

increases expression

Thimerosal results in increased expression of PHF20 mRNA

NCBI chr20:35,772,015...35,950,370
Ensembl chr20:35,771,974...35,950,370

G

PHD finger protein 20 like 1

decreases expression

Thimerosal results in decreased expression of PHF20L1 mRNA

NCBI chr 8:132,775,388...132,848,807
Ensembl chr 8:132,775,358...132,848,807

G

PHD finger protein 21A

decreases expression

Thimerosal results in decreased expression of PHF21A mRNA

NCBI chr11:45,929,319...46,121,454
Ensembl chr11:45,929,319...46,121,454

G

phosphorylase kinase regulatory subunit beta

decreases expression

Thimerosal results in decreased expression of PHKB mRNA

NCBI chr16:47,461,299...47,701,523
Ensembl chr16:47,461,123...47,701,523

G

pleckstrin homology like domain family B member 2

decreases expression

Thimerosal results in decreased expression of PHLDB2 mRNA

NCBI chr 3:111,732,496...111,976,517
Ensembl chr 3:111,732,497...111,976,517

G

pleckstrin homology like domain family B member 3

decreases expression

Thimerosal results in decreased expression of PHLDB3 mRNA

NCBI chr19:43,475,103...43,504,746
Ensembl chr19:43,474,954...43,504,935

G

putative homeodomain transcription factor 2

increases expression

Thimerosal results in increased expression of PHTF2 mRNA

NCBI chr 7:77,798,773...77,957,504
Ensembl chr 7:77,798,773...77,957,503

G

phosphatidylinositol 4-kinase type 2 alpha

decreases expression

Thimerosal results in decreased expression of PI4K2A mRNA

NCBI chr10:97,640,671...97,676,434
Ensembl chr10:97,640,671...97,676,434

G

protein inhibitor of activated STAT 2

multiple interactions

[NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PIAS2 mRNA

NCBI chr18:46,803,218...46,920,145
Ensembl chr18:46,803,218...46,920,160

G

phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 alpha

increases expression

Thimerosal results in increased expression of PIK3C2A mRNA

NCBI chr11:17,086,575...17,207,986
Ensembl chr11:17,077,730...17,207,986

G

phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha

increases expression

Thimerosal results in increased expression of PIK3CA mRNA

NCBI chr 3:179,148,126...179,240,093
Ensembl chr 3:179,148,114...179,240,093

G

peptidylprolyl cis/trans isomerase, NIMA-interacting 4

decreases expression

Thimerosal results in decreased expression of PIN4 mRNA

NCBI chr X:72,181,676...72,263,964
Ensembl chr X:72,181,353...72,302,926

G

pirin

increases expression

Thimerosal results in increased expression of PIR mRNA

NCBI chr X:15,384,799...15,493,333
Ensembl chr X:15,384,799...15,493,564

G

phosphatidylinositol transfer protein membrane associated 2

multiple interactions

[NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PITPNM2 mRNA

NCBI chr12:122,983,480...123,151,848
Ensembl chr12:122,983,480...123,151,090

G

protein kinase N3

decreases expression

Thimerosal results in decreased expression of PKN3 mRNA

NCBI chr 9:128,702,503...128,720,916
Ensembl chr 9:128,702,503...128,720,916

G

phospholipase A and acyltransferase 1

decreases expression

Thimerosal results in decreased expression of PLAAT1 mRNA

NCBI chr 3:193,240,606...193,281,426
Ensembl chr 3:193,241,128...193,277,738

G

phospholipase C beta 4

decreases expression

Thimerosal results in decreased expression of PLCB4 mRNA

NCBI chr20:9,068,678...9,480,808
Ensembl chr20:9,067,825...9,504,593

G

phospholipase C gamma 1

increases cleavage

Thimerosal results in increased cleavage of PLCG1 protein

NCBI chr20:41,137,543...41,177,626
Ensembl chr20:41,136,960...41,196,801

G

pleckstrin homology domain containing A2

decreases expression

Thimerosal results in decreased expression of PLEKHA2 mRNA

NCBI chr 8:38,901,346...38,973,912
Ensembl chr 8:38,901,235...38,973,912

G

pleckstrin homology domain containing A5

decreases expression

Thimerosal results in decreased expression of PLEKHA5 mRNA

NCBI chr12:19,129,733...19,376,400
Ensembl chr12:19,129,669...19,376,400

G

pleckstrin homology domain containing A6

decreases expression

Thimerosal results in decreased expression of PLEKHA6 mRNA

NCBI chr 1:204,218,853...204,378,168
Ensembl chr 1:204,218,853...204,377,665

G

pleckstrin homology domain containing B1

decreases expression

Thimerosal results in decreased expression of PLEKHB1 mRNA

NCBI chr11:73,646,581...73,662,819
Ensembl chr11:73,646,178...73,662,819

G

pleckstrin homology and FYVE domain containing 2

multiple interactions

[NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLEKHF2 mRNA

NCBI chr 8:95,133,785...95,156,685
Ensembl chr 8:95,115,642...95,156,698

G

pleckstrin homology and RhoGEF domain containing G4

decreases expression

Thimerosal results in decreased expression of PLEKHG4 mRNA

NCBI chr16:67,277,580...67,289,480
Ensembl chr16:67,277,510...67,289,499

G

polo like kinase 2

increases expression

Thimerosal results in increased expression of PLK2 mRNA

NCBI chr 5:58,453,982...58,460,086
Ensembl chr 5:58,453,982...58,460,139

G

procollagen-lysine,2-oxoglutarate 5-dioxygenase 1

decreases expression

Thimerosal results in decreased expression of PLOD1 mRNA

NCBI chr 1:11,934,717...11,975,537
Ensembl chr 1:11,934,205...11,975,538

G

phospholipid phosphatase related 3

decreases expression

Thimerosal results in decreased expression of PLPPR3 mRNA

NCBI chr19:812,488...823,797
Ensembl chr19:812,488...821,955

G

plexin C1

decreases expression

Thimerosal results in decreased expression of PLXNC1 mRNA

NCBI chr12:94,148,577...94,307,675
Ensembl chr12:94,148,577...94,307,675

G

pro-melanin concentrating hormone

increases expression

Thimerosal results in increased expression of PMCH mRNA

NCBI chr12:102,196,459...102,197,833
Ensembl chr12:102,196,459...102,197,833

G

PML nuclear body scaffold

decreases expression

Thimerosal results in decreased expression of PML mRNA

NCBI chr15:73,994,716...74,047,827
Ensembl chr15:73,994,673...74,047,827

G

patatin like phospholipase domain containing 3

decreases expression

Thimerosal results in decreased expression of PNPLA3 mRNA

NCBI chr22:43,923,805...43,947,582
Ensembl chr22:43,923,792...43,964,488

G

DNA polymerase epsilon 4, accessory subunit

increases expression

Thimerosal results in increased expression of POLE4 mRNA

NCBI chr 2:74,958,643...74,970,128
Ensembl chr 2:74,958,643...74,970,128

G

RNA polymerase II subunit J4 (pseudogene)

decreases expression

Thimerosal results in decreased expression of POLR2J4 mRNA

NCBI chr 7:43,940,895...44,019,194
Ensembl chr 7:43,940,895...44,019,175

G

RNA polymerase mitochondrial

decreases expression

Thimerosal results in decreased expression of POLRMT mRNA

NCBI chr19:617,221...633,537
Ensembl chr19:617,221...633,537

G

proopiomelanocortin

increases expression

Thimerosal results in increased expression of POMC mRNA; Thimerosal results in increased expression of POMC protein

NCBI chr 2:25,160,860...25,168,580
Ensembl chr 2:25,160,853...25,168,903

G

protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-)

decreases expression

Thimerosal results in decreased expression of POMGNT2 mRNA

NCBI chr 3:43,079,234...43,106,079
Ensembl chr 3:43,079,229...43,106,085

G

POP1 homolog, ribonuclease P/MRP subunit

multiple interactions

[NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of POP1 mRNA

NCBI chr 8:98,117,293...98,159,835
Ensembl chr 8:98,117,293...98,159,835

G

POU class 1 homeobox 1

increases expression

Thimerosal results in increased expression of POU1F1 mRNA

NCBI chr 3:87,259,404...87,276,584
Ensembl chr 3:87,259,404...87,276,584

G

PTPRF interacting protein alpha 4

decreases expression

Thimerosal results in decreased expression of PPFIA4 mRNA

NCBI chr 1:203,026,491...203,078,736
Ensembl chr 1:203,026,491...203,078,740

G

PPFIA binding protein 1

decreases expression

Thimerosal results in decreased expression of PPFIBP1 mRNA

NCBI chr12:27,524,206...27,695,564
Ensembl chr12:27,523,431...27,695,564

G

peptidylprolyl isomerase A

decreases expression

Thimerosal results in decreased expression of PPIA mRNA

NCBI chr 7:44,796,681...44,803,117
Ensembl chr 7:44,796,680...44,824,564

G

peptidylprolyl isomerase like 2

decreases expression

Thimerosal results in decreased expression of PPIL2 mRNA

NCBI chr22:21,666,012...21,700,015
Ensembl chr22:21,666,000...21,700,015

G

protein phosphatase 1 regulatory inhibitor subunit 14A

decreases expression

Thimerosal results in decreased expression of PPP1R14A mRNA

NCBI chr19:38,251,237...38,256,374
Ensembl chr19:38,251,237...38,256,532

G

protein phosphatase 1 regulatory subunit 3B

decreases expression

Thimerosal results in decreased expression of PPP1R3B mRNA

NCBI chr 8:9,136,255...9,151,539
Ensembl chr 8:9,136,255...9,151,574

G

protein phosphatase 1 regulatory subunit 3E

decreases expression

Thimerosal results in decreased expression of PPP1R3E mRNA

NCBI chr14:23,295,652...23,302,859
Ensembl chr14:23,295,652...23,302,859

G

PR/SET domain 2

decreases expression

Thimerosal results in decreased expression of PRDM2 mRNA

NCBI chr 1:13,700,188...13,825,079
Ensembl chr 1:13,700,188...13,825,079

G

PRELI domain containing 2

decreases expression

Thimerosal results in decreased expression of PRELID2 mRNA

NCBI chr 5:145,228,985...145,835,342
Ensembl chr 5:145,471,799...145,835,369

G

prolyl endopeptidase like

increases expression

Thimerosal results in increased expression of PREPL mRNA

NCBI chr 2:44,317,607...44,361,862
Ensembl chr 2:44,316,281...44,361,862

G

phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 2

increases expression

Thimerosal results in increased expression of PREX2 mRNA

NCBI chr 8:67,952,046...68,237,032
Ensembl chr 8:67,952,046...68,237,032

G

DNA primase subunit 2

increases expression

Thimerosal results in increased expression of PRIM2 mRNA

NCBI chr 6:57,221,540...57,646,850
Ensembl chr 6:57,314,805...57,646,850

G

proline rich membrane anchor 1

decreases expression

Thimerosal results in decreased expression of PRIMA1 mRNA

NCBI chr14:93,718,298...93,788,994
Ensembl chr14:93,718,298...93,788,485

G

protein kinase AMP-activated non-catalytic subunit beta 2

decreases expression

Thimerosal results in decreased expression of PRKAB2 mRNA

NCBI chr 1:147,155,106...147,172,470
Ensembl chr 1:147,155,106...147,172,550

G

PRKAG2 antisense RNA 1

decreases expression

Thimerosal results in decreased expression of PRKAG2-AS1 mRNA

NCBI chr 7:151,877,042...151,879,223
Ensembl chr 7:151,877,042...151,879,229

G

PRKCQ antisense RNA 1

decreases expression

Thimerosal results in decreased expression of PRKCQ-AS1 mRNA

NCBI chr10:6,580,425...6,585,361
Ensembl chr10:6,580,419...6,616,921

G

protein kinase D2

decreases expression

Thimerosal results in decreased expression of PRKD2 mRNA

NCBI chr19:46,674,316...46,717,114
Ensembl chr19:46,674,275...46,717,127

G

protein kinase D3

increases expression

Thimerosal results in increased expression of PRKD3 mRNA

NCBI chr 2:37,250,502...37,324,833
Ensembl chr 2:37,250,502...37,324,833

G

PRKR interacting protein 1

decreases expression

Thimerosal results in decreased expression of PRKRIP1 mRNA

NCBI chr 7:102,396,363...102,426,666
Ensembl chr 7:102,363,872...102,426,676

G

prolactin

increases expression

Thimerosal results in increased expression of PRL mRNA; Thimerosal results in increased expression of PRL protein

NCBI chr 6:22,287,246...22,302,835
Ensembl chr 6:22,287,244...22,302,826

G

prolactin receptor

increases expression

Thimerosal results in increased expression of PRLR mRNA

NCBI chr 5:35,048,756...35,230,487
Ensembl chr 5:35,048,756...35,230,487

G

pre-mRNA processing factor 6

decreases expression

Thimerosal results in decreased expression of PRPF6 mRNA

NCBI chr20:63,981,132...64,033,100
Ensembl chr20:63,981,132...64,033,100

G

proline rich 14 like

decreases expression

Thimerosal results in decreased expression of PRR14L mRNA

NCBI chr22:31,681,347...31,750,132
Ensembl chr22:31,676,256...31,750,140

G

proline rich 5 like

decreases expression

Thimerosal results in decreased expression of PRR5L mRNA

NCBI chr11:36,296,288...36,465,204
Ensembl chr11:36,296,288...36,465,204

G

proline rich coiled-coil 2C

decreases expression

Thimerosal results in decreased expression of PRRC2C mRNA

NCBI chr 1:171,485,530...171,593,511
Ensembl chr 1:171,485,530...171,593,511

G

proline rich transmembrane protein 1

decreases expression

Thimerosal results in decreased expression of PRRT1 mRNA

NCBI chr 6:32,148,363...32,153,083
Ensembl chr 6:32,148,359...32,153,083

G

proteasome activator subunit 4

decreases expression

Thimerosal results in decreased expression of PSME4 mRNA

NCBI chr 2:53,864,069...53,970,993
Ensembl chr 2:53,864,069...53,970,993

G

proteasome inhibitor subunit 1

decreases expression

Thimerosal results in decreased expression of PSMF1 mRNA

NCBI chr20:1,113,263...1,172,246
Ensembl chr20:1,113,240...1,189,415

G

polypyrimidine tract binding protein 2

increases expression

Thimerosal results in increased expression of PTBP2 mRNA

NCBI chr 1:96,721,784...96,823,739
Ensembl chr 1:96,721,665...96,823,738

G

patched domain containing 4

increases expression

Thimerosal results in increased expression of PTCHD4 mRNA

NCBI chr 6:47,856,673...48,111,197
Ensembl chr 6:47,856,673...48,111,197

G

protein tyrosine kinase 2

multiple interactions
increases response to substance

[[Thimerosal results in increased abundance of Reactive Oxygen Species] which results in increased activity of CASP3 protein] which results in increased cleavage of PTK2 protein; Acetylcysteine inhibits the reaction [[[Thimerosal results in increased abundance of Reactive Oxygen Species] which results in increased activity of CASP3 protein] which results in increased cleavage of PTK2 protein]; benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [[[Thimerosal results in increased abundance of Reactive Oxygen Species] which results in increased activity of CASP3 protein] which results in increased cleavage of PTK2 protein]
PTK2 protein results in increased susceptibility to Thimerosal

NCBI chr 8:140,657,900...141,002,079
Ensembl chr 8:140,657,900...141,002,216

G

parathymosin

decreases expression

Thimerosal results in decreased expression of PTMS mRNA

NCBI chr12:6,766,363...6,770,952
Ensembl chr12:6,765,516...6,770,952

G

PTOV1 extended AT-hook containing adaptor protein

decreases expression

Thimerosal results in decreased expression of PTOV1 mRNA

NCBI chr19:49,850,705...49,860,742
Ensembl chr19:49,850,735...49,860,744

G

protein tyrosine phosphatase 4A3

decreases expression

Thimerosal results in decreased expression of PTP4A3 mRNA

NCBI chr 8:141,392,021...141,432,454
Ensembl chr 8:141,391,995...141,432,454

G

protein tyrosine phosphatase non-receptor type 12

decreases expression

Thimerosal results in decreased expression of PTPN12 mRNA

NCBI chr 7:77,537,295...77,640,069
Ensembl chr 7:77,537,295...77,640,069

G

protein tyrosine phosphatase non-receptor type 4

increases expression

Thimerosal results in increased expression of PTPN4 mRNA

NCBI chr 2:119,759,922...119,984,899
Ensembl chr 2:119,759,922...119,984,899

G

protein tyrosine phosphatase receptor type A

decreases expression

Thimerosal results in decreased expression of PTPRA mRNA

NCBI chr20:2,864,184...3,038,669
Ensembl chr20:2,873,420...3,039,076

G

protein tyrosine phosphatase receptor type K

increases expression

Thimerosal results in increased expression of PTPRK mRNA

NCBI chr 6:127,968,785...128,520,599
Ensembl chr 6:127,968,785...128,520,616

G

purine rich element binding protein B

decreases expression

Thimerosal results in decreased expression of PURB mRNA

NCBI chr 7:44,876,299...44,885,530
Ensembl chr 7:44,876,299...44,885,530

G

peroxisomal membrane protein 4

decreases expression

Thimerosal results in decreased expression of PXMP4 mRNA

NCBI chr20:33,702,758...33,720,310
Ensembl chr20:33,702,758...33,720,319

G

glycogen phosphorylase L

decreases expression

Thimerosal results in decreased expression of PYGL mRNA

NCBI chr14:50,905,217...50,944,483
Ensembl chr14:50,857,891...50,944,483

G

pyridine nucleotide-disulphide oxidoreductase domain 1

increases expression

Thimerosal results in increased expression of PYROXD1 mRNA

NCBI chr12:21,437,655...21,471,250
Ensembl chr12:21,437,615...21,471,250

G

quinolinate phosphoribosyltransferase

decreases expression

Thimerosal results in decreased expression of QPRT mRNA

NCBI chr16:29,679,008...29,698,699
Ensembl chr16:29,663,279...29,698,699

G

RAB29, member RAS oncogene family

decreases expression

Thimerosal results in decreased expression of RAB29 mRNA

NCBI chr 1:205,767,986...205,775,482
Ensembl chr 1:205,767,986...205,775,482

G

RAB30, member RAS oncogene family

increases expression

Thimerosal results in increased expression of RAB30 mRNA

NCBI chr11:82,973,133...83,071,897
Ensembl chr11:82,973,133...83,071,923

G

RAB3B, member RAS oncogene family

affects expression

Thimerosal affects the expression of RAB3B mRNA

NCBI chr 1:51,907,956...51,990,700
Ensembl chr 1:51,907,956...51,990,700

G

RAB3 GTPase activating protein catalytic subunit 1

increases expression

Thimerosal results in increased expression of RAB3GAP1 mRNA

NCBI chr 2:135,052,292...135,176,396
Ensembl chr 2:135,052,289...135,176,667

G

RAB, member of RAS oncogene family like 3

increases expression

Thimerosal results in increased expression of RABL3 mRNA

NCBI chr 3:120,684,938...120,742,680
Ensembl chr 3:120,684,938...120,742,993

G

RAD18 E3 ubiquitin protein ligase

increases expression

Thimerosal results in increased expression of RAD18 mRNA

NCBI chr 3:8,877,075...8,963,472
Ensembl chr 3:8,775,402...8,963,773

G

RAD23 homolog A, nucleotide excision repair protein

decreases expression

Thimerosal results in decreased expression of RAD23A mRNA

NCBI chr19:12,945,862...12,953,642
Ensembl chr19:12,945,855...12,953,642

G

Ral GTPase activating protein catalytic subunit alpha 2

increases expression

Thimerosal results in increased expression of RALGAPA2 mRNA

NCBI chr20:20,389,530...20,712,644
Ensembl chr20:20,389,530...20,712,644

G

Rap guanine nucleotide exchange factor 2

increases expression

Thimerosal results in increased expression of RAPGEF2 mRNA

NCBI chr 4:159,103,079...159,360,173
Ensembl chr 4:159,103,013...159,360,174

G

Rap guanine nucleotide exchange factor 5

decreases expression

Thimerosal results in decreased expression of RAPGEF5 mRNA

NCBI chr 7:22,118,236...22,357,154
Ensembl chr 7:22,118,236...22,357,154

G

Rap guanine nucleotide exchange factor like 1

decreases expression

Thimerosal results in decreased expression of RAPGEFL1 mRNA

NCBI chr17:40,177,010...40,195,650
Ensembl chr17:40,177,010...40,195,656

G

retinoic acid receptor responder 1

increases expression

Thimerosal results in increased expression of RARRES1 mRNA

NCBI chr 3:158,696,892...158,732,457
Ensembl chr 3:158,696,892...158,732,489

G

RAS p21 protein activator 2

increases expression

Thimerosal results in increased expression of RASA2 mRNA

NCBI chr 3:141,487,027...141,615,344
Ensembl chr 3:141,487,027...141,615,344

G

RasGEF domain family member 1A

increases expression
decreases expression

Thimerosal results in increased expression of RASGEF1A mRNA
Thimerosal results in decreased expression of RASGEF1A mRNA

PMID:24675092 PMID:27188386

NCBI chr10:43,194,535...43,267,065
Ensembl chr10:43,194,535...43,267,065

G

Ras association domain family member 4

decreases expression

Thimerosal results in decreased expression of RASSF4 mRNA

NCBI chr10:44,959,802...44,995,891
Ensembl chr10:44,959,407...44,995,891

G

Ras association domain family member 8

decreases expression

Thimerosal results in decreased expression of RASSF8 mRNA

NCBI chr12:25,958,232...26,079,889
Ensembl chr12:25,958,232...26,079,892

G

RB associated KRAB zinc finger

decreases expression

Thimerosal results in decreased expression of RBAK mRNA

NCBI chr 7:5,045,860...5,069,487
Ensembl chr 7:5,045,821...5,069,487

G

RNA binding fox-1 homolog 3

decreases expression

Thimerosal results in decreased expression of RBFOX3 mRNA

NCBI chr17:79,089,345...79,665,571
Ensembl chr17:79,089,345...79,611,051

G

RNA binding motif protein 22

decreases expression

Thimerosal results in decreased expression of RBM22 mRNA

NCBI chr 5:150,690,792...150,701,062
Ensembl chr 5:150,690,792...150,701,077

G

RNA binding motif protein 26

decreases expression

Thimerosal results in decreased expression of RBM26 mRNA

NCBI chr13:79,311,827...79,406,255
Ensembl chr13:79,311,824...79,406,477

G

RNA binding motif protein 7

decreases expression

Thimerosal results in decreased expression of RBM7 mRNA

NCBI chr11:114,400,666...114,410,607
Ensembl chr11:114,400,030...114,414,203

G

RNA binding motif protein 8A

decreases expression

Thimerosal results in decreased expression of RBM8A mRNA

NCBI chr 1:145,921,556...145,927,484
Ensembl chr 1:145,921,556...145,927,678

G

recombination signal binding protein for immunoglobulin kappa J region

decreases expression

Thimerosal results in decreased expression of RBPJ mRNA

NCBI chr 4:26,105,449...26,435,131
Ensembl chr 4:26,163,455...26,435,131

G

RNA binding protein, mRNA processing factor 2

decreases expression

Thimerosal results in decreased expression of RBPMS2 mRNA

NCBI chr15:64,739,891...64,775,589
Ensembl chr15:64,739,891...64,775,589

G

RCAN family member 3

decreases expression

Thimerosal results in decreased expression of RCAN3 mRNA

NCBI chr 1:24,502,344...24,541,040
Ensembl chr 1:24,502,351...24,541,040

G

REST corepressor 2

decreases expression

Thimerosal results in decreased expression of RCOR2 mRNA

NCBI chr11:63,911,230...63,927,762
Ensembl chr11:63,911,230...63,917,164

G

receptor accessory protein 6

decreases expression

Thimerosal results in decreased expression of REEP6 mRNA

NCBI chr19:1,491,181...1,497,927
Ensembl chr19:1,491,166...1,497,927

G

RELT like 1

decreases expression

Thimerosal results in decreased expression of RELL1 mRNA

NCBI chr 4:37,586,304...37,686,376
Ensembl chr 4:37,590,800...37,686,376

G

RALBP1 associated Eps domain containing 1

increases expression

Thimerosal results in increased expression of REPS1 mRNA

NCBI chr 6:138,903,493...138,988,253
Ensembl chr 6:138,903,493...138,988,261

G

replication factor C subunit 1

increases expression

Thimerosal results in increased expression of RFC1 mRNA

NCBI chr 4:39,287,456...39,366,362
Ensembl chr 4:39,287,456...39,366,375

G

regulatory factor X7

decreases expression

Thimerosal results in decreased expression of RFX7 mRNA

NCBI chr15:56,087,280...56,245,082
Ensembl chr15:56,087,280...56,245,082

G

Rho related BTB domain containing 2

decreases expression

Thimerosal results in decreased expression of RHOBTB2 mRNA

NCBI chr 8:22,950,813...23,020,199
Ensembl chr 8:22,987,417...23,020,509

G

Rho related BTB domain containing 3

decreases expression

Thimerosal results in decreased expression of RHOBTB3 mRNA

NCBI chr 5:95,717,624...95,796,361
Ensembl chr 5:95,713,522...95,824,383

G

ras homolog family member U

decreases expression

Thimerosal results in decreased expression of RHOU mRNA

NCBI chr 1:228,644,647...228,746,669
Ensembl chr 1:228,735,479...228,746,664

G

ribosomal modification protein rimK like family member A

decreases expression

Thimerosal results in decreased expression of RIMKLA mRNA

NCBI chr 1:42,380,792...42,424,232
Ensembl chr 1:42,380,792...42,424,232

G

regulating synaptic membrane exocytosis 1

increases expression

Thimerosal results in increased expression of RIMS1 mRNA

NCBI chr 6:71,886,550...72,403,145
Ensembl chr 6:71,886,550...72,403,150

G

RNA 5'-phosphate and 3'-OH ligase 1

increases expression

Thimerosal results in increased expression of RLIG1 mRNA

NCBI chr12:88,035,536...88,050,160
Ensembl chr12:88,033,846...88,050,160

G

relaxin 2

decreases expression

Thimerosal results in decreased expression of RLN2 mRNA

NCBI chr 9:5,299,864...5,339,326
Ensembl chr 9:5,299,864...5,304,716

G

RNA component of mitochondrial RNA processing endoribonuclease

decreases expression

Thimerosal results in decreased expression of RMRP mRNA

NCBI chr 9:35,657,750...35,658,019
Ensembl chr 9:35,657,754...35,658,017

G

ribonuclease A family member 4

decreases expression

Thimerosal results in decreased expression of RNASE4 mRNA

NCBI chr14:20,684,560...20,701,216
Ensembl chr14:20,684,560...20,701,216

G

ribonuclease T2

decreases expression

Thimerosal results in decreased expression of RNASET2 mRNA

NCBI chr 6:166,922,113...166,956,550
Ensembl chr 6:166,922,113...166,957,191

G

ring finger protein 130

decreases expression

Thimerosal results in decreased expression of RNF130 mRNA

NCBI chr 5:179,911,651...180,071,759
Ensembl chr 5:179,911,651...180,072,113

G

ring finger protein 43

decreases expression

Thimerosal results in decreased expression of RNF43 mRNA

NCBI chr17:58,352,500...58,417,534
Ensembl chr17:58,353,676...58,417,595

G

RNA guanine-7 methyltransferase

increases expression

Thimerosal results in increased expression of RNMT mRNA

NCBI chr18:13,726,673...13,764,556
Ensembl chr18:13,726,660...13,764,556

G

RAR related orphan receptor A

decreases expression

Thimerosal results in decreased expression of RORA mRNA

NCBI chr15:60,488,284...61,229,302
Ensembl chr15:60,488,284...61,229,302

G

ribosomal protein L7

increases expression

Thimerosal results in increased expression of RPL7 mRNA

NCBI chr 8:73,290,242...73,294,466
Ensembl chr 8:73,290,242...73,295,789

G

ribosomal protein S23

decreases expression

Thimerosal results in decreased expression of RPS23 mRNA

NCBI chr 5:82,273,320...82,278,354
Ensembl chr 5:82,273,320...82,278,396

G

ribosomal protein S27 like

increases expression

Thimerosal results in increased expression of RPS27L mRNA

NCBI chr15:63,148,249...63,157,477
Ensembl chr15:63,125,872...63,158,021

G

RRAD, Ras related glycolysis inhibitor and calcium channel regulator

increases expression

Thimerosal results in increased expression of RRAD mRNA

NCBI chr16:66,921,685...66,925,535
Ensembl chr16:66,921,685...66,925,535

G

radial spoke head component 9

decreases expression

Thimerosal results in decreased expression of RSPH9 mRNA

NCBI chr 6:43,645,036...43,672,600
Ensembl chr 6:43,645,036...43,672,600

G

retrotransposon Gag like 8A

decreases expression

Thimerosal results in decreased expression of RTL8A mRNA

NCBI chr X:135,050,932...135,052,135
Ensembl chr X:135,050,932...135,052,196

G

retrotransposon Gag like 8C

decreases expression

Thimerosal results in decreased expression of RTL8C mRNA

NCBI chr X:135,032,355...135,033,546
Ensembl chr X:135,032,355...135,033,546

G

reticulon 4 receptor

decreases expression

Thimerosal results in decreased expression of RTN4R mRNA

NCBI chr22:20,241,415...20,268,318
Ensembl chr22:20,241,415...20,283,246

G

RUN and FYVE domain containing 2

increases expression

Thimerosal results in increased expression of RUFY2 mRNA

NCBI chr10:68,341,112...68,407,277
Ensembl chr10:68,341,107...68,407,294

G

RUN and SH3 domain containing 2

decreases expression

Thimerosal results in decreased expression of RUSC2 mRNA

NCBI chr 9:35,490,111...35,561,895
Ensembl chr 9:35,490,111...35,561,898

G

ryanodine receptor 3

increases expression

Thimerosal results in increased expression of RYR3 mRNA

NCBI chr15:33,310,967...33,866,102
Ensembl chr15:33,310,962...33,866,121

G

spalt like transcription factor 4

decreases expression

Thimerosal results in decreased expression of SALL4 mRNA

NCBI chr20:51,782,331...51,802,521
Ensembl chr20:51,782,331...51,802,521

G

SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1

decreases expression

Thimerosal results in decreased expression of SAMHD1 mRNA

NCBI chr20:36,889,773...36,951,708
Ensembl chr20:36,890,229...36,951,893

G

suppressor APC domain containing 2

multiple interactions

[NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SAPCD2 mRNA

NCBI chr 9:137,062,127...137,070,557
Ensembl chr 9:137,062,127...137,070,557

G

secretion associated Ras related GTPase 1B

increases expression

Thimerosal results in increased expression of SAR1B mRNA

NCBI chr 5:134,601,149...134,632,828
Ensembl chr 5:134,601,149...134,649,271

G

salvador family WW domain containing protein 1

decreases expression

Thimerosal results in decreased expression of SAV1 mRNA

NCBI chr14:50,633,580...50,668,306
Ensembl chr14:50,632,058...50,668,306

G

stabilizer of axonemal microtubules 2

increases expression

Thimerosal results in increased expression of SAXO2 mRNA

NCBI chr15:82,262,818...82,284,927
Ensembl chr15:82,262,810...82,284,930

G

stearoyl-CoA desaturase

decreases expression

Thimerosal results in decreased expression of SCD mRNA

NCBI chr10:100,347,233...100,364,826
Ensembl chr10:100,347,233...100,364,826

G

short coiled-coil protein

increases expression

Thimerosal results in increased expression of SCOC mRNA

NCBI chr 4:140,257,308...140,385,728
Ensembl chr 4:140,257,286...140,385,728

G

secernin 3

decreases expression

Thimerosal results in decreased expression of SCRN3 mRNA

NCBI chr 2:174,395,730...174,430,071
Ensembl chr 2:174,395,730...174,429,575

G

scratch family transcriptional repressor 1

increases expression

Thimerosal results in increased expression of SCRT1 mRNA

NCBI chr 8:144,330,565...144,336,482
Ensembl chr 8:144,330,565...144,336,482

G

SCY1 like pseudokinase 2

decreases expression

Thimerosal results in decreased expression of SCYL2 mRNA

NCBI chr12:100,267,177...100,341,715
Ensembl chr12:100,267,140...100,341,715

G

syndecan 1

decreases expression

Thimerosal results in decreased expression of SDC1 mRNA

NCBI chr 2:20,200,797...20,225,475
Ensembl chr 2:20,200,797...20,225,433

G

SECIS binding protein 2 like

decreases expression

Thimerosal results in decreased expression of SECISBP2L mRNA

NCBI chr15:48,988,638...49,046,446
Ensembl chr15:48,988,476...49,046,447

G

SEL1L adaptor subunit of SYVN1 ubiquitin ligase

decreases expression

Thimerosal results in decreased expression of SEL1L mRNA

NCBI chr14:81,471,547...81,533,853
Ensembl chr14:81,471,547...81,533,853

G

semaphorin 3F

decreases expression

Thimerosal results in decreased expression of SEMA3F mRNA

NCBI chr 3:50,155,058...50,189,075
Ensembl chr 3:50,155,045...50,189,075

G

ssemaphorin 4F

decreases expression

Thimerosal results in decreased expression of SEMA4F mRNA

NCBI chr 2:74,654,247...74,709,713
Ensembl chr 2:74,654,228...74,683,853

G

semaphorin 6A

decreases expression

Thimerosal results in decreased expression of SEMA6A mRNA

NCBI chr 5:116,443,555...116,574,823
Ensembl chr 5:116,443,555...116,574,823

G

SUMO specific peptidase 7

increases expression

Thimerosal results in increased expression of SENP7 mRNA

NCBI chr 3:101,324,205...101,513,212
Ensembl chr 3:101,324,205...101,513,241

G

Sep (O-phosphoserine) tRNA:Sec (selenocysteine) tRNA synthase

increases expression
multiple interactions

Thimerosal results in increased expression of SEPSECS mRNA
[NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SEPSECS mRNA

NCBI chr 4:25,120,014...25,160,582
Ensembl chr 4:25,120,014...25,160,550

G

septin 9

decreases expression

Thimerosal results in decreased expression of SEPTIN9 mRNA

NCBI chr17:77,281,499...77,500,596
Ensembl chr17:77,280,569...77,500,596

G

serine incorporator 2

decreases expression

Thimerosal results in decreased expression of SERINC2 mRNA

NCBI chr 1:31,409,777...31,434,678
Ensembl chr 1:31,409,565...31,434,680

G

serpin family E member 1

increases expression

Thimerosal results in increased expression of SERPINE1 mRNA

NCBI chr 7:101,127,104...101,139,247
Ensembl chr 7:101,127,104...101,139,247

G

serpin family H member 1

increases expression

Thimerosal results in increased expression of SERPINH1 mRNA

NCBI chr11:75,562,253...75,572,783
Ensembl chr11:75,562,056...75,572,783

G

SET domain containing 2, histone lysine methyltransferase

decreases expression

Thimerosal results in decreased expression of SETD2 mRNA

NCBI chr 3:47,016,436...47,164,840
Ensembl chr 3:47,016,428...47,164,113

G

SET domain containing 9

increases expression

Thimerosal results in increased expression of SETD9 mRNA

NCBI chr 5:56,909,260...56,928,900
Ensembl chr 5:56,909,260...56,925,532

G

senataxin

decreases expression

Thimerosal results in decreased expression of SETX mRNA

NCBI chr 9:132,261,356...132,356,744
Ensembl chr 9:132,261,356...132,354,986

G

seizure related 6 homolog like 2

decreases expression

Thimerosal results in decreased expression of SEZ6L2 mRNA

NCBI chr16:29,871,159...29,899,550
Ensembl chr16:29,871,159...29,899,550

G

splicing factor 3a subunit 2

decreases expression

Thimerosal results in decreased expression of SF3A2 mRNA

NCBI chr19:2,236,824...2,248,655
Ensembl chr19:2,236,824...2,248,655

G

splicing factor 3b subunit 1

decreases expression

Thimerosal results in decreased expression of SF3B1 mRNA

NCBI chr 2:197,389,784...197,435,093
Ensembl chr 2:197,388,515...197,435,079

G

splicing factor 3b subunit 4

decreases expression

Thimerosal results in decreased expression of SF3B4 mRNA

NCBI chr 1:149,923,317...149,927,803
Ensembl chr 1:149,923,317...149,927,803

G

splicing factor proline and glutamine rich

decreases expression

Thimerosal results in decreased expression of SFPQ mRNA

NCBI chr 1:35,176,380...35,193,145
Ensembl chr 1:35,176,378...35,193,446

G

SWI5 dependent homologous recombination repair protein 1

increases expression

Thimerosal results in increased expression of SFR1 mRNA

NCBI chr10:104,120,166...104,126,383
Ensembl chr10:104,122,058...104,126,385

G

secreted frizzled related protein 1

decreases expression

Thimerosal results in decreased expression of SFRP1 mRNA

NCBI chr 8:41,261,962...41,309,473
Ensembl chr 8:41,261,962...41,309,473

G

sphingosine-1-phosphate lyase 1

increases expression

Thimerosal results in increased expression of SGPL1 mRNA

NCBI chr10:70,815,948...70,881,184
Ensembl chr10:70,815,905...70,895,816

G

SH3 domain binding glutamate rich protein like 3

decreases expression

Thimerosal results in decreased expression of SH3BGRL3 mRNA

NCBI chr 1:26,280,086...26,281,522
Ensembl chr 1:26,280,086...26,281,522

G

shiftless antiviral inhibitor of ribosomal frameshifting

decreases expression

Thimerosal results in decreased expression of SHFL mRNA

NCBI chr19:10,086,317...10,093,243
Ensembl chr19:10,086,122...10,093,252

G

shisa family member 5

decreases expression

Thimerosal results in decreased expression of SHISA5 mRNA

NCBI chr 3:48,467,876...48,504,810
Ensembl chr 3:48,467,798...48,504,826

G

SHOC2 leucine rich repeat scaffold protein

increases expression

Thimerosal results in increased expression of SHOC2 mRNA

NCBI chr10:110,919,370...111,013,665
Ensembl chr10:110,919,367...111,017,307

G

siah E3 ubiquitin protein ligase 1

increases expression

Thimerosal results in increased expression of SIAH1 mRNA

NCBI chr16:48,360,531...48,387,246
Ensembl chr16:48,356,364...48,448,402

G

suppressor of IKBKE 1

decreases expression

Thimerosal results in decreased expression of SIKE1 mRNA

NCBI chr 1:114,769,479...114,780,685
Ensembl chr 1:114,769,479...114,780,685

G

signal-induced proliferation-associated 1

decreases expression

Thimerosal results in decreased expression of SIPA1 mRNA

NCBI chr11:65,638,101...65,650,912
Ensembl chr11:65,638,101...65,650,918

G

signal regulatory protein alpha

decreases expression

Thimerosal results in decreased expression of SIRPA mRNA

NCBI chr20:1,894,167...1,940,592
Ensembl chr20:1,894,167...1,940,592

G

sirtuin 1

multiple interactions

SIRT1 protein affects the reaction [Resveratrol inhibits the reaction [[SOD1 protein results in increased susceptibility to Thimerosal] which results in decreased expression of KCNIP3 protein]]

NCBI chr10:67,884,656...67,918,390
Ensembl chr10:67,884,656...67,918,390

G

SIX homeobox 5

decreases expression

Thimerosal results in decreased expression of SIX5 mRNA

NCBI chr19:45,764,785...45,769,252
Ensembl chr19:45,764,785...45,769,252

G

SIX homeobox 6

increases expression

Thimerosal results in increased expression of SIX6 mRNA

NCBI chr14:60,509,146...60,512,850
Ensembl chr14:60,509,146...60,512,850

G

spindle and kinetochore associated complex subunit 2

increases expression

Thimerosal results in increased expression of SKA2 mRNA

NCBI chr17:59,109,857...59,155,186
Ensembl chr17:59,109,857...59,155,260

G

SKI3 subunit of superkiller complex

decreases expression

Thimerosal results in decreased expression of SKIC3 mRNA

NCBI chr 5:95,463,894...95,554,977
Ensembl chr 5:95,461,755...95,555,050

G

solute carrier family 10 member 7

increases expression

Thimerosal results in increased expression of SLC10A7 mRNA

NCBI chr 4:146,253,981...146,521,940
Ensembl chr 4:146,253,975...146,522,372

G

solute carrier family 12 member 2

increases expression

Thimerosal results in increased expression of SLC12A2 mRNA

NCBI chr 5:128,083,766...128,189,677
Ensembl chr 5:128,083,766...128,189,677

G

solute carrier family 16 member 1

decreases expression

Thimerosal results in decreased expression of SLC16A1 mRNA

NCBI chr 1:112,911,847...112,956,196
Ensembl chr 1:112,911,847...112,957,593

G

solute carrier family 16 member 14

increases expression

Thimerosal results in increased expression of SLC16A14 mRNA

NCBI chr 2:230,034,982...230,068,924
Ensembl chr 2:230,034,982...230,068,993

G

solute carrier family 16 member 6

increases expression

Thimerosal results in increased expression of SLC16A6 mRNA

NCBI chr17:68,267,026...68,291,479
Ensembl chr17:68,267,026...68,291,267

G

solute carrier family 16 member 9

increases expression

Thimerosal results in increased expression of SLC16A9 mRNA

NCBI chr10:59,650,764...59,710,079
Ensembl chr10:59,650,764...59,736,002

G

solute carrier family 18 member B1

decreases expression

Thimerosal results in decreased expression of SLC18B1 mRNA

NCBI chr 6:132,769,370...132,798,637
Ensembl chr 6:132,769,370...132,813,339

G

solute carrier family 1 member 1

increases expression

Thimerosal results in increased expression of SLC1A1 protein

NCBI chr 9:4,490,468...4,587,469
Ensembl chr 9:4,490,468...4,587,469

G

solute carrier family 22 member 4

decreases activity

Thimerosal results in decreased activity of SLC22A4 protein

NCBI chr 5:132,294,394...132,344,190
Ensembl chr 5:132,294,394...132,344,190

G

solute carrier family 25 member 1

decreases expression

Thimerosal results in decreased expression of SLC25A1 mRNA

NCBI chr22:19,175,581...19,178,736
Ensembl chr22:19,175,581...19,178,739

G

solute carrier family 25 member 21

multiple interactions

[NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC25A21 mRNA

NCBI chr14:36,677,921...37,172,606
Ensembl chr14:36,677,921...37,172,606

G

solute carrier family 25 member 23

decreases expression

Thimerosal results in decreased expression of SLC25A23 mRNA

NCBI chr19:6,436,081...6,459,792
Ensembl chr19:6,436,079...6,465,203

G

solute carrier family 25 member 44

increases expression

Thimerosal results in increased expression of SLC25A44 mRNA

NCBI chr 1:156,194,104...156,212,796
Ensembl chr 1:156,193,932...156,212,796

G

solute carrier family 29 member 2

decreases expression

Thimerosal results in decreased expression of SLC29A2 mRNA

NCBI chr11:66,362,521...66,372,446
Ensembl chr11:66,362,521...66,372,214

G

solute carrier family 2 member 1

decreases expression

Thimerosal results in decreased expression of SLC2A1 mRNA

NCBI chr 1:42,925,353...42,958,868
Ensembl chr 1:42,925,353...42,958,893

G

solute carrier family 2 member 12

decreases expression

Thimerosal results in decreased expression of SLC2A12 mRNA

NCBI chr 6:133,987,581...134,052,624
Ensembl chr 6:133,987,581...134,052,624

G

solute carrier family 2 member 3

decreases expression

Thimerosal results in decreased expression of SLC2A3 mRNA

NCBI chr12:7,919,230...7,936,187
Ensembl chr12:7,919,230...8,019,007

G

solute carrier family 30 member 5

multiple interactions

[NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC30A5 mRNA

NCBI chr 5:69,094,014...69,131,069
Ensembl chr 5:69,093,991...69,131,069

G

solute carrier family 38 member 1

decreases expression

Thimerosal results in decreased expression of SLC38A1 mRNA

NCBI chr12:46,183,063...46,269,043
Ensembl chr12:46,183,063...46,270,017

G

solute carrier family 5 member 3

increases expression

Thimerosal results in increased expression of SLC5A3 mRNA

NCBI chr21:34,073,578...34,106,260
Ensembl chr21:34,073,578...34,106,260

G

solute carrier family 5 member 7

decreases expression

Thimerosal results in decreased expression of SLC5A7 mRNA

NCBI chr 2:107,986,524...108,013,994
Ensembl chr 2:107,986,523...108,013,994

G

solute carrier family 7 member 1

decreases expression

Thimerosal results in decreased expression of SLC7A1 mRNA

NCBI chr13:29,509,414...29,595,688
Ensembl chr13:29,509,414...29,595,688

G

solute carrier family 7 member 3

decreases expression

Thimerosal results in decreased expression of SLC7A3 mRNA

NCBI chr X:70,925,579...70,931,096
Ensembl chr X:70,925,579...70,931,125

G

solute carrier family 8 member A1

increases expression

Thimerosal results in increased expression of SLC8A1 mRNA

NCBI chr 2:40,097,270...40,512,435
Ensembl chr 2:40,097,270...40,611,053

G

SLCO4A1 antisense RNA 1

multiple interactions

[NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLCO4A1-AS1 mRNA

NCBI chr20:62,663,027...62,666,621
Ensembl chr20:62,663,019...62,666,724

G

SWI/SNF related, matrix associated, actin dependent regulator of chromatin subfamily c member 2

affects expression

Thimerosal affects the expression of SMARCC2 mRNA

NCBI chr12:56,162,359...56,189,483
Ensembl chr12:56,162,359...56,189,567

G

structural maintenance of chromosomes 1A

decreases expression

Thimerosal results in decreased expression of SMC1A mRNA

NCBI chr X:53,374,149...53,422,728
Ensembl chr X:53,374,149...53,422,728

G

structural maintenance of chromosomes flexible hinge domain containing 1

decreases expression

Thimerosal results in decreased expression of SMCHD1 mRNA

NCBI chr18:2,655,726...2,805,017
Ensembl chr18:2,655,726...2,805,017

G

small integral membrane protein 3

decreases expression

Thimerosal results in decreased expression of SMIM3 mRNA

NCBI chr 5:150,778,757...150,796,734
Ensembl chr 5:150,778,757...150,796,734

G

spermine oxidase

decreases expression

Thimerosal results in decreased expression of SMOX mRNA

NCBI chr20:4,148,828...4,187,727
Ensembl chr20:4,120,980...4,187,747

G

SNAI3 antisense RNA 1

decreases expression

Thimerosal results in decreased expression of SNAI3-AS1 mRNA

NCBI chr16:88,663,373...88,687,186
Ensembl chr16:88,663,298...88,687,282

G

synaptosome associated protein 25

decreases expression

Thimerosal results in decreased expression of SNAP25 protein

NCBI chr20:10,218,830...10,307,418
Ensembl chr20:10,172,395...10,308,258

G

synuclein alpha interacting protein

multiple interactions

[NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SNCAIP mRNA

NCBI chr 5:122,311,353...122,464,219
Ensembl chr 5:122,311,354...122,464,219

G

small nuclear ribonucleoprotein polypeptide A

decreases expression

Thimerosal results in decreased expression of SNRPA mRNA

NCBI chr19:40,751,203...40,765,389
Ensembl chr19:40,750,637...40,765,389

G

sorting nexin 2

increases expression

Thimerosal results in increased expression of SNX2 mRNA

NCBI chr 5:122,774,996...122,834,543
Ensembl chr 5:122,775,079...122,834,543

G

sorting nexin family member 21

decreases expression

Thimerosal results in decreased expression of SNX21 mRNA

NCBI chr20:45,833,799...45,843,276
Ensembl chr20:45,833,799...45,843,276

G

sorting nexin 4

increases expression

Thimerosal results in increased expression of SNX4 mRNA

NCBI chr 3:125,446,650...125,520,202
Ensembl chr 3:125,446,650...125,520,202

G

sorting nexin 9

decreases expression

Thimerosal results in decreased expression of SNX9 mRNA

NCBI chr 6:157,823,246...157,945,077
Ensembl chr 6:157,700,387...157,945,077

G

superoxide dismutase 1

multiple interactions
increases response to substance

[SOD1 protein mutant form results in increased susceptibility to Thimerosal] which results in increased acetylation of and results in increased ubiquitination of KCNIP3 protein; [SOD1 protein mutant form results in increased susceptibility to Thimerosal] which results in increased expression of PDYN mRNA; [SOD1 protein results in increased susceptibility to Thimerosal] which results in decreased expression of KCNIP3 protein; [SOD1 protein results in increased susceptibility to Thimerosal] which results in increased cleavage of CASP3 protein; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [[SOD1 protein results in increased susceptibility to Thimerosal] which results in decreased expression of KCNIP3 protein]; Resveratrol inhibits the reaction [[SOD1 protein mutant form results in increased susceptibility to Thimerosal] which results in increased acetylation of and results in increased ubiquitination of KCNIP3 protein]; Resveratrol inhibits the reaction [[SOD1 protein mutant form results in increased susceptibility to Thimerosal] which results in increased expression of PDYN mRNA]; Resveratrol inhibits the reaction [[SOD1 protein results in increased susceptibility to Thimerosal] which results in decreased expression of KCNIP3 protein]; Resveratrol inhibits the reaction [[SOD1 protein results in increased susceptibility to Thimerosal] which results in increased cleavage of CASP3 protein]; SIRT1 protein affects the reaction [Resveratrol inhibits the reaction [[SOD1 protein results in increased susceptibility to Thimerosal] which results in decreased expression of KCNIP3 protein]]

NCBI chr21:31,659,693...31,668,931
Ensembl chr21:31,659,666...31,668,931

G

SON DNA and RNA binding protein

decreases expression

Thimerosal results in decreased expression of SON mRNA

NCBI chr21:33,543,038...33,577,481
Ensembl chr21:33,543,038...33,577,481

G

sorbin and SH3 domain containing 2

increases expression

Thimerosal results in increased expression of SORBS2 mRNA

NCBI chr 4:185,585,523...185,956,372
Ensembl chr 4:185,585,444...185,956,652

G

sorbin and SH3 domain containing 3

decreases expression

Thimerosal results in decreased expression of SORBS3 mRNA

NCBI chr 8:22,544,973...22,575,788
Ensembl chr 8:22,544,986...22,575,788

G

sortilin related receptor 1

decreases expression

Thimerosal results in decreased expression of SORL1 mRNA

NCBI chr11:121,452,314...121,633,763
Ensembl chr11:121,452,314...121,633,763

G

SRY-box transcription factor 18

decreases expression

Thimerosal results in decreased expression of SOX18 mRNA

NCBI chr20:64,047,582...64,049,639
Ensembl chr20:64,047,582...64,049,639

G

SRY-box transcription factor 7

decreases expression

Thimerosal results in decreased expression of SOX7 mRNA

NCBI chr 8:10,723,768...10,730,511
Ensembl chr 8:10,723,768...10,730,511

G

SRY-box transcription factor 8

decreases expression

Thimerosal results in decreased expression of SOX8 mRNA

NCBI chr16:981,770...986,979
Ensembl chr16:981,444...986,979

G

SRY-box transcription factor 9

increases expression

Thimerosal results in increased expression of SOX9 mRNA

NCBI chr17:72,121,020...72,126,416
Ensembl chr17:72,121,020...72,126,416

G

Sp4 transcription factor

decreases expression

Thimerosal results in decreased expression of SP4 mRNA

NCBI chr 7:21,428,083...21,514,822
Ensembl chr 7:21,428,043...21,514,822

G

Sp5 transcription factor

decreases expression

Thimerosal results in decreased expression of SP5 mRNA

NCBI chr 2:170,715,337...170,718,078
Ensembl chr 2:170,715,337...170,718,078

G

Sp8 transcription factor

increases expression

Thimerosal results in increased expression of SP8 mRNA

NCBI chr 7:20,782,279...20,786,886
Ensembl chr 7:20,782,279...20,786,886

G

sperm associated antigen 4

decreases expression

Thimerosal results in decreased expression of SPAG4 mRNA

NCBI chr20:35,615,829...35,621,094
Ensembl chr20:35,615,829...35,621,094

G

sperm associated antigen 9

increases expression

Thimerosal results in increased expression of SPAG9 mRNA

NCBI chr17:50,962,174...51,120,868
Ensembl chr17:50,962,174...51,120,868

G

spermatogenesis associated 18

increases expression

Thimerosal results in increased expression of SPATA18 mRNA

NCBI chr 4:52,051,304...52,097,299
Ensembl chr 4:52,051,304...52,097,299

G

spermatogenesis associated 2

decreases expression

Thimerosal results in decreased expression of SPATA2 mRNA

NCBI chr20:49,903,391...49,915,529
Ensembl chr20:49,903,391...49,915,529

G

spermatogenesis and centriole associated 1 like

decreases expression

Thimerosal results in decreased expression of SPATC1L mRNA

NCBI chr21:46,161,160...46,184,459
Ensembl chr21:46,161,148...46,184,476

G

sperm antigen with calponin homology and coiled-coil domains 1

increases expression

Thimerosal results in increased expression of SPECC1 mRNA

NCBI chr17:20,009,359...20,319,026
Ensembl chr17:20,008,865...20,319,026

G

spen family transcriptional repressor

decreases expression

Thimerosal results in decreased expression of SPEN mRNA

NCBI chr 1:15,847,707...15,940,456
Ensembl chr 1:15,836,095...15,940,456

G

sperm microtubule inner protein 4

decreases expression

Thimerosal results in decreased expression of SPMIP4 mRNA

NCBI chr 7:25,125,772...25,180,354
Ensembl chr 7:25,134,692...25,180,356

G

signal peptide peptidase like 2B

decreases expression

Thimerosal results in decreased expression of SPPL2B mRNA

NCBI chr19:2,328,684...2,355,095
Ensembl chr19:2,328,615...2,355,095

G

spectrin beta, non-erythrocytic 1

decreases expression

Thimerosal results in decreased expression of SPTBN1 mRNA

NCBI chr 2:54,456,327...54,671,446
Ensembl chr 2:54,456,327...54,671,446

G

squalene epoxidase

decreases expression

Thimerosal results in decreased expression of SQLE mRNA

NCBI chr 8:124,998,505...125,022,283
Ensembl chr 8:124,998,497...125,022,283

G

steroid 5 alpha-reductase 3

decreases expression

Thimerosal results in decreased expression of SRD5A3 mRNA

NCBI chr 4:55,346,242...55,373,100
Ensembl chr 4:55,346,213...55,373,100

G

sarcalumenin

decreases expression

Thimerosal results in decreased expression of SRL mRNA

NCBI chr16:4,189,374...4,242,080
Ensembl chr16:4,189,374...4,242,080

G

SRP receptor subunit alpha

decreases expression

Thimerosal results in decreased expression of SRPRA mRNA

NCBI chr11:126,235,930...126,268,895
Ensembl chr11:126,262,938...126,269,144

G

serine and arginine repetitive matrix 1

decreases expression

Thimerosal results in decreased expression of SRRM1 mRNA

NCBI chr 1:24,643,302...24,673,281
Ensembl chr 1:24,631,716...24,673,281

G

serine/arginine repetitive matrix 2

decreases expression

Thimerosal results in decreased expression of SRRM2 mRNA

NCBI chr16:2,752,638...2,771,412
Ensembl chr16:2,752,626...2,772,538

G

serine and arginine rich splicing factor 4

increases expression

Thimerosal results in increased expression of SRSF4 mRNA

NCBI chr 1:29,147,743...29,181,900
Ensembl chr 1:29,147,743...29,181,900

G

structure specific recognition protein 1

decreases expression

Thimerosal results in decreased expression of SSRP1 mRNA

NCBI chr11:57,325,988...57,335,892
Ensembl chr11:57,325,986...57,335,892

G

ST7 antisense RNA 1

decreases expression

Thimerosal results in decreased expression of ST7-AS1 mRNA

NCBI chr 7:116,952,446...116,954,334
Ensembl chr 7:116,952,446...116,954,334

G

STAG1 cohesin complex component

increases expression

Thimerosal results in increased expression of STAG1 mRNA

NCBI chr 3:136,336,236...136,752,378
Ensembl chr 3:136,336,236...136,752,403

G

STAG2 cohesin complex component

increases expression

Thimerosal results in increased expression of STAG2 mRNA

NCBI chr X:123,960,560...124,102,656
Ensembl chr X:123,960,212...124,422,664

G

stanniocalcin 1

decreases expression

Thimerosal results in decreased expression of STC1 mRNA

NCBI chr 8:23,841,929...23,854,806
Ensembl chr 8:23,841,929...23,854,806

G

stanniocalcin 2

decreases expression

Thimerosal results in decreased expression of STC2 mRNA

NCBI chr 5:173,314,723...173,328,414
Ensembl chr 5:173,314,723...173,328,447

G

stromal interaction molecule 2

increases expression

Thimerosal results in increased expression of STIM2 mRNA

NCBI chr 4:26,860,841...27,025,381
Ensembl chr 4:26,857,601...27,025,381

G

serine/threonine kinase 35

increases expression

Thimerosal results in increased expression of STK35 mRNA

NCBI chr20:2,101,827...2,148,555
Ensembl chr20:2,101,827...2,177,038

G

stonin 2

decreases expression

Thimerosal results in decreased expression of STON2 mRNA

NCBI chr14:81,260,652...81,436,465
Ensembl chr14:81,260,652...81,436,465

G

sperm tail PG-rich repeat containing 1

decreases expression

Thimerosal results in decreased expression of STPG1 mRNA

NCBI chr 1:24,356,999...24,415,044
Ensembl chr 1:24,356,999...24,416,934

G

syntaxin 2

decreases expression

Thimerosal results in decreased expression of STX2 mRNA

NCBI chr12:130,789,600...130,839,250
Ensembl chr12:130,789,600...130,839,254

G

syntaxin 4

increases expression

Thimerosal results in increased expression of STX4 mRNA

NCBI chr16:31,033,095...31,040,168
Ensembl chr16:31,032,889...31,042,975

G

serine/threonine/tyrosine interacting protein

decreases expression

Thimerosal results in decreased expression of STYX mRNA

NCBI chr14:52,730,166...52,774,989
Ensembl chr14:52,730,166...52,774,989

G

Sad1 and UNC84 domain containing 2

increases expression

Thimerosal results in increased expression of SUN2 mRNA

NCBI chr22:38,734,734...38,755,998
Ensembl chr22:38,733,290...38,794,143

G

SPT16 homolog, facilitates chromatin remodeling subunit

decreases expression

Thimerosal results in decreased expression of SUPT16H mRNA

NCBI chr14:21,351,476...21,384,019
Ensembl chr14:21,351,476...21,384,019

G

synaptonemal complex protein 2

increases expression

Thimerosal results in increased expression of SYCP2 mRNA

NCBI chr20:59,863,571...59,933,637
Ensembl chr20:59,863,564...59,933,655

G

synaptonemal complex protein 3

increases expression

Thimerosal results in increased expression of SYCP3 mRNA

NCBI chr12:101,728,648...101,739,462
Ensembl chr12:101,728,648...101,739,472

G

synaptotagmin binding cytoplasmic RNA interacting protein

decreases expression

Thimerosal results in decreased expression of SYNCRIP mRNA

NCBI chr 6:85,607,784...85,643,870
Ensembl chr 6:85,607,779...85,644,063

G

spectrin repeat containing nuclear envelope protein 2

decreases expression

Thimerosal results in decreased expression of SYNE2 mRNA

NCBI chr14:63,761,596...64,226,449
Ensembl chr14:63,761,899...64,226,433

G

synaptogyrin 3

decreases expression

Thimerosal results in decreased expression of SYNGR3 mRNA

NCBI chr16:1,989,970...1,994,275
Ensembl chr16:1,989,660...1,994,275

G

synaptojanin 2 binding protein

decreases expression

Thimerosal results in decreased expression of SYNJ2BP mRNA

NCBI chr14:70,366,499...70,417,090
Ensembl chr14:70,366,499...70,417,090

G

synaptotagmin 6

decreases expression

Thimerosal results in decreased expression of SYT6 mRNA

NCBI chr 1:114,089,292...114,153,869
Ensembl chr 1:114,089,291...114,153,880

G

synaptotagmin like 4

decreases expression

Thimerosal results in decreased expression of SYTL4 mRNA

NCBI chr X:100,674,491...100,732,121
Ensembl chr X:100,671,783...100,732,123

G

TATA-box binding protein associated factor 9

increases expression

Thimerosal results in increased expression of TAF9 mRNA

NCBI chr 5:69,364,743...69,369,824
Ensembl chr 5:69,362,026...69,370,013

G

TATA-box binding protein associated factor 9b

affects expression

Thimerosal affects the expression of TAF9B mRNA

NCBI chr X:78,129,748...78,139,650
Ensembl chr X:78,129,748...78,139,650

G

tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2

decreases expression

Thimerosal results in decreased expression of TANC2 mRNA

NCBI chr17:62,966,235...63,427,703
Ensembl chr17:62,966,235...63,427,703

G

TAO kinase 1

decreases expression

Thimerosal results in decreased expression of TAOK1 mRNA

NCBI chr17:29,390,363...29,551,903
Ensembl chr17:29,390,363...29,551,903

G

transporter 2, ATP binding cassette subfamily B member

decreases expression

Thimerosal results in decreased expression of TAP2 mRNA

NCBI chr 6:32,821,831...32,838,739
Ensembl chr 6:32,821,833...32,838,739

G

transcription activation suppressor family member 2

increases expression

Thimerosal results in increased expression of TASOR2 mRNA

NCBI chr10:5,684,838...5,763,740
Ensembl chr10:5,684,731...5,763,779

G

Tax1 binding protein 1

increases expression

Thimerosal results in increased expression of TAX1BP1 mRNA

NCBI chr 7:27,739,373...27,829,767
Ensembl chr 7:27,739,331...27,844,564

G

TBC1 domain family member 16

decreases expression

Thimerosal results in decreased expression of TBC1D16 mRNA

NCBI chr17:79,932,343...80,035,872
Ensembl chr17:79,932,343...80,035,872

G

TBC1 domain family member 8B

decreases expression

Thimerosal results in decreased expression of TBC1D8B mRNA

NCBI chr X:106,802,673...106,876,150
Ensembl chr X:106,802,673...106,876,150

G

transducin beta like 1 X-linked

decreases expression

Thimerosal results in decreased expression of TBL1X mRNA

NCBI chr X:9,463,295...9,719,740
Ensembl chr X:9,463,320...9,741,037

G

TBL1X/Y related 1

increases expression

Thimerosal results in increased expression of TBL1XR1 mRNA

NCBI chr 3:177,019,344...177,201,800
Ensembl chr 3:177,019,340...177,228,000

G

transforming growth factor beta regulator 4

decreases expression

Thimerosal results in decreased expression of TBRG4 mRNA

NCBI chr 7:45,100,100...45,111,697
Ensembl chr 7:45,100,100...45,112,047

G

testicular cell adhesion molecule 1, pseudogene

increases expression

Thimerosal results in increased expression of TCAM1 mRNA

NCBI chr17:63,857,016...63,864,379
Ensembl chr17:63,849,292...63,864,379
Ensembl chr17:63,849,292...63,864,379

G

transcription elongation factor A like 2

decreases expression

Thimerosal results in decreased expression of TCEAL2 mRNA

NCBI chr X:102,125,679...102,127,712
Ensembl chr X:102,125,679...102,140,426

G

transcription factor 7 like 1

decreases expression

Thimerosal results in decreased expression of TCF7L1 mRNA

NCBI chr 2:85,133,392...85,310,387
Ensembl chr 2:85,133,392...85,310,387

G

tudor domain containing 6

increases expression

Thimerosal results in increased expression of TDRD6 mRNA

NCBI chr 6:46,680,268...46,704,319
Ensembl chr 6:46,687,875...46,704,319

G

tudor domain containing 7

decreases expression

Thimerosal results in decreased expression of TDRD7 mRNA

NCBI chr 9:97,412,096...97,496,125
Ensembl chr 9:97,412,096...97,496,125

G

tudor and KH domain containing

decreases expression

Thimerosal results in decreased expression of TDRKH mRNA

NCBI chr 1:151,766,486...151,790,534
Ensembl chr 1:151,770,107...151,791,416

G

TEA domain transcription factor 1

decreases expression

Thimerosal results in decreased expression of TEAD1 mRNA

NCBI chr11:12,674,421...12,944,737
Ensembl chr11:12,674,421...12,944,737

G

trans-2,3-enoyl-CoA reductase

decreases expression

Thimerosal results in decreased expression of TECR mRNA

NCBI chr19:14,527,726...14,565,980
Ensembl chr19:14,517,085...14,565,980

G

tet methylcytosine dioxygenase 1

decreases expression

Thimerosal results in decreased expression of TET1 mRNA

NCBI chr10:68,560,337...68,694,487
Ensembl chr10:68,560,337...68,694,487

G

tet methylcytosine dioxygenase 2

decreases expression

Thimerosal results in decreased expression of TET2 mRNA

NCBI chr 4:105,145,875...105,279,803
Ensembl chr 4:105,145,875...105,279,816

G

tet methylcytosine dioxygenase 3

decreases expression

Thimerosal results in decreased expression of TET3 mRNA

NCBI chr 2:73,983,631...74,135,498
Ensembl chr 2:73,984,910...74,108,176

G

testis expressed 10

decreases expression

Thimerosal results in decreased expression of TEX10 mRNA

NCBI chr 9:100,302,084...100,352,942
Ensembl chr 9:100,302,077...100,352,942

G

transforming growth factor beta 1

increases expression

Thimerosal results in increased expression of TGFB1

NCBI chr19:41,330,323...41,353,922
Ensembl chr19:41,301,587...41,353,922

G

thioesterase superfamily member 4

increases expression

Thimerosal results in increased expression of THEM4 mRNA

NCBI chr 1:151,870,866...151,909,511
Ensembl chr 1:151,870,866...151,909,637

G

thymocyte selection associated family member 2

decreases expression

Thimerosal results in decreased expression of THEMIS2 mRNA

NCBI chr 1:27,872,544...27,886,675
Ensembl chr 1:27,872,543...27,886,685

G

thrombopoietin

decreases expression

Thimerosal results in decreased expression of THPO mRNA

NCBI chr 3:184,371,935...184,379,688
Ensembl chr 3:184,371,935...184,381,968

G

thyroid hormone receptor associated protein 3

decreases expression

Thimerosal results in decreased expression of THRAP3 mRNA

NCBI chr 1:36,207,637...36,305,357
Ensembl chr 1:36,224,432...36,305,357

G

Thy-1 cell surface antigen

decreases expression

Thimerosal results in decreased expression of THY1 mRNA

NCBI chr11:119,415,476...119,424,985
Ensembl chr11:119,415,476...119,424,985

G

transketolase

decreases expression

Thimerosal results in decreased expression of TKT mRNA

NCBI chr 3:53,224,712...53,256,022
Ensembl chr 3:53,224,712...53,256,052

G

TLE family member 4, transcriptional corepressor

decreases expression

Thimerosal results in decreased expression of TLE4 mRNA

NCBI chr 9:79,571,965...79,726,882
Ensembl chr 9:79,571,773...79,726,882

G

transmembrane channel like 5

multiple interactions

[NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TMC5 mRNA

NCBI chr16:19,410,539...19,499,113
Ensembl chr16:19,410,496...19,499,113

G

transmembrane channel like 6

decreases expression

Thimerosal results in decreased expression of TMC6 mRNA

NCBI chr17:78,107,397...78,132,427
Ensembl chr17:78,107,397...78,132,407

G

transmembrane protein with EGF like and two follistatin like domains 2

increases expression

Thimerosal results in increased expression of TMEFF2 mRNA

NCBI chr 2:191,949,046...192,194,933
Ensembl chr 2:191,949,043...192,194,933

G

transmembrane protein 240

decreases expression

Thimerosal results in decreased expression of TMEM240 mRNA

NCBI chr 1:1,534,778...1,540,624
Ensembl chr 1:1,534,778...1,540,624

G

transmembrane protein 33

decreases expression

Thimerosal results in decreased expression of TMEM33 mRNA

NCBI chr 4:41,935,137...41,960,803
Ensembl chr 4:41,935,129...41,960,803

G

transmembrane protein 74B

decreases expression

Thimerosal results in decreased expression of TMEM74B mRNA

NCBI chr20:1,180,570...1,189,409
Ensembl chr20:1,180,561...1,185,415

G

transmembrane protein 97

decreases expression

Thimerosal results in decreased expression of TMEM97 mRNA

NCBI chr17:28,319,200...28,328,685
Ensembl chr17:28,319,200...28,328,685

G

tropomodulin 2

increases expression

Thimerosal results in increased expression of TMOD2 mRNA

NCBI chr15:51,751,597...51,816,363
Ensembl chr15:51,751,597...51,816,363

G

transmembrane O-mannosyltransferase targeting cadherins 3

decreases expression

Thimerosal results in decreased expression of TMTC3 mRNA

NCBI chr12:88,142,307...88,199,887
Ensembl chr12:88,142,296...88,199,887

G

tumor necrosis factor

increases secretion
multiple interactions

Thimerosal results in increased secretion of TNF protein
Glutathione inhibits the reaction [Thimerosal inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein]]; Thimerosal inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein]

PMID:17079650 PMID:18495191 PMID:20417223

NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336

G

TNF superfamily member 13b

increases expression

Thimerosal results in increased expression of TNFSF13B mRNA

NCBI chr13:108,269,629...108,308,484
Ensembl chr13:108,251,240...108,308,484

G

TNFAIP3 interacting protein 1

decreases expression

Thimerosal results in decreased expression of TNIP1 mRNA

NCBI chr 5:151,029,943...151,087,685
Ensembl chr 5:151,029,945...151,093,577

G

troponin I3, cardiac type

decreases expression

Thimerosal results in decreased expression of TNNI3 mRNA

NCBI chr19:55,151,767...55,157,732
Ensembl chr19:55,151,767...55,157,773

G

transducer of ERBB2, 2

decreases expression

Thimerosal results in decreased expression of TOB2 mRNA

NCBI chr22:41,433,494...41,446,801
Ensembl chr22:41,433,494...41,446,801

G

DNA topoisomerase II alpha

decreases activity

Thimerosal results in decreased activity of TOP2A protein

NCBI chr17:40,388,525...40,417,896
Ensembl chr17:40,388,525...40,417,896

G

TOX high mobility group box family member 2

decreases expression

Thimerosal results in decreased expression of TOX2 mRNA

NCBI chr20:43,914,852...44,069,616
Ensembl chr20:43,914,852...44,069,616

G

tumor protein p53

affects activity

Thimerosal affects the activity of TP53 protein

NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,538

G

tumor protein p53 binding protein 1

decreases expression

Thimerosal results in decreased expression of TP53BP1 mRNA

NCBI chr15:43,403,061...43,510,640
Ensembl chr15:43,403,061...43,510,728

G

two pore segment channel 1

decreases expression

Thimerosal results in decreased expression of TPCN1 mRNA

NCBI chr12:113,221,464...113,298,585
Ensembl chr12:113,221,050...113,298,585

G

tumor protein D52

decreases expression

Thimerosal results in decreased expression of TPD52 mRNA

NCBI chr 8:80,031,082...80,171,564
Ensembl chr 8:80,034,745...80,231,232

G

triosephosphate isomerase 1

decreases expression

Thimerosal results in decreased expression of TPI1 mRNA

NCBI chr12:6,867,420...6,870,948
Ensembl chr12:6,867,119...6,870,948

G

tropomyosin 4

decreases expression

Thimerosal results in decreased expression of TPM4 mRNA

NCBI chr19:16,067,538...16,103,002
Ensembl chr19:16,067,021...16,103,002

G

tripeptidyl peptidase 1

decreases expression

Thimerosal results in decreased expression of TPP1 mRNA

NCBI chr11:6,612,768...6,619,422
Ensembl chr11:6,612,768...6,619,448

G

tripeptidyl peptidase 2

decreases expression

Thimerosal results in decreased expression of TPP2 mRNA

NCBI chr13:102,596,986...102,679,958
Ensembl chr13:102,596,958...102,679,958

G

translocated promoter region, nuclear basket protein

decreases expression

Thimerosal results in decreased expression of TPR mRNA

NCBI chr 1:186,311,652...186,375,253
Ensembl chr 1:186,311,652...186,375,693

G

TP53RK binding protein

increases expression

Thimerosal results in increased expression of TPRKB mRNA

NCBI chr 2:73,729,873...73,737,345
Ensembl chr 2:73,729,104...73,737,400

G

TRAF3IP2 antisense RNA 1

increases expression

Thimerosal results in increased expression of TRAF3IP2-AS1 mRNA

NCBI chr 6:111,483,472...111,602,295
Ensembl chr 6:111,483,459...111,598,783

G

TNF receptor associated factor 5

decreases expression

Thimerosal results in decreased expression of TRAF5 mRNA

NCBI chr 1:211,326,635...211,374,946
Ensembl chr 1:211,326,615...211,374,946

G

translocation associated membrane protein 1

increases expression

Thimerosal results in increased expression of TRAM1 mRNA

NCBI chr 8:70,573,218...70,608,416
Ensembl chr 8:70,573,218...70,608,416

G

trafficking protein particle complex subunit 13

increases expression

Thimerosal results in increased expression of TRAPPC13 mRNA

NCBI chr 5:65,625,027...65,666,233
Ensembl chr 5:65,625,004...65,666,233

G

tRNA aspartic acid methyltransferase 1

decreases expression

Thimerosal results in decreased expression of TRDMT1 mRNA

NCBI chr10:17,137,336...17,201,672
Ensembl chr10:17,137,336...17,202,054

G

transcriptional regulating factor 1

decreases expression

Thimerosal results in decreased expression of TRERF1 mRNA

NCBI chr 6:42,224,931...42,452,224
Ensembl chr 6:42,224,931...42,452,051

G

tribbles pseudokinase 3

decreases expression

Thimerosal results in decreased expression of TRIB3 mRNA

NCBI chr20:380,760...397,559
Ensembl chr20:362,835...397,559

G

tripartite motif containing 13

increases expression

Thimerosal results in increased expression of TRIM13 mRNA

NCBI chr13:49,997,042...50,018,467
Ensembl chr13:49,995,888...50,020,481

G

tripartite motif containing 14

decreases expression

Thimerosal results in decreased expression of TRIM14 mRNA

NCBI chr 9:98,035,797...98,119,222
Ensembl chr 9:98,069,275...98,119,222

G

tripartite motif containing 22

increases expression

Thimerosal results in increased expression of TRIM22 mRNA

NCBI chr11:5,689,790...5,710,863
Ensembl chr11:5,689,610...5,737,089

G

tripartite motif containing 23

increases expression

Thimerosal results in increased expression of TRIM23 mRNA

NCBI chr 5:65,589,690...65,624,333
Ensembl chr 5:65,589,690...65,625,975

G

tripartite motif containing 28

decreases expression

Thimerosal results in decreased expression of TRIM28 mRNA

NCBI chr19:58,544,064...58,550,715
Ensembl chr19:58,544,064...58,550,722

G

tripartite motif containing 59

decreases expression

Thimerosal results in decreased expression of TRIM59 mRNA

NCBI chr 3:160,435,503...160,449,786
Ensembl chr 3:160,432,445...160,485,773

G

tripartite motif containing 9

decreases expression

Thimerosal results in decreased expression of TRIM9 mRNA

NCBI chr14:50,975,266...51,095,105
Ensembl chr14:50,975,262...51,096,061

G

tRNA methyltransferase 10A

increases expression

Thimerosal results in increased expression of TRMT10A mRNA

NCBI chr 4:99,546,711...99,564,039
Ensembl chr 4:99,546,709...99,564,039

G

transient receptor potential cation channel subfamily M member 3

increases expression

Thimerosal results in increased expression of TRPM3 mRNA

NCBI chr 9:70,529,060...71,446,971
Ensembl chr 9:70,529,060...71,446,904

G

thyroid stimulating hormone subunit beta

increases expression

Thimerosal results in increased expression of TSHB mRNA; Thimerosal results in increased expression of TSHB protein

NCBI chr 1:115,029,826...115,034,309
Ensembl chr 1:115,029,826...115,034,302

G

tetraspanin 33

decreases expression

Thimerosal results in decreased expression of TSPAN33 mRNA

NCBI chr 7:129,144,707...129,169,699
Ensembl chr 7:129,144,707...129,169,699

G

tetratricopeptide repeat domain 39C

multiple interactions

[NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TTC39C mRNA

NCBI chr18:23,992,887...24,135,600
Ensembl chr18:23,992,773...24,135,610

G

tweety family member 2

decreases expression

Thimerosal results in decreased expression of TTYH2 mRNA

NCBI chr17:74,213,571...74,262,020
Ensembl chr17:74,213,571...74,262,020

G

tubulin beta 2A class IIa

decreases expression

Thimerosal results in decreased expression of TUBB2A mRNA

NCBI chr 6:3,153,666...3,157,544
Ensembl chr 6:3,153,497...3,157,544

G

tubulin beta 4B class IVb

decreases expression

Thimerosal results in decreased expression of TUBB4B mRNA

NCBI chr 9:137,241,287...137,243,707
Ensembl chr 9:137,241,287...137,243,707

G

tubulin gamma complex component 3

increases expression

Thimerosal results in increased expression of TUBGCP3 mRNA

NCBI chr13:112,485,011...112,605,630
Ensembl chr13:112,485,011...112,588,205

G

thioredoxin domain containing 9

increases expression

Thimerosal results in increased expression of TXNDC9 mRNA

NCBI chr 2:99,306,184...99,336,333
Ensembl chr 2:99,318,982...99,340,702

G

thioredoxin interacting protein

decreases expression

Thimerosal results in decreased expression of TXNIP mRNA

NCBI chr 1:145,992,435...145,996,579
Ensembl chr 1:145,992,435...145,996,579

G

ubiquitin conjugating enzyme E2 L3

decreases expression

Thimerosal results in decreased expression of UBE2L3 mRNA

NCBI chr22:21,549,447...21,624,034
Ensembl chr22:21,549,447...21,624,034

G

ubinuclein 1

decreases expression

Thimerosal results in decreased expression of UBN1 mRNA

NCBI chr16:4,847,481...4,882,401
Ensembl chr16:4,846,665...4,882,401

G

ubinuclein 2

decreases expression

Thimerosal results in decreased expression of UBN2 mRNA

NCBI chr 7:139,231,237...139,330,428
Ensembl chr 7:139,230,356...139,308,236

G

ubiquitin protein ligase E3 component n-recognin 1

increases expression

Thimerosal results in increased expression of UBR1 mRNA

NCBI chr15:42,942,897...43,106,038
Ensembl chr15:42,942,897...43,106,113

G

uncoupling protein 2

decreases expression

Thimerosal results in decreased expression of UCP2 mRNA

NCBI chr11:73,974,672...73,983,202
Ensembl chr11:73,974,672...73,982,843

G

UDP-glucose ceramide glucosyltransferase

decreases expression

Thimerosal results in decreased expression of UGCG mRNA

NCBI chr 9:111,896,814...111,935,369
Ensembl chr 9:111,896,814...111,935,369

G

UDP-glucose glycoprotein glucosyltransferase 1

decreases expression

Thimerosal results in decreased expression of UGGT1 mRNA

NCBI chr 2:128,091,200...128,195,677
Ensembl chr 2:128,091,200...128,195,677

G

UDP glycosyltransferase 8

decreases expression

Thimerosal results in decreased expression of UGT8 mRNA

NCBI chr 4:114,598,402...114,678,225
Ensembl chr 4:114,598,770...114,678,225

G

U2AF homology motif kinase 1

decreases expression

Thimerosal results in decreased expression of UHMK1 mRNA

NCBI chr 1:162,497,174...162,529,631
Ensembl chr 1:162,497,251...162,529,631

G

UPF1 RNA helicase and ATPase

decreases expression

Thimerosal results in decreased expression of UPF1 mRNA

NCBI chr19:18,831,959...18,868,230
Ensembl chr19:18,831,959...18,868,230

G

uridine phosphorylase 1

increases expression

Thimerosal results in increased expression of UPP1 mRNA

NCBI chr 7:48,088,704...48,108,736
Ensembl chr 7:48,088,628...48,108,736

G

ubiquitin specific peptidase 1

decreases expression

Thimerosal results in decreased expression of USP1 mRNA

NCBI chr 1:62,436,395...62,451,804
Ensembl chr 1:62,436,297...62,451,804

G

ubiquitin specific peptidase 10

decreases expression

Thimerosal results in decreased expression of USP10 mRNA

NCBI chr16:84,700,000...84,779,922
Ensembl chr16:84,699,986...84,779,922

G

ubiquitin specific peptidase 16

increases expression

Thimerosal results in increased expression of USP16 mRNA

NCBI chr21:29,024,668...29,054,488
Ensembl chr21:29,024,629...29,054,488

G

ubiquitin specific peptidase 25

affects expression

Thimerosal affects the expression of USP25 mRNA

NCBI chr21:15,729,982...15,880,064
Ensembl chr21:15,729,982...15,880,064

G

ubiquitin specific peptidase 29

decreases expression

Thimerosal results in decreased expression of USP29 mRNA

NCBI chr19:57,119,087...57,131,926
Ensembl chr19:57,119,138...57,131,926

G

ubiquitin specific peptidase 34

affects expression

Thimerosal affects the expression of USP34 mRNA

NCBI chr 2:61,187,463...61,471,087
Ensembl chr 2:61,187,463...61,471,087

G

ubiquitin specific peptidase 49

decreases expression

Thimerosal results in decreased expression of USP49 mRNA

NCBI chr 6:41,789,896...41,895,375
Ensembl chr 6:41,789,896...41,895,375

G

ubiquitin specific peptidase 51

decreases expression

Thimerosal results in decreased expression of USP51 mRNA

NCBI chr X:55,484,616...55,489,848
Ensembl chr X:55,484,616...55,489,848

G

VANGL planar cell polarity protein 1

decreases expression

Thimerosal results in decreased expression of VANGL1 mRNA

NCBI chr 1:115,641,970...115,698,221
Ensembl chr 1:115,641,970...115,698,224

G

VAMP associated protein B and C

decreases expression

Thimerosal results in decreased expression of VAPB mRNA

NCBI chr20:58,389,229...58,451,101
Ensembl chr20:58,389,229...58,451,101

G

vasodilator stimulated phosphoprotein

decreases expression

Thimerosal results in decreased expression of VASP mRNA

NCBI chr19:45,507,479...45,526,983
Ensembl chr19:45,506,579...45,526,989

G

vesicle amine transport 1

decreases expression

Thimerosal results in decreased expression of VAT1 mRNA

NCBI chr17:43,014,607...43,022,385
Ensembl chr17:43,014,607...43,025,123

G

valosin containing protein

decreases expression

Thimerosal results in decreased expression of VCP mRNA

NCBI chr 9:35,056,064...35,072,625
Ensembl chr 9:35,053,928...35,072,668

G

vascular endothelial growth factor A

decreases expression

Thimerosal results in decreased expression of VEGFA mRNA

NCBI chr 6:43,770,211...43,786,487
Ensembl chr 6:43,770,184...43,786,487

G

vascular endothelial growth factor B

decreases expression

Thimerosal results in decreased expression of VEGFB mRNA

NCBI chr11:64,234,584...64,239,264
Ensembl chr11:64,234,584...64,239,264

G

VPS37B subunit of ESCRT-I

decreases expression

Thimerosal results in decreased expression of VPS37B mRNA

NCBI chr12:122,865,330...122,896,124
Ensembl chr12:122,865,330...122,896,127

G

VPS53 subunit of GARP complex

decreases expression

Thimerosal results in decreased expression of VPS53 mRNA

NCBI chr17:508,668...714,839
Ensembl chr17:508,503...721,717

G

V-set and immunoglobulin domain containing 10 like

decreases expression

Thimerosal results in decreased expression of VSIG10L mRNA

NCBI chr19:51,331,541...51,342,139
Ensembl chr19:51,331,536...51,342,139

G

WAPL cohesin release factor

decreases expression

Thimerosal results in decreased expression of WAPL mRNA

NCBI chr10:86,435,256...86,521,792
Ensembl chr10:86,435,256...86,521,792

G

WASP family member 2

decreases expression

Thimerosal results in decreased expression of WASF2 mRNA

NCBI chr 1:27,404,230...27,490,167
Ensembl chr 1:27,404,230...27,490,167

G

WASP like actin nucleation promoting factor

decreases expression

Thimerosal results in decreased expression of WASL mRNA

NCBI chr 7:123,681,943...123,749,003
Ensembl chr 7:123,681,943...123,749,003

G

WD repeat and FYVE domain containing 3

increases expression

Thimerosal results in increased expression of WDFY3 mRNA

NCBI chr 4:84,669,597...84,966,690
Ensembl chr 4:84,668,765...84,966,690

G

WD repeat domain 49

increases expression

Thimerosal results in increased expression of WDR49 mRNA

NCBI chr 3:167,478,684...167,657,923
Ensembl chr 3:167,478,684...167,653,983

G

WD repeat domain 54

decreases expression

Thimerosal results in decreased expression of WDR54 mRNA

NCBI chr 2:74,421,730...74,425,755
Ensembl chr 2:74,421,678...74,425,755

G

WD repeat domain 59

decreases expression

Thimerosal results in decreased expression of WDR59 mRNA

NCBI chr16:74,871,362...74,985,123
Ensembl chr16:74,871,362...75,000,173

G

WD repeat domain 86

decreases expression

Thimerosal results in decreased expression of WDR86 mRNA

NCBI chr 7:151,368,955...151,410,712
Ensembl chr 7:151,375,909...151,410,727

G

WAS/WASL interacting protein family member 3

decreases expression

Thimerosal results in decreased expression of WIPF3 mRNA

NCBI chr 7:29,806,508...29,917,061
Ensembl chr 7:29,806,486...29,917,061

G

WNK lysine deficient protein kinase 1

decreases expression

Thimerosal results in decreased expression of WNK1 mRNA

NCBI chr12:752,579...911,452
Ensembl chr12:752,579...911,452

G

Wnt family member 3

decreases expression

Thimerosal results in decreased expression of WNT3 mRNA

NCBI chr17:46,762,506...46,818,692
Ensembl chr17:46,762,506...46,833,154

G

X-linked inhibitor of apoptosis

affects expression
decreases expression
multiple interactions

Thimerosal affects the expression of XIAP protein
Thimerosal results in decreased expression of XIAP protein
Glutathione inhibits the reaction [Thimerosal results in decreased expression of XIAP protein]

PMID:12140745 PMID:16649253

NCBI chr X:123,859,708...123,913,972
Ensembl chr X:123,859,712...123,913,972

G

zinc finger CCCH-type containing 12C

increases expression

Thimerosal results in increased expression of ZC3H12C mRNA

NCBI chr11:110,093,392...110,171,841
Ensembl chr11:110,093,392...110,171,841

G

zinc finger protein 382

decreases expression

Thimerosal results in decreased expression of ZFP382 mRNA

NCBI chr19:36,605,313...36,634,114
Ensembl chr19:36,604,817...36,634,114

G

zinc finger protein 655

increases expression

Thimerosal results in increased expression of ZFP655 mRNA

NCBI chr 7:99,558,642...99,576,453
Ensembl chr 7:99,558,406...99,576,453

G

zinc finger protein 878

decreases expression

Thimerosal results in decreased expression of ZFP958 mRNA

NCBI chr19:12,043,602...12,052,961
Ensembl chr19:12,043,805...12,052,961

Term paths to the root

Path 1
Term	Annotations
CHEBI ontology	26041
chemical entity	26020
molecular entity	25998
ion	18773
anion	17957
organic anion	3769
carboxylic acid anion	2558
aromatic carboxylate	1341
5,5'-dehydrodivanillate(2-)	0
5,6,6'-trihydroxy-5'-methoxy[biphenyl]-3,3'-dicarboxylate	0
6-hydroxyphenazine-1-carboxylate	0
7-carboxymellein(1-)	0
8-carboxy-8-demethylriboflavin 5'-phosphate(4-)	0
Diazo-2,tetrapotassium salt	0
benzoates +	1341
ribavirin carboxylate	0
Path 2
Term	Annotations
CHEBI ontology	26041
subatomic particle	26016
composite particle	26016
hadron	26016
baryon	26016
nucleon	26016
atomic nucleus	26016
atom	26016
main group element atom	25841
p-block element atom	25841
carbon group element atom	25441
carbon atom	25399
organic molecular entity	25399
organic ion	10241
organic anion	3769
carboxylic acid anion	2558
aromatic carboxylate	1341
5,5'-dehydrodivanillate(2-)	0
5,6,6'-trihydroxy-5'-methoxy[biphenyl]-3,3'-dicarboxylate	0
6-hydroxyphenazine-1-carboxylate	0
7-carboxymellein(1-)	0
8-carboxy-8-demethylriboflavin 5'-phosphate(4-)	0
Diazo-2,tetrapotassium salt	0
benzoates +	1341
ribavirin carboxylate	0

paths to the root